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Abstract
This work investigated the effects of ageing on the cutaneous response to the 
injection of bacterial, fungal and viral antigens in humans. Previous studies 
have shown reduced cutaneous delayed type hypersensitivity (DTH) 
responses in the old and it has been assumed that this is due to an overall 
decline in cell- mediated immunity that occurs with ageing. However, it has 
remained unclear as to whether DTH responses in old skin are truly reflective 
of immune responses in all compartments of the immune system. Reduced 
clinical responsiveness in the skin to the intradermal injection of antigen was 
identified despite good peripheral T cell responses in the old and it was 
hypothesised that this may be reflective of a skin-specific defect that occurs 
during ageing. Possible mechanisms for this were investigated by performing 
both skin suction blisters and skin biopsies following injection of antigen into 
the skin. In the old there was a significant reduction in the infiltration of CD4+ 
lymphocytes in the skin that correlated with a reduced clinical response. A 
reduction in CXCR3 expression was found on CLA-i-CD4-i- T cells isolated 
from the peripheral blood in old subjects. In addition, a reduction in the levels 
of cutaneous pro- inflammatory mediators was identified. This was associated 
with reduced CD4+ T cell activation and proliferation in situ as determined by 
CD69 and Ki67 expression on lymphocytes isolated directly ex vivo from the 
skin. A defect in initiation of the DTH response was considered. Although a 
possible decrease in the numbers of CD14+ monocytes was identified, no 
difference in monocyte activation or the numbers of CD1a or DC-SIGN 
positive dendritic cells was found in the old. The data suggests that both 
decreased cell migration in to the skin in addition to decreased expansion of 
infiltrating cells contributes to the defective cutaneous response to antigenic 
challenge during ageing.
Contents
Acknowledgements..................................................................................................3
Dedication................................................................................................................. 4
Abstract......................................................................................................................5
Contents................................................................................................................... 6
List of Figures.........................................................................................................11
List of tables............................................................................................................15
List of photo plates.................................................................................................15
Abbreviations..........................................................................................................16
Publications, presentations and prize list............................................................ 19
1. Introduction.......................................................................................................25
1.1 The skin and the immune system.............................................................. 25
1.2 T cell mediated immune responses...........................................................26
1.2.1 Primary immune responses................................................................ 26
1.2.2 Memory I  cell responses.................................................................... 28
1.2.3. Memory T cell phenotype.................................................................. 28
1.2.4 Delayed type hypersensitivity responses and the skin......................30
1.2.5 Initiation of secondary immune responses in the skin..................... 31
1.2.6 T cell proliferation and clonal expansion during a memory recall 
response..........................................................................................................33
1.3 Innate Immunity............................................................................................34
1.3.1 Innate immunity and the skin.............................................................. 34
1.4 Chemokines and cytokines........................................................................35
1.4.1 The role of cytokines and chemokines in immune responses in the 
skin...................................................................................................................36
1.4.2 Skin related chemokine receptors and their role in lymphocyte 
homing into the skin....................................................................................... 39
1.5 The effects of ageing on immunity............................................................41
1.5.1 The impact of ageing on health......................................................... 41
1.5.2 Effects of ageing on T lymphocytes..........................................43
1.5.3 Effects of ageing on innate immunity.................................................47
1.5.4 Effects of ageing on skin structure..................................................... 49
1.5.5 Effects of ageing on cutaneous vasculature.....................................50
1.6 Models used to study immune responses in the skin............................. 52
1.6.1 Differences between human and murine models............................. 52
1.7 Aims and objectives....................................................................................54
2. Materials and Methods.................................................................................... 56
2.1 Volunteer recruitment..................................................................................56
2.2 Skin testing...................................................................................................56
2.2.1 Mantoux tests.......................................................................................56
2.2.2 Candida skin testing............................................................................ 57
2.2.3 Varicella zoster virus (VZV) skin testing........................................... 57
2.2.4 Assessment of skin test responses.................................................... 57
2.3 Skin sampling.............................................................................................. 59
2.3.1 Suction blisters.....................................................................................59
2.3.2 Skin biopsy........................................................................................... 64
2.4 Blood samples............................................................................................. 64
2.4.1 PBMC isolation.....................................................................................65
2.5 Flow cytometry............................................................................................ 65
2.5.1 Surface staining by direct immunofluorescence.............................. 67
2.5.2 Intracellular staining............................................................................. 67
2.5.3 Detection of antigen specific cells...................................................... 68
2.5.4 Enumeration of T lymphocytes...........................................................69
2.6 In vitro cell culture....................................................................................... 70
2.6.1 Measurement of cellular proliferation by pH] thymidine incorporation 
.........................................................................................................................70
2.7 Cytokine/ chemokine assays..................................................................... 71
2.7.1 Multiple cytokine assay by cytometric bead array (BD^*  ^Cytometric 
Bead Array (CBA) Cell Signalling Flex Set System)................................. 71
2.7.2 Multiplex bead immunoassay (Luminex technique).........................72
2.7.3 Transwell chemotaxis assays............................................................. 72
2.8 Immunohistology......................................................................................... 74
2.8.1 Indirect Immunoperoxidase technique...............................................74
2.8.2 Control slides........................................................................................ 76
2.8.3 Biotin/streptavidin/horseradish peroxidase technique......................76
2.8.4 Quantification of Immunohistochemistry........................................... 77
2.9 Statistics................................................................................................. 78
7
3. Cutaneous and peripheral blood responses to antigen in the young and old. 
................................................................................................................................. 79
3.1 Introduction..................................................................................................79
3.2 The Mantoux test......................................................................................... 80
3.2.1 Clinical responses to the Mantoux tes t..............................................80
3.2.2 Peripheral blood responses to the Mantoux test.............................. 81
3.2.3 Correlation of clinical score with peripheral blood responses.........82
3.3 Candida skin testing....................................................................................85
3.3.1 Clinical and peripheral blood responses to Candida antigen..........85
3.3.2 Clinical response to Candida antigen................................................85
3.3.3 Peripheral blood response to Candida antigen and correlation with 
clinical response............................................................................................ 87
3.4 Varicella zoster virus (VZV) skin testing................................................... 89
3.4.1 Clinical and peripheral blood responses to the Varicella Zoster Virus 
(VZV)............................................................................................................... 89
3.5 Effects of cytomegalovirus (CMV) infection on immune responses 93
3.6 Discussion................................................................................................... 97
4. Characterising the lymphocytic response to antigen in the old.................. 100
4.1 Introduction................................................................................................100
4.2 Number of T lymphocytes at site of response in sk in ........................... 102
4.2.1 Cell numbers retrieved from skin suction blisters following the MT 
using the Trucount technique......................................................................102
4.2.2 Cell numbers counted from skin biopsies following Candin skin test 
(CD3+, CD4+, CD8+ cells)......................................................................... 103
4.2.3 Numbers of CD3+ and CD4+ cells................................................... 104
4.2.4 Numbers of CD8+ cells...................................................................... 109
4.3 Number of perivascular infiltrates seen during course of response to 
Candin in the young and old............................................................................111
4.4 Activation of lymphocytes (CD69 expression) isolated from site of MT 
response............................................................................................................113
4.5 Ki67 expression in the skin....................................................................... 115
4.5.1 Proliferation of lymphocytes isolated from skin suction blisters at the 
site of the Mantoux Test (Ki67 expression)............................................... 115
4.5.2 Proliferation of cells identified in skin biopsies at site of Candin skin
test (Ki67 expression)..................................................................................119
4.6. Antigenic specificity of cells present at site of response in skin 123
4.6.1 Antigenic specificity of skin suction blister T lymphocytes isolated at 
the site of the MT in young and old............................................................ 124
4.6.2 Antigenic specificity of skin suction blister T lymphocytes isolated at 
the site of Candin skin test in young and old............................................ 128
4.7 Discussion................................................................................................ 131
5. Skin homing receptor expression on peripheral blood lymphocytes and the 
production of cytokines and chemokines at the site of antigenic challenge. 137
5.1 Introduction................................................................................................137
5.2 Adhesion molecule expression on circulating T ce lls ........................... 138
5.2.1 Cutaneous lymphocyte antigen expression on T lymphocytes in 
peripheral blood............................................................................................138
5.2.2 CD1 la  (LFA-1) expression on peripheral blood T lymphocytes. 144
5.3.1 CCR4 expression................................................................................146
5.3.2. CCL17 and CCL27 concentrations............................................... 147
5.4 CXCR3 and IP-10 expression................................................................. 150
5.4.1 CXCR3 expression............................................................................ 150
5.4.2 IP-10 concentrations.......................................................................... 150
5.5 Transwell migration assays: migration of CLA-k CD4+ T lymphocytes 153
5.6 CCR8 and CCL1 (1-309) expression....................................................... 158
5.6.1 CCR8 expression on peripheral blood lymphocytes......................158
5.6.2 CCL1 concentrations......................................................................... 161
5.7 Pro-inflammatory cytokine production within the skin at the site of the 
DTH response.................................................................................................. 161
5.7.1 Tumor necrosis factor (TNF) levels................................................162
5.7.2 Interferon gamma (IFN-y) levels..................................................... 163
5.7.3 IL-6 levels......................................................................................... 165
5.8 Immunosuppressive cytokines: IL-10 levels..........................................166
5.9 Chemokines involved in amplification of the immune response:
RANTES, MCP-1, MIP- la , IL-8.....................................................................167
6. Innate immunity and initiation of the immune response in the skin- the 
effects of ageing on macrophages and dendritic cells.....................................178
6.1 Introduction................................................................................................ 178
6.2 Proportions of cell types present at early time points in young and old. 
 180
6.3 Monocyte and macrophage cell numbers within the skin ....................181
6.3.1 Numbers of CD14+ cells in young and old skin biopsies following 
Candin injection............................................................................................ 181
6.3.2 Numbers of CD684- cells....................................................................184
6.4 Activation of CD14-h monocytes at the site of the immune response . 188
6.4.1 Expression of HLA DR, CD40, CD80, CD86 on G DI4+ monocytes 
 188
6.4.2 Expression of the inhibitory receptor ILT3................................... 192
6.4.3 Expression of the mannose binding lectin protein receptor CD206 
.......................................................................................................................193
6.5 Dendritic cells.............................................................................................194
6.5.1 GDI a expression................................................................................194
6.5.2 HLA-DR expression........................................................................... 198
6.5.3 Dermal dendritic cells: DG-SIGN expression............................... 200
6.6 Discussion..................................................................................................203
7. Summary and future directions......................................................................209
8. References......................................................................................................223
10
List of Figures
FIGURE 2.1 The clinical DTH response in the skin and skin sampling.......... 61
FIGURE 2.2 Skin suction blister induction........................................................ 62
FIGURE 3.1 Clinical response to the Mantoux test in the young and old. .. 81
FIGURE 3.2 PBMC proliferation in response to PRO antigen (10/yg/ml)..........
in the young and old............................................................................... 82
FIGURE 3.3 Correlation of the clinical score following the Mantoux test with
PBMC proliferation................................................................................... 83
FIGURE 3.4 Clinical response to the injection of Candin skin test solution in
the young and old.....................................................................................86
FIGURE 3.5 Proliferation of PBMCs in response to Candida antigen and 
correlation with the clinical response to the Candin skin test in the
young and old........................................................................................... 88
FIGURE 3.6 Proliferation of PBMCs in response to VZV antigen and
correlation with the clinical response to the VZV skin test in the young
and old....................................................................................................... 91
FIGURE 3.7 Effect of CMV infection on the clinical response to Candin and
VZV skin test responses in the old.........................................................95
FIGURE 3.8 PBMC- derived CD4+ T lymphocyte intracellular IFN-y
expression following culture with CMV antigen.....................................96
FIGURE 4.1 Numbers of CD3+ and CD4+ lymphocytes in young and old
blisters at the site of the MT.................................................................. 102
FIGURE 4.2 Numbers of CD3+, CD4+ and CD8+ in normal skin in young and
old............................................................................................................ 104
FIGURE 4.3 Numbers of CD3+ and CD4+ perivascular cells in skin biopsies
from young and old individuals after Candin skin testing.................. 108
FIGURE 4.4 Numbers of CD8+ perivascular cells in skin biopsies taken from
young and old individuals after Candin skin testing........................... 110
FIGURE 4.5 Numbers of perivascular infiltrates in skin biopsies from young
and old individuals..................................................................................112
FIGURE 4.6 T lymphocyte intracellular Ki67 and CD69 expression in skin 
suction blister cells and PBMCs collected at day 7 after the Mantoux 
test following culture with PPD antigen................................................114
11
FIGURE 4.7 Percentage of CD4+CD69+ T lymphocytes in the old compared 
with the young at the site of the MT and in peripheral blood at
Day 7 ....................................................................................................... 115
FIGURE 4.8 Percentage CD4+ Ki67+ lymphocytes in peripheral blood and SB 
at Day 7 after the MT and injection of the Mantoux control
solution.....................................................................................................118
FIGURE 4.9 Numbers of Ki67 cells in perivascular infiltrates in young
compared with old at Day 7 ...................................................................122
FIGURE 4.10 The kinetics of PPD-specific T cell infiltration in the skin
following the MT in young and old........................................................ 126
FIGURE 4.11 T lymphocyte intracellular IFN- y expression in day 7 Mantoux
test blister cells in young, old and control samples............................ 127
FIGURE 4.12 Kinetics of candida-specific T cell infiltration in the skin following
Candin skin testing in young and old................................................... 129
FIGURE 4.13 T lymphocyte intracellular IFN- y expression in day 3, 7 and 15
Candin skin test blister cells in young individuals............................... 130
FIGURE 5.1 Expression of CLA on T lymphocytes in young and old: CD3 and 
CD4+ subsets, CD4+CD45RO subsets and CD4+ antigen specific
cells...........................................................................................................141
FIGURE 5.2 CLA expression on the CD4+CD45Ro+ T lymphocyte
population................................................................................................ 142
FIGURE 5.3 T cell intracellular IFN- y expression in CLA+ CD4+
lymphocytes.............................................................................................143
FIGURE 5.4 Expression of CD1 la  on CLA+ and CLA- CD4+ T lymphocytes in
the young and old................................................................................... 144
FIGURE 5.5 CD1 la  expression on CD4+CLA+ and CD4+CLA- T
lymphocytes.............................................................................................145
FIGURE 5.6 Expression of CCR4 on CLA+ and CLA- CD4+ T lymphocytes in
the young and old....................................................................................147
FIGURE 5.7 Concentrations of CCL27 and CCL17 in blister fluid................148
FIGURE 5.8 CCR4+ expression on CLA+ and CLA- CD4+ T
lymphocytes............................................................................................. 149
FIGURE 5.9 CXCR3 expression on CLA+ and CLA- CD4+ T
lymphocytes............................................................................................. 151
12
FIGURE 5.10 Expression of CXCR3 on CLA+ CD4+ T cells in young and old 
and levels of IP-10 in blister fluid at day 3 following Candin or saline
injection.................................................................................................... 152
FIGURE 5.11 CXCR4 expression on CLA+ and CLA- CD4+ T
lymphocytes..............................................................................................155
FIGURE 5.12 Expression of CXCR4 on CLA+ CD4+ T cells in young and old 
and levels of SDF in blister fluid at Day 3 following the Candin skin
test............................................................................................................. 156
FIGURE 5.13 Transwell migration assays: Total CD4+ and CLA+CD4+ T cell
migration in response to IP 10 and SDF............................................... 157
FIGURE 5.14 CCR8+ expression on CLA+ and CLA- CD4+ T
lymphocytes.............................................................................................. 159
FIGURE 5.15 Expression of CCR8 on CLA+ CD4+ T cells in young and old
and levels of CCL1 in blister fluid...........................................................160
FIGURE 5.16 Concentrations of TNF in blister fluid from blisters induced at
day 3 following Candin and saline injection.......................................... 163
FIGURE 5.17 Concentrations of IFN-a in blister fluid from blisters induced at
day 3 following Candin and saline injection.......................................... 164
FIGURE 5.18 Concentrations of IL-6 in blister fluid from blisters induced at
day 3 following Candin and saline injection..........................................165
FIGURE 5.19 Concentrations of IL-10 in blister fluid from blisters induced at
day 3 following Candin and saline injection.......................................... 166
FIGURE 5.20 Concentrations of MCP-1, MIP-1 a, RANTES, IL-8 in blister fluid 
from blisters induced at day 3 following Candin and saline
injection.................................................................................................... 168
FIGURE 6.1 Percentages of lymphocytes, monocytes and neutrophils present
in the SB cell population in young and old........................................... 181
FIGURE 6.2 Numbers of interstitial and perivascular CD14+ cells in young 
and old skin biopsies following injection of Candin skin test
solution......................................................................................................183
FIGURE 6.3 Numbers of interstitial and perivascular CD68+ cells in young 
and old skin biopsies following injection of Candin skin test 
solution......................................................................................................185
13
FIGURE 6.4 Expression of surface markers on CD14+ monocytes isolated 
from peripheral blood (PBMCs) and skin suction blisters induced
following Candin injection......................................................................189
FIGURE 6.5 Expression of surface markers on CD14+ monocytes isolated 
from peripheral blood (PBMCs) and skin suction blisters induced
following Candin injection (flow cytometry)......................................... 190
FIGURE 6.6 Expression of ILT3 receptor in CD14+ monocytes on skin suction
blisters and PBMCs at 24 hours after injection of Candin................ 192
FIGURE 6.7 Expression of CD206 receptor in CD14+ monocytes on skin 
suction blisters and PBMCs at 24 hours after injection of
Candin..................................................................................................... 193
FIGURE 7.1 Mechanisms for reduced cutaneous immunity in the
old............................................................................................................213
14
List of tables
TABLE 1.1 Cells of the Adaptive and innate Immune system.......................25
TABLE 1.2 Chemokines and the skin............................................................... 38
TABLE 1.3 Immune risk phenotype.................................................................. 42
TABLE 2.1 Exclusion criteria.............................................................................56
TABLE 2.2 Assessment of skin test responses.............................................. 58
TABLE 2.3 Antibodies used for flow cytometry................................................66
TABLE 2.4 Antibodies used for immunohistochemistry..................................74
List of photo plates
PHOTO PLATE 1. Infiltration of CD4, CD3 and CD8+ cells at the site of
antigen injection in the young.......................................... 106
PHOTO PLATE 2. Ki67+ cells in the skin following Candin skin testing.... 120
PHOTO PLATE 3. Skin biopsies stained for CD14+ and CD68+ cells 186
PHOTO PLATE 4. CDIa staining in young and old skin biopsies...............196
PHOTO PLATE 5 HLA-DR staining in young and old skin biopsies following
Candin skin testing...........................................................199
PHOTO PLATE 6. DC-SIGN staining in skin biopsies..................................201
15
Abbreviations
APC Antigen presenting cell
APC Allophycocyanin
BCG Bacillus of Calmette and Guerin
BSA Bovine serum albumin
CCL CC chemokine ligand
CCR CC chemokine receptor
CD Cluster of differentiation
CLA Cutaneous lymphocyte antigen
CMV Cytomegalovirus
CNS Central nervous system
Con A Concanavalin A
Cpm Counts per minute
CTACK Cutaneous T cell-attracting chemokine
Cy5 Cyanin 5
DC Dendritic cell
DDC Dermal dendritic cell
DMEC Dermal microvascular endothelial cell
DTH Delayed type hypersensitivity
DKC Dyskeratosis congenita
EBV Epstein Barr Virus
El Erythema-index
E-selectin Endothelial cell selectin
FCS Foetal calf serum
FITC Fluorescein isothiocyanate
FSC Forward scatter
GM-CSF Granulocyte monocyte-colony stimulating factor
ICAM Intercellular adhesion molecule
IFN Interferon
«g Immunoglobulin
IL Interleukin
ILT3 Immunoglobulin like transcript 3
16
IP-10
l-TAC
JAK
HLA
KC
LC
LFA
LPS
MDC
MFI
MHC
Mig
MIP
MT
mRNA
NFAT
PAMPs
PBMC
PBS
PBSA
PDG
PE
PECy5.5
PerOP
PHA
PKC
PPD
P-selectin
PRRs
RBC
RPMI
SB
SO
Interferon gamma inducible protein 10
Interferon T cell alpha chemoattractant
Janus kinase
Human leukocyte antigen
Keratinocyte
Langerhans cell
Leucocyte function-associated antigen 
Lipopolysaccharide 
Macrophage derived chemokine 
Mean fluorescent intensity 
Major histocompatibility complex 
Monokine induced by interferon gamma 
Macrophage-inflammatory protein 
Mantoux test
Messenger ribonucleic acid
Nuclear factor of activated I  cells
Pathogen associated molecular patterns
Peripheral blood mononuclear cells
Phosphate buffered saline
Phosphate buffered saline with bovine serum
albumin and sodium azide
Plasmacytoid dendritic cell
Phycoerythrin
Phycoerythrin-cyanin 5.5
Peridinin chlorophyll protein
Phytohemagglutinin
Protein kinase 0
Tuberculin purified protein derivative 
Platelet selectin 
Pattem recognition receptors 
Red blood cell
Roselyn Park Memorial Institute 
Skin suction blister 
Standard deviation
17
SDF Stromal cell-derived factor
SEB Staphylococcal enterotoxin B
SEM Standard error of the mean
SLC Secondary lymphoid chemokine
SSC Side scatter
SCID Severe combined immune deficiency
STAT Signal tranducers and activators of
transcription 
Tcm Central memory T cell
Tem Effector memory T cell
Th T helper cell
Treg Regulatory T cells
TARO Thymus- and activation regulated chemokine
TB Tuberculosis
TOR T cell receptor
TGF Transforming growth factor
TLR Toll-like receptor
TNF Tumour necrosis factor
VCAM Vascular cell adhesion molecule
VEGF Vascular endothelial cell growth factor
VLA Very late antigen
VZV Varicella voster virus
WBC White blood cell
18
Publications, presentations and prize 
list
PUBLICATIONS
Vukmanovic-Stejic M, 
Reed JR, Lacy KE,
Mantoux Test as a model for secondary immune 
responses in humans.
Rustin MHA, Akbar AN Immunol Lett. 2006; 107 (2),93-101
Fletcher JM, 
Vukmanovic-Stejic M, 
Dunne PJ, Birch KE, 
Cook JE, Jackson SE, 
Salmon M, Rustin MH, 
Akbar AN
Cytomegalovirus- specific CD4+ I  cells in healthy 
carriers are continuously driven to replicative 
exhaustion. J Immunol. 2005; 175(12):8218-25
Birch KE,
Vukmanovic- Stejic M, 
Reed JR, Rustin MHA 
Akbar AN.
The immunomodulatory effects of regulatory T 
cells: implications for immune regulation in the 
skin. Br J Dermatol. 2005;152(3):409-17
Birch KE,
Vukmanovic-Stejic M, 
Reed JR, Rustin MHA, 
Akbar AN
The role of regulatory T cells in cutaneous 
disorders. In Regulatory T cells in Inflammation 
Progress in Inflammation Research). Eds. 
Akbar AN, Taams L, Wauber MHM.
Pub. Birkhauser 2004: 205-219
19
Reed JR,
Vukmanovic-Stejic, 
Soares M, Cook J, 
Fletcher J, Orteu OH, 
Jackson S, Birch K, 
Foster G, Salmon M, 
Beverley P, Rustin M, 
Akbar A
Telomere erosion in Memory T cells induced by 
telomerase inhibition at the site of antigenic challenge 
challenge in vivo.
J Exp Med 2004;199(10);1433-43
ABSTRACTS:
Lacy K, Vukmanovic- 
Stejic M , Agius E 
Rustin MH, Akbar AN.
Decreased T cell recruitment and expansion after 
cutaneous antigenic challenge of old individuals. 
J Invest Dermatol. 2007;127:S121 (722)
Lacy K, Agius E 
Vukamanovic-Stejic M,
Induction of FOXP3 expression in CD4+ T cells 
during a secondary immune response in vivo. 
Banham AH,Rustin MH, J Invest Dermatol. 2007; 127: S114 (684) 
Akbar AN.
Lacy K, Vukmanovic- 
Stejic M , Reed JR 
Rustin MH, Akbar AN.
Cutaneous immunity does not predict systemic 
immunity in old individuals.
J Invest Dermatol. 2006; 126:111
20
Birch K,
Vukmanovic- Stejic M, 
Reed J, Rustin MH, 
Akbar A
Effects of ageing on the Cutaneous Delayed Type 
Hypersensitivity Reaction to Tuberculin Purified 
Protein Derivative
J Invest Dermatol. 2004; 123(2)iv- A77.
Birch K,
Vukanovic- Stejic M, 
McQuaid A, Akbar A, 
Rustin M
Regulatory T cells and the skin.
Br J Dermatol 2004. 151 (Supp. 68): 40
21
PRESENTATIONS
Local/ Regional Oral Presentations:
Jun 2005 Postgraduate Colloquium. Division of Immunology and 
Molecular Pathology, University College London.
Dissociation between cutaneous and systemic immunity with 
ageing.
Lacy KE, Reed JR, Vukmanovic-Stejic M, Rustin MHA,
Akbar AN.
National Oral Presentations:
Jul 2006 British Association of Dermatology annual conference (Senior 
Skin group meeting):
The effects of ageing on cutaneous immunity.
Lacy KE, Reed JR, Vukmanovic-Stejic M, Rustin MHA,
Akbar AN.
May 2006 THESIS (The Skin Investigation Society) meeting:
Dissociation between cutaneous and systemic immunity with 
ageing.
Lacy KE, Reed JR, Vukmanovic-Stejic M, Rustin MHA,
Akbar AN.
Apr 2006 British Society of Investigative Dermatology:
Dissociation between cutaneous and systemic immunity with 
ageing.
Lacy KE, Reed JR, Vukmanovic-Stejic M, Rustin MHA,
Akbar AN.
Sep 2004 Birmingham University Division of Immunity and Infection.
Effects of ageing on the delayed type hypersensitivity reaction to 
PPD.
22
Lacy KE, Reed JR, Vukmanovic-Stejic M, Rustin MHA,
Akbar AN.
National Poster Presentations:
Jul 2005 British Society for Research in to Ageing:
Dissociation of cutaneous and systemic immunity in ageing.
Lacy KE, Reed JR, Vukmanovic-Stejic M, Rustin MHA,
Akbar AN.
Dec 2004 British Society of Immunology:
Changes in the delayed-type hypersensitivity reaction to purified 
protein derivative in ageing.
Lacy KE, Reed JR, Vukmanovic-Stejic M, Rustin MHA,
Akbar AN.
Jul 2004 British Association of Dermatology:
Immune regulation by regulatory T cells: implications for the
pathogenesis of dermatological diseases and their 
management.
Lacy KE, Reed JR, Vukmanovic-Stejic M, Rustin MHA,
Akbar AN.
23
International Oral Presentations:
Sep 2006 European Congress of Immunology:
Dissociation of cutaneous and systemic immunity in ageing 
Lacy KE, Reed JR, Vukmanovic-Stejic M, Rustin MHA,
Akbar AN.
May 2006 Society of Investigative Dermatology:
Cutaneous immunity does not predict systemic immunity in old 
individuals.
Lacy KE, Reed JR, Vukmanovic-Stejic M, Rustin MHA,
Akbar AN.
International Poster Presentations:
May 2007 Society of Investigative Dermatology:
Decreased T cell recruitment and expansion after cutaneous 
antigenic challenge of old individuals.
The induction of FOXP3 expression in CD4+ T cells during a 
secondary cutaneous immune response in vivo.
Lacy KE, Agius E, Vukmanovic-Stejic M, Rustin MHA,
Akbar AN.
Sep 2004 European Society of Dermatological Research
Effects of ageing on the cutaneous delayed type hypersensitivity 
reaction to tuberculin purified protein derivative
Lacy KE, Reed JR, Vukmanovic-Stejic M, Rustin MHA,
Akbar AN.
PRIZES
Quiagen 2005 Award, Divisional Postgraduate Colloquium University College London 
for oral presentation
24
1. Introduction
1.1 The skin and the immune system.
The skin is the largest organ of the body and has a critical role in acting as a 
barrier to the environment in addition to maintaining homeostasis by 
preventing water loss and regulating body temperature. As well as providing 
a mechanical barrier to pathogens, the skin has a highly specialized immune 
system in order to respond to the wide variety of antigens that it constantly 
encounters. Cells capable of both innate and adaptive immune responses are 
resident within the skin and can be recruited into the skin at sites of 
inflammation (Table 1.1), allowing for the provision of immuno-surveillance 
and protective immunity. In particular, these different cell types play an 
important role in the initiation and amplification of immune responses, with 
close interlinking between innate and adaptive pathways.
Several cell types present in the skin are organ-specific, making cutaneous 
immune responses unique. The epidermis is densely populated by antigen 
presenting cells known as Langerhans cells that are thought to play a major 
role in primary immune responses in the skin. In addition, the skin has organ- 
specific T lymphocytes, identified by certain cell surface molecules, which are 
thought to re-circulate between lymph nodes and skin. Constantly exposed to 
light, the skin also has specialized cells (melanocytes and kératinocytes) that 
are highly resistant to the DNA damaging effects of ultraviolet irradiation 
TABLE 1.1 Cells of the Adaptive and Innate Immune system
RESIDENT RECRUITED
ADAPTIVE T lymphocytes T lymphocytes
B lymphocytes
INNATE Dendritic cells
• Langerhans cells
• Dermal dendritic 
cells
Dendritic cells 
• Plasmacytoid 
dendritic cells
Kératinocytes Monocytes
Endothelial cells
• Vascular
• Lymphatic
Granulocytes
• Neutrophils
• Basophils
• Eosinophils
Mast cells Epithelioid cells
Tissue macrophages
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1.2 T cell mediated immune responses
1.2.1 Primary immune responses
Primary T cell responses are mediated by naïve T cells that, after leaving the 
thymus, circulate between the blood and secondary lymphoid organs including 
the lymph nodes, spleen and Payer’s p a t c h e s ^ Naïve T cells express high 
levels of L-selectin and CCL7, the ligands for the vascular addressins (CD34 
and GlyCAM-1) and secondary lymphoid tissue chemokine (SLC) 
respectively, which enables them to enter the lymph nodes via the high 
endothelial venules^.
Initiation of a primary immune response is thought to occur within the 
secondary lymphoid tissue following naïve T cell recognition of processed 
peptide antigen complexed to major histocompatability (MHC) molecules on 
the surface of antigen-presenting cells (APCs)'^’^ . Recognition of antigen 
results in the triggering of the T cell receptor (TCP)/ CD3 complex as well as 
CD4 or CD8 co-receptors with the formation of an immunological synapse 
between the T cell and APC. Cell triggering is also dependent on the ligation 
of additional co-stimulatory, accessory and adhesion molecules such as 
CD28, LFA-1, CD40L, 0X40 that serve to augment T cell activation and 
expansion by stabilising the immunological synapse and inducing intracellular 
signalling molecules®’ .^ Naïve T cells subsequently undergo rapid 
proliferation and differentiate into effector cells.
Following activation, some CD4+ T cells will migrate towards the B-cell follicle 
in which they are activated and provide help to B cells^°. Both CD4 and CD8 
effector T cells will also localize to the extralymphoid tissues via the efferent 
lymph vessels and thoracic duct where they will be involved in immune 
responses in the periphery. Effector T cell subsets show tropism for different 
tissues^^ such as the skin and this is thought to be determined by the 
induction of tissue-homing receptor expression following priming in addition to 
the expression of ligands for the receptor in the skin vascular bed.
The induction of tissue homing receptors specific for a certain tissue type is 
thought to depend on lymph node environment and the dendritic cells derived 
from the tissue in which antigen is encountered^^. The cutaneous lymphocyte
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antigen (CLA) is thought to identify a subgroup of effector T cells with 
preferential capacity for homing to cutaneous tissues whereas a4p7 integrin 
expressing cells home to the intestine^^. CLA is a ligand for both endothelial 
cell selectin (E-selectin) and platelet selectin (P-selectin) which are expressed 
constitutively on dermal microvessels and whose expression is up regulated 
following cutaneous inflammation^"^'^^. Studies have shown that CLA 
expression is preferentially expressed on T cells during naïve T cell activation 
in skin-draining lymph nodes, demonstrated in mice with the use of TCR 
transgenic T cell adoptive transfer models^^’ ®^. In addition, skin derived 
antigen presenting cells (APCs) are also thought to play a crucial role in that 
Langerhans cells have been shown to be more effective in generating skin- 
tropic effector cells than peripheral lymph node dendritic cells^^.
During a primary immune response the increase in the number of cells within 
inflamed non-lymphoid tissue is thought to be dependent on the recruitment 
and retention of cells derived from clonal expansion within the lymph node, 
rather than as a result of in situ proliferation^^'^°. Effector T cells attracted to 
the site of inflammation are able to directly or indirectly eliminate the foreign 
antigen by the production of various cytokines and other cytotoxic agents. 
CD8-+- T lymphocytes have direct cytotoxic activity through the secretion of 
perforins, granzymes and cytokines such as interferon gamma (IFN-y) and 
tumour necrosis factor (TNF). CD4-f- effector T lymphocytes provide help to 
enhance CD8+ T lymphocyte differentiation and activate macrophages and B 
cells. Activation of effector CD4+ cells at the site of inflammation results in 
cellular differentiation with resulting polarised patterns of cytokine production. 
IL-12 and IFN-a promote the development of Th1 polarised cells that secrete 
IFN-y and TNF whereas IL-4 promotes the generation of Th2 polarised cells 
that secrete IL-4, IL-5 and IL-10^^^^. Some CD4+ T cells secrete both types 
of effector cytokines and are known as ThO cells. In general, Th1 responses 
are thought to be protective against intracellular infections whereas Th2 
responses are effective against extracellular infections.
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Following clearance of antigen, there is subsequently a contraction phase 
where there is a dramatic reduction in the numbers of T cells. The reduction 
in the numbers of T cells present at the site is thought to involve multiple 
pathways, resulting predominantly in apoptosis^^^^, either as a result of 
activation induced cell death^'*’^  ^ or cytokine deprivation^^. A few antigen- 
specific cells survive however and become long-lived memory I  cells. The 
precise pathway by which effector T cells become memory T cells remains 
unclear although a linear model of differentiation has been proposed whereby 
a subset of effector cells escape apoptosis and revert to a quiescent group of 
memory cells^®’^ .^
1.2.2 Memory T cell responses
Memory or recall responses occur more rapidly and are more pronounced 
than primary responses^®’^ °. This may be due to an increase in the frequency 
of antigen specific memory T cells within the T cell pool compared with naïve 
cells. However, it is also thought that memory T cells have a reduced 
requirement for activation in that they respond to lower concentrations of 
antigen, use less co-stimulatory signals, need a shorter duration of antigenic 
stimulation^^ and enter in to cell cycle more rapidly following TCR 
stimulation^^. Memory T cells also express different patterns of adhesion 
molecules and chemotactic receptors, enabling them to interact with APCs 
more effectively and also to migrate in to inflamed non-lymphoid tissues. 
Memory T cells differ from naïve T cells in their tissue distribution and 
circulation pattern. They can be found in both lymphoid and non-lymphoid 
sites^ ’^ "^  and are readily activated by antigen in all tissues^^^^. Tissues such 
as the liver, lung and gut are major reservoirs of antigen experienced T cells.
1.2.3. Memory T cell phenotype
CD45, the leukocyte common antigen, is used to differentiate naïve from 
effector and memory T cells. The relative expression of the CD45 isoform can 
be used to distinguish the state of T cell differentiation^®. CD45 is a receptor 
like protein tyrosine phosphatase (RTF) and is expressed on all nucleated 
haematopoietic cells including leucocytes®®. The precise role and ligand for
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the receptor have yet to be fully determined'^° however CD45 appears to play 
an important role in T cell signal t ra n s d u c t i o n ' ^ ^ Naïve T cells express the 
CD45RA isoform, however following activation the expression of CD45RO is 
rapidly upregulated and CD45RA expression is lost over a few days'^^. All 
CD45RA+ naïve T cells also express high levels of CD45RB. CD45RO+ T 
cells can be divided in to CD45RB high and low subsets depending on 
whether they have recently been primed or have undergone numerous rounds 
of stimulation and are highly differentiated respectively'^'*. The loss of the co­
stimulatory molecules CD27 and CD28 on memory T cells can also be used to 
identify cells with a more differentiated phenotype'*^.
Recent studies have shown that human memory CD8+ T cells can re-express 
CD45RA and lose CD45RO expression in a process known as reversion'*® '*®. 
CD8+ revertant T cells, unlike naïve T cells, express low levels of L-selectin 
(CD62L) and CCR7 but high levels of LFA-1. Limited evidence also suggests 
that CD4+ T cells may also revert to CD45RA+ phenotype'*®. The precise role 
of revertant memory cells has yet to be identified but they may form a more 
stable, non-cycling memory population.
CD45RA- memory T cells can be further divided on the basis of expression of 
CD62L and CCR7®®. Central memory cells express both CD62L and CCR7 
and are located primarily in secondary lymphoid organs. Although these cells 
lack immediate effector function, they proliferate well, produce IL-2, efficiently 
stimulate dendritic cells and differentiate into CCR7- effector cells upon 
secondary stimulation. In contrast, effector memory T cells do not express 
CD62L or CCR7®*,express tissue homing receptors and can reside in both 
secondary lymphoid tissues as well as non-lymphoid tissues®^. These cells 
have been found to rapidly secrete effector cytokines IFN-y, IL-4 and IL-5 after 
restimulation®® but may not proliferate as efficiently as the central memory T 
cells. It has therefore been proposed that the effector memory subset is 
specialised for quickly entering inflamed tissues in order to provide immediate 
effector function whereas the central memory subset is responsible for a more 
sustained memory response.
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1.2.4 Delayed type hypersensitivity responses and the skin
Delayed type hypersensitivity (DTH) responses in the skin can be induced by 
either the topical application of hapten or the intradermal injection of antigen in 
to the skin and are representative of a cutaneous T cell mediated memory 
response^®"*. The delayed type hypersensitivity response to the intradermal 
injection of bacterial, viral and fungal antigens can therefore be used to 
assess individuals’ cell-mediated immune responses to particular antigens. A 
positive skin test denotes prior antigenic exposure, T cell competency and an 
intact inflammatory response.
Responsiveness to DTH skin testing is assessed by the diameter of induration 
induced in the forearm skin in humans at 48 hours or by the amount of ear or 
footpad swelling at 24 hours in mice. In humans, following the injection of 
intradermal antigen, a clinical response is seen within a few hours with white 
or rose-coloured induration of the skin. The visible response in the skin peaks 
by 48-72 hours with a localized red, indurated area of skin. Rarely, vesicles 
and petechiae may also be seen. Ulceration at the site of injection has also 
been reported. The clinical response then reduces and resolves by 10-14 
days^\
DTH responses are used clinically to detect either infection with or previous 
exposure to various pathogens including Mycobacterium tuberculosis. The 
classical model of DTH is the Mantoux test where a sterile aqueous solution of 
tuberculin purified protein derivative, a complex mixture of peptides and 
carbohydrates derived from M. tuberculosis, is injected intradermally in to the 
skin^ ®"^ . It is used widely as an experimental model in that it produces a 
reproducible clinical response in the skin in young, healthy individuals 
previously exposed to M. tuberculosis and those immunized with the Bacillus 
of Calmette and Guerin (BCG) vaccine®' ,^ prepared from live attenuated 
strains of M. bows®®. The likelihood of previous immunization versus acute 
infection is determined by the diameter of the clinical response with a 
diameter of over 15mm regarded as suspicious of current infection®®, 
warranting further investigation (NICE guidelines, March 2006).
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DTH responses against common pathogens such as Candida or vaccine 
antigens (Tetanus) can also be used clinically as a measure of overall cell 
mediated immunity. The Gandin skin test, using a sterile solution produced 
from the culture filtrate and cells of two strains of Candida albicans, has been 
licenced for the evaluation of cellular immune responses in the skin in patients 
with HIV and is reported to have prognostic value in cancer^^^^.
Histological analysis indicates that the DTH response in the skin is biphasic 
with an early non-specific infiltration of cells that occurs in all individuals and a 
second specific peak that is only seen in those who have previously been 
sensitized to the antigen^°’®V Initially, at around 4-6 hours there is an 
infiltration of neutrophils in to the skin®  ^ followed by macrophages that peak in 
numbers at around 24-48 hours®^. Around 12 hours after challenge T 
lymphocytes and dendritic cells have been shown to appear around dermal 
blood vessels®^ After 48 hours the majority of infiltrating cells are T 
lymphocytes with CD4-h lymphocytes exceeding CD84- lymphocytes at all time 
points®^’^ . Only a very small number of B lymphocytes have been observed 
at the site of DTH responses®^ The majority of cells are seen to 
accumulate perivascularly, however T cells and macrophages are also found 
within the interstitium in the upper dermis and also around adnexal structures 
such as hair follicles and sweat glands® '^® .^ Lymphocytes may also be seen 
infiltrating the epidermis®^'^.
Previous investigations have focused on the histological findings during the 
course of the clinical response up to around 96 hours however we have 
observed that while the peak clinical response occurs at 3 days, the peak of 
lymphocytic infiltration is not reached until day 7^. Thus, many studies have 
overlooked the fact that significant T cell reactivity persists beyond time points 
where a visible clinical response is seen in the skin.
1.2.5 Initiation of secondary immune responses in the skin
The pathways involved in the elicitation of a cutaneous memory immune 
response remain poorly defined. Studies have shown that large numbers of 
both CD4+ and CD8-H T lymphocytes are resident within normal skin^^’^ .^ In
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addition, the vast majority of (skin homing) CLA+ memory T cells within the 
body are thought to be located within the skin^^. Schaerli et al further 
characterised the resident skin population and found that the most T cells 
resident in the skin express CCR8 and they proposed that these cells act as 
immune surveillance cells®®.
The conventional model of DTH responses in the skin suggests that 
lymphocytic recruitment to the skin occurs following secondary lymph node T 
cell proliferation after migration of antigen presenting cells from the skin to the 
draining lymph node. Although Langerhans cells are conventionally regarded 
as the main antigen presenting cells of the skin® ,^ it is unknown whether they 
are able to take up and process antigen that has been injected intradermally. 
Their contribution to the DTH response is therefore unclear. Another 
population of dendritic cells in the dermis, known as dermal dendritic cells, 
may play an important role in DTH responses®®. Other cells within the skin 
also have antigen-presenting capability such as macrophages®® and 
kératinocytes^®^® and may play a more prominent role in antigen presentation 
following secondary immune challenge. Human dermal microvascular 
endothelial cells (DMEC) may present antigen to circulating memory cells^" ’^^ ®. 
DMEC express high levels of MHC class 1 and class 2 molecules and can 
induce human CD4-»- and CD8+ memory but not naïve T cells to proliferate 
and secrete cytokines in vitro.
It is possible that interactions between resident T cells and antigen presenting 
cells are responsible for the initiation of DTH responses in the skin without the 
need for the initial migration of dendritic cells to the lymph nodes. Although T 
cell activation has been observed in draining lymph nodes following 
secondary challenge, this occurs at a reduced rate compared with the primary 
response^®. Based on calculations of circulating volumes and cardiac output it 
has been estimated that the time taken for antigen to reach the inguinal lymph 
nodes from the toe would take around 12 hours^^, however DTH responses 
are seen as early as 4 hours. In addition, recall immune responses in humans 
occur in spite of compromised afferent lymphatics^®. All of these findings
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suggest that localised initiation of the immune response may occur within the 
skin.
The close apposition of antigen presenting cells and T cells within the skin 
during recall responses^^®° may indicate that the activation of resident 
antigen- specific T cells by antigen presenting cells within the skin is possible. 
Activation of antigen specific cells within the skin could potentially result in the 
initiation of the immune response via the secretion of acute phase pro- 
inflammatory mediators such as TNF-a and IFN-y resulting in the activation 
and recruitment of monocytes, neutrophils and memory T cells. Resident T 
cells may also be able to traffic to the lymph node where they are able to 
accelerate appropriate T and B cell responses.
One of the problems with this model however is the large diversity of antigen- 
specific cells required in order to accommodate the vast array of antigens that 
are encountered by the skin. Antigen specific cells may only be resident at 
the sites of previous antigenic challenge. This theory is supported by the 
observation that repeated allergen exposure to a site of previous allergic 
contact dermatitis in guinea pigs results in a more rapid clinical response, not 
seen at other non-exposed sites®\ In addition, in humans, IFN-gamma 
producing CD84- T cells have been found in the epidermis of fixed drug 
eruptions before and after secondary challenge®^.
1.2.6 T cell proliferation and clonal expansion during a memory recall 
response.
As with primary immune responses, expansion and then subsequent 
contraction of T cell numbers occurs during the course of the DTH response 
at the site of inflammation. Although studies in mice have demonstrated the 
persistence of memory T cells within non-lymphoid tissues that appear to 
convey protective immunity^^’^ , other studies have shown that memory T cells 
resident within non-lymphoid tissues do not proliferate upon reactivation®" ’^®^. 
Blocking chemokine or integrin mediated recruitment of T lymphocytes during 
DTH responses in mice diminishes the response®®®  ^ suggesting that
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recruitment of T cells within the circulation or resident within secondary 
lymphoid tissues is critical in mediating a recall response. In mice, therefore, 
the increase in the number of lymphocytes at the site of secondary immune 
responses is unlikely to be due to proliferation of antigen-specific cells within 
non-lymphoid tissues.
Published work from our laboratory, however, suggests that the expansion of 
PPD specific CD44- T cells during the course of the Mantoux test response in 
humans is due to the in situ proliferation of T cell clones present in the skin at 
early time points®®. This conclusion is supported by the findings that there 
was a high level of the proliferation marker Ki67 present in the skin around 
Day 7 and that there was an increase in the number of antigen specific cells 
up to day 14. However, there was no associated change in the number of 
circulating Ki67 or PPD-specific T cells in the peripheral blood that would be 
expected if the T cells were recruited to the skin following proliferation in the 
lymph node. Heteroduplex analysis also indicated that similar clones were 
present at early and late stages of the response®®.
DTH responses may therefore be mediated by several mechanisms in 
different species, some of which may become redundant under certain 
conditions, including activation of resident cells and the recruitment of memory 
T cells from the peripheral blood some of which will have been pre-activated 
in the draining lymphoid tissue.
1.3 innate Immunity
Innate immunity is an evolutionarily ancient component of host defense 
mechanisms®® and provides the first line of defense against pathogens using 
pattern recognition receptors (PRRs)®®, a group of which are known as Toll­
like receptors (TLRs)®\
1.3.1 Innate immunity and the skin
The skin is an important part of the innate immune system, forming a barrier 
to prevent the entry and colonization of pathogens. The epithelial cell 
membranes express PRRs that are capable of responding to pathogen
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associated molecular patterns (PAMPs) by secreting a variety of antibacterial 
peptides including defensins, cathelicidins and dermicidins^^’^ .^ The absence 
of defensins in the skin has been proposed as a mechanism for recurrent 
infection seen in atopic dermatitis^'*. In addition, constant shedding of the 
epithelial cells along with the secretion of sebum, lysozyme and mucins helps 
to reduce bacterial burden on the skin surface.
If the skin’s integrity is breached then macrophages have an important role to 
play in detecting danger signals via their PRRs either from PAMPs or 
endogenous signals released in damaged tissue^^'^^. Macrophages act to 
phagocytose invading organisms and are able to present antigen in the 
context of MHC. They also secrete cytokines, resulting in the recruitment and 
activation of neutrophils and natural killer cells and the induction of 
maturation, differentiation and migration of dendritic cells. This then allows for 
the development of an adaptive immune response with subsequent clearance 
of the pathogen. Professional antigen presenting cells in the skin, 
Langerhans and dermal dendritic cells, are also able to become activated at 
the site of injury or pathogen invasion through PRRs®®. Both types of 
dendritic cell are thought to serve to amplify the immune response by the 
production of pro-inflammatory cytokines but also process antigen and 
emigrate to the draining lymph node where antigen is presented to antigen- 
specific T cells.
1.4 Chemokines and cytokines
Cytokines and chemokines play a crucial role in the body’s defence against 
pathogens. In the early stages of infection a family of chemoattractant 
cytokines, known as chemokines, are secreted by a variety of cells within the 
affected tissue. They act as chemoattractants for leukocytes®® such as 
monocytes and neutrophils, in addition to functioning in lymphocyte 
development and migration. Chemokines contribute to immune response 
initiation, influencing cells involved in both innate and adaptive immune 
responses, and may also have a role in immune pathology. In addition to their 
involvement in inflammation, chemokines also have an important role to play 
in homeostasis and immune surveillance of healthy tissues. Chemokines fall
35
in to 2 main structural groups: those characterised by a CC structure with two 
cysteine residues near the amino terminus and CXC chemokines in which the 
two cysteine residues near the amino terminus are separated by another 
amino acid.
1.4.1 The role of cytokines and chemokines in immune responses in the 
skin.
Cytokines and chemokines are thought to be involved in all phases of 
inflammation in the skin. Multiple cell types in the skin, including 
kératinocytes, T and B lymphocytes, monocytes, endothelial cells, fibroblasts, 
mast cells, dendritic cells, granulocytes and platelets are known to produce 
cytokines. The initiation of the response to infection in the skin, known as the 
acute phase response, is thought to be dependent on the production of 
tumour necrosis factor (TNF), IL-6 and IFN-7^ ®^ . TNF is secreted by a variety 
of cells including monocytes and macrophages, T cells, fibroblasts and 
endothelial cells. Following stimulation by exogenous factors such as 
bacterial lipopolysaccharide, viruses and other organisms large quantities of 
TNF are released within minutes and synthesis is rapidly increased under the 
influence of IFN-y^°°.
TNF acts to increase vascular permeability and blood flow resulting in the 
observed erythema and induration at the site as well as increasing expression 
of various adhesion molecules E-selectin, Intercellular adhesion molecule 
(ICAM) and vascular cell adhesion molecule (VCAM) on the endothelium^°^ 
with resulting recruitment of lymphocytes to the site of the immune response 
and also activation and chemotaxis of neutrophils and monocytes^°^. IFN-y 
produced predominantly by activated T lymphocytes increases MHC- II 
expression on monocytes and macrophages^°^ in addition to stimulating 
further release of TNF-a by monocyte a c t i v a t i o n I L -6 is produced by 
activated monocytes and is important for T cell activation and 
differentiation^°^’ °^®.
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Following acute initiation of the immune response in the skin further cellular 
activation and recruitment is mediated by the production of a range of 
cytokines and chemokines from several resident skin cell types, as shown in 
Table 1.2. MCP-1, MIP 1-a and RANTES are classified as CC chemokines 
and are thought to have an essential role in humans in the activation and 
chemoattraction of monocytes to sites of inflammation. The CXC 
chemokines, such as IL-8 and IP-10, are thought to attract and activate 
neutrophils^®^. A mixture of both CC and CXC chemokines have been shown 
to have an affect on the induction of directional migration of human T cells and 
T cell subsets including memory effector T cells.
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TABLE 1.2 Chemokines and the skin.
Chemokine Produced by Receptors Cells
attracted
Cells
activated
CCL17
(TARO)
Endothelial
cells
CCR4 T cell
Dendritic cell 
NK cell
T cell
CCL27
(OTACK)
Kératinocytes CCR10 T cell
IP-10 Kératinocytes
Fibroblasts
CXCR3 T cell
MCP-1 Macrophages
Monocytes
Kératinocytes
Endothelial
cells
Fibroblasts
CCR2B Monocytes 
T cells 
Dendritic 
cells 
NK cells 
Basophils
Macrophages
Fibroblasts
Endothelial
cells
MIP la Monocytes 
T cells 
Fibroblasts 
Dendritic cells
CCR1, 3, 5 Monocytes
T cells
Dendritic
cells
NK cells
Basophils
Neutrophils
Mast cells 
Basophils
RANTES T cells
Endothelial
cells
Platelets
Macrophages
Kératinocytes
Fibroblasts
Dendritic cells
CCR1, 3, 5 Monocytes
T cells
Dendritic
cells
NK cells
Basophils
Eosinophils
T cells 
Basophils
IL-8 Monocytes
Macrophages
Kératinocytes
Fibroblasts
Endothelial
cells
Mast cells
CXCR1, 2 Neutrophils Neutrophils
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1.4.2 Skin related chemokine receptors and their role in lymphocyte 
homing into the skin.
A number of chemokines and their receptors are associated with the homing 
of T cells to the skin. The initial process of lymphocyte recruitment is 
dependent on the interaction between adhesion molecules expressed on the 
surface of both lymphocytes and the endothelium of the dermal 
microvasculature. This process can be broken down in to 3 main steps: 
rolling, adhesion and transmigration. Due to the sheer forces encountered 
within the blood stream, lymphocytes do not bind to resting endothelium. 
However, in inflamed skin the expression of selectins, a group of carbohydrate 
mediated adhesion proteins, on endothelium allow for transient reversible 
binding of endothelial cells with inflammatory T cells. This results in a process 
known as rolling where the inflammatory cells are slowed and are seen to 
move in a linear direction, rolling along the endothelium. In the skin, E- 
selectin is thought to be the most important selectin to be expressed on 
endothelial cells^°®, the upregulation of the expression of which is thought to 
be mediated by TNF and |FN-Y^'^°^. Memory T cells localizing to the skin 
express the cutaneous lymphocyte antigen (CLA) which functions as a ligand 
for E - s e le c t i n ^ C L A  expression on the cell surface arises from the 
specialized glycosylation of P-selectin glycoprotein ligand jg found
only on T cells that have undergone primary activation in the draining lymph 
nodes of the skin^®. While only 10-25% of T cells in the peripheral blood 
express CLA, 80-90% of cells at sites of cutaneous inflammation express this 
marker^ indicating that CLA expression plays a major role in the selective 
recruitment of skin-specific T cells in to the skin.
After selectin mediated rolling on the endothelium, lymphocytes become 
activated and firmly attach to the endothelium through the adhesion of beta 2 
integrins to LFA-1 and VLA-4 and the immunoglobulin superfamily members 
ICAM- 1, 2 and VCAM-1 that are expressed on the endothelial surface^*. 
The expression of endothelial ICAM and VCAM is upregulated in inflamed 
skin, induced by IL-V^®, I F N - Y a n d  TNF-a^^®.
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In inflamed skin, certain chemokines are bound to the endothelium and 
interact with receptors on the lymphocyte cell surface, resulting in a 
morphological change in integrin receptor affinity and avidity for their ligands, 
promoting endothelial adherence. Further lymphocyte adhesion to 
endothelium and subsequent transendothelial migration of CLA+ T cells in the 
skin is thought to be critically dependent on the interactions between the 
chemokines CCL17 (TARC) and CCL27 (CTACK) with their receptors CCR4 
and CCR10 respectively®^. CCR4 and CCR10 seem to have redundant and 
overlapping roles in mediating the recruitment of T cells in to inflamed skin. 
While CCR4 is expressed on >75% of CLA+CD4+ T lymphocytes, CCR10 is 
only expressed on around 28% of CLA+ memory T l y m p h o c y t e s ^ I n  
addition virtually all CCR10+CLA+ T lymphocytes also express CCR4^^^. 
CCL17 (the ligand for CCR4) expression is found predominantly on dermal 
vascular endothelium, whereas CCL27 (the ligand for CCR10) is produced 
mainly by kératinocytes in the epidermis®^. The expression of these ligands 
within the skin matches the location of T cells bearing the appropriate 
receptors in that CCR4+ T cells are found in the dermis^^® and CCR10+ T 
cells are found in the dermis and epidermis in inflamed skin^^®. CCR4 has an 
additional role in the initiation of immune responses as it is thought to be 
important in the mediation of dendritic cell and memory I  cell interactions via 
the ligand macrophage derived chemokine (MDC) in both the dermis and 
secondary lymphoid tissues^^°'^^\
Although it is not tissue specific, CXCR3 is thought to be an important skin 
homing receptor. Predominantly expressed on memory I  cells, CXCR3 
expression is thought to define a subset of memory I  cells homing to sites of 
Th1 inflammation including the skin, intestine and CNS^^^. The importance of 
CXCR3 in skin inflammation is highlighted by the fact that a significant subset 
of CXCR3 positive CD4+ T cells also express the skin specific receptor 
CCR4^^®. CXCR3 is the receptor for the inflammatory chemokines IFN-y 
inducible protein (IP-10), monokine induced by IFN-y (Mig) and IFN T cell a 
chemoattractant (l-TAC)^ '^^. Several skin cell types including kératinocytes, 
monocytes and fibroblasts have been shown to produce IP-10 and l-TAC,
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stimulated by IFN-y^^^. CXCR3 may have a role in pathological inflammation 
both in the skin and other organs such as the liver, with upregulation of the 
receptor on T lymphocytes at sites of chronic inflammation^^®. In inflammatory 
skin disease, it has been shown that greater than 75% of cells express 
CXCR3. In addition, the pattern of T cell infiltration in different skin diseases 
is dependent on the location of expression of ligands for CXCR3 within the 
skin
Recent work has shown that the majority of resident skin T lymphocytes are 
CCR8 positive and respond to its selective ligand CCL1 (1-309)®®. It is thought 
that CCR8/ CCL1 interactions may be crucial for immunosurveillance and 
homeostatic T cell trafficking in normal skin as CCL1 is expressed on dermal 
endothelial cells in addition to epidermal Langerhans cells in normal, 
uninflammed skin®®. The role of the CCR8/ CCL1 axis in the recruitment of 
cells during acute inflammation is currently unclear although it is of interest 
that CCR8-I- T lymphocytes have a pre-activated (CD69+) phenotype and 
have been shown to secrete the pro-inflammatory cytokines TNF-a and IFN- 
7®®, both of which are crucial for the acute phase response in memory recall 
responses in the skin. In addition, the CCL1-CCR8 axis has been implicated 
in atopic skin inflammation^^®.
1.5 The effects of ageing on immunity
1.5.1 The impact of ageing on health.
Over the last century human life expectancy has increased dramatically in 
developed countries. The number of people aged 60 years or over in the UK 
is projected to increase from 12 million (20%) of the population in 2001 to 18.6 
million (30%) in 2031^^® (National office for statistics). This is likely to place 
significant demands on the provision of healthcare as many diseases in the 
elderly are more frequent and severe. In particular, infectious diseases are 
seen more commonly in the elderly and are often associated with poor 
outcome with higher rates of morbidity and mortality^®®. The immune system 
is thought to decline with ageing although the relevance of this to the 
development of disease has not been fully characterized^®^ The concept of
41
the immune risk phenotype (Table1.3) has emerged as a result of long- term 
studies^^^'^^^ that have attempted to identify serological markers of immune 
function thought to be predictive of poor health with increased mortality and 
morbidity.
TABLE 1.3________________________________________
Immune -risk phenotype:
• CD4/CD8 ratio less than 1
• Poor T cell proliferative response
• Low levels of B cells
• Increase in terminally differentiated memory T cells
• CMV positivity
• Increased level of IL6 and TNF-a
Pyogenic bacteria are the most common cause for infection in the old causing 
urinary tract infection, pneumonia, diverticulitis, endocarditis, bacteraemia and 
skin and soft tissue infection^^®. Previous studies have shown three- fold 
increases in the prevalence of community acquired pneumonia^^^ and a 20 
times increase in urinary tract infection in the old^ ^®. The clinical presentation 
of very old patients with bacterial infection also differs from presentation in the 
young with fewer symptoms such as reduced or absent fever in around 20- 
30% of severe infections^^®. Certain viral infections are also more common, in 
particular influenza "^^®, herpes zoster reactivation (shingles)^'^^ and viral 
gastroenteritis^Unfortunately vaccinations, such as those used to protect 
against influenza virus infection, have been shown to have a reduced efficacy 
in the old^ "^ .^ It has also been proposed that infections themselves may lead 
to the development of age related diseases such as atherosclerosis^'^'*’ '^^  ^ and 
dementia^"^®’ "^^ .^ Recent work has shown that chronic infections with latent 
infections such as CMV have potentially deleterious effects on the immune 
system, resulting in so-called immunosenescence^^^.
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An increase in certain types of cancer affecting various organs is seen with 
advancing age, in particular carcinomas^'^®’ '^^ .^ In the skin, the number of 
cancers is well recognized to increase with age. The number of recorded 
non-melanoma skin cancers in the UK in 2001 was around 62,700 of which 
80% of the cases occurred in individuals aged 60 and over^^°. Autoimmunity 
has also been shown to increase with ageing^^^ with increased production of 
autoantibodies and the development of late onset diseases such as thyroid 
disease, pulmonary fibrosis and Sjogrens syndrome^^^.
1.5.2 Effects of ageing on T lymphocytes
Although there is evidence to suggest that changes in several immune cell 
types occur with ageing, certain specific observations suggest that I  cell 
memory responses are impaired with ageing. In particular, the reactivation of 
latent organisms such as VZV^^^, EBV and mycobacter iaoccu rs  more 
frequently with age. Reactivation of VZV and reduction in immunity following 
smallpox vaccination has been shown to be correlated with a decline in 
antigen- specific memory T cell number rather than reduced antibody 
levels^^^’^^® suggesting that I  but not B cells are impaired. In the skin, there 
are several studies that have shown a reduction in the DTH response, a 
classical memory T cell response, following the injection of numerous 
antigens including tuberculin purified protein derivative, tetanus toxoid, 
Candida, trichophyton and mumps in the old^^ '^^®V DTH responses to the 
topical application of various haptens have also been shown to be reduced, 
with higher doses of hapten required for the development of contact 
hypersensitisation^^^^^ .^
In early life, the thymus is thought to play an important role in the generation 
of naïve T cells, however the thymus involutes with ageing and is almost 
completely replaced by fat by the age of 6 0 ^ In spite of involution of the 
thymus, the absolute number of T lymphocytes remains relatively stable with 
age^®  ^ indicating that the population of T cells is maintained by turnover of 
pre-existing populations of cells. However, the functional quality and 
proportions of antigen-specific cells can be dramatically altered with age 
resulting in a decline in overall immune function and a potential loss of
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immune memory to certain types of infection. Old individuals have 
significantly higher numbers of T cells specific for certain types of chronic, 
persistent viruses with massive clonal expansion of cells specific for infections 
such as However, these cells have a reduced functional
capacity^^^^^^ and may result in the crowding out of T cells specific for other 
infections and a resulting loss in T cell receptor diversity^^"*.
The functional capacity of T cells is reduced with ageing. Numerous studies 
in the old have shown reduced proliferative capacity of T lymphocytes to 
various mitogens including PHA, Con A and A reduction in
proliferative capacity has also shown to be linked to mortality and morbidity in 
the populations studied^®°. T cell proliferation requires the presence of IL-2 
and IL-2 receptors both of which have consistently been shown to decline with 
ageing^®^’ ®^^. In addition, increased production of IL-10 in the old^^^’ ®^^ may 
act to suppress proliferative r e s po n se s^ IL - 10  neutralizing antibodies have 
been shown to restore proliferative responses of elderly PBMGs to responses 
equivalent to those seen in their younger counterparts^^^. Increased 
production of IL-6 has also been observed in the old and is associated with 
increased mortality^^^.
It has been proposed that there is a shift in Thi to Th2 type T cell responses 
in the old^ ®^ . Whereas Thi cells produce cytokines favouring a cell-mediated 
response, in particular IL-2 and IFN-y, Th2 cells produce IL-10, IL-4, IL-5 upon 
activation favouring humoral responses. The shift in cytokine production may 
help to explain the apparent reduction in cell-mediated responses in the old 
with increased autoimmunity due to the augmentation of B cell mediated 
antibody production. However, although consistent results have been 
observed for reduced and increased IL-10 production^^^’ ®^^ in the
old, variable reports of IFN-y and IL 4 production have been cited according to 
the model and the type of stimulation used. Studies in aged mice have shown 
reduced production of IFN-y with Con A stimulation but increased or normal 
levels following stimulation with phorbol esters^®\ In human studies using
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both healthy and frail elderly -subjects both increased and decreased 
production of IFN-y^®  ^and IL-4^®  ^have been reported.
T cells also have been shown to have alterations at a biochemical and 
molecular level with ageing. There is a decrease in transmembrane signalling 
following activation of the T cell receptor, thought to be due to a decrease in 
protein tyrosine phosphorylation and generation of second messengers, 
calcium ion mobilization and translocation of protein kinase ci82;i86-i89 
addition there is an observed reduction in the induction of transcription factors 
NFAT and NF kappa B following T cell activation which may explain the 
observed decreased expression of several cytokines. Whisler et al showed 
that the decreased expression of IL-2 by T cells correlated with impairment in 
the activation of AP-1 and NF-AT transcription factors^®^. Increased oxidative 
stress following the generation of reactive oxygen species which results in 
increased DNA damage and alteration may also affect T cell function with 
ageing^ ®®.
The proportions of highly differentiated effector memory T cells are 
significantly increased in the old in comparison to younger subjects^^^’^^ .^ 
Recent research has also focused on the accumulation of so- called revertant 
cells in the old^®\ These CD45RA+ cells are thought to accumulate in 
response to chronic infection with and EBV^® ,^ and their numbers are
significantly increased in both the CD44- and CD8-1- pools of old individuals^^\
All normal somatic cells in humans, including T lymphocytes, are able to 
divide a finite number of times and this is known as replicative senescence^ 
Telomere length can be used to identify cells at different stages of 
differentiation due to cellular division^^^’^^ ®. Telomeres are repeating 
hexameric sequences of nucleotides at the end of chromosomes that shorten 
by 50-100 base pairs per cell division due to the inability of DNA polymerase 
to fully replicate the ends of chromosomes during cell division. Telomere 
length can be restored by the enzyme telomerase^^^^°^, however shortening
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of telomere length eventually leads to chromosomal instability, end to end 
fusions and cell growth arrest or apoptosis.
Highly differentiated memory T cells have short telomere lengths, lose 
telomerase activity and have a reduced capacity to divide^°^. Their 
persistence in vivo is therefore likely to be limited. DNA derived from blood 
and skin has been shown to have overall shorter telomere lengths in the 
old^°^. Shortening of telomere length may in part be due to downregulation of 
costimulatory CD28 receptor in memory T cells as upregulation of telomerase 
is dependent not only on TCR stimulation but also transduction of 
costimulatory signals through 0028^°^. Thus chronic activation of T cells due 
to ageing, persistent viral infection or repeated exposure to antigen may result 
not only in loss of 0028 expression but also loss of telomerase activity and 
shortening of telomere length.
Telomere shortening has been demonstrated with ageing in both B and T 
lymphocytes with a loss of around 34-54 bp per yeai^®"*. There is good 
evidence to suggest that telomere erosion has a negative impact on immunity 
in addition to mortality and age related disease^°^'^°^. This is highlighted by 
the syndrome known as Dyskeratosis Congenita (DKC) where patients have 
deficient telomerase activity and an associated reduction in peripheral blood 
mononuclear cell (PBMC) telomere length compared with individuals of a 
similar age^ °®'^ °®. 83% of individuals with this disease have absent or reduced 
cutaneous DTH reactions^^° suggesting that T cell memory is 
compromised^^\ In addition, Werners Syndrome is characterised by 
premature ageing of the skin related to telomere dysfunction in 
fibroblasts^^ ’^^ ^^ .
In spite of the potential complications of telomere shortening seen in 
association with ageing T lymphocytes, down-regulation of telomerase may 
also have an important beneficial role during the course of acute inflammatory 
responses. We have previously shown marked telomere shortening of PPD 
specific cells in the skin, but not blood, during the course of a DTH response 
to PPD in young individuals®®. Telomerase activity in these cells was found to
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be inhibited by IFN-a produced within the microenvironment of the skin. 
Removal of cells from the skin allowed for reversible reactivation of 
telomerase activity, suggesting that maintenance of the memory T cell 
population may be enabled by upregulation of telomerase once cells had 
emigrated from the skin. This mechanism may be important for limiting 
uncontrolled T cell proliferation during secondary immune responses. In the 
old, inhibition of telomerase may have a beneficial effect by helping to balance 
the pro-inflammatory milieu seen with ageing, referred to by some authors as 
inflamm-ageing^^^.
1.5.3 Effects of ageing on Innate immunity
Although research in the past has focused on adaptive immune dysfunction 
with ageing, there is now increasing evidence to suggest that cells involved in 
innate immunity may also be affected by ageing^^"  ^ and that impaired innate 
immunity may predict frailty in old age^^^. Stimulation of whole blood with LPS 
in the old results in low production of pro-inflammatory cytokines, indicating 
that certain cell types involved in innate immunity may become defective with 
ageing^ ^^ .
Several changes in monocytes and macrophages have been identified with 
ageing^^®. Although the number of blood monocytes in the old and young is 
similar, there is a decline in the numbers of macrophages and their precursors 
in the bone marrow of the elderly^^^’^ ®^. Ageing human and rodent 
macrophage populations have reduced MHC-II expression^^^’^ ^^  and it has 
been suggested that this results in poor T cell responses. Defects at the level 
of TLR expression and function on macrophages have also been 
demonstrated in murine models. Renshaw et al demonstrated a reduction in 
TLR4 expression and other TLRs in mice^^^ although other more recent 
studies have been unable to replicate these findings^^^. Defects in TLR 
signaling pathways have also been demonstrated in mice including defects in 
the protein kinases mitogen activated protein kinase (MARK) p38 and c-Jun 
N-terminal kinase (JNK)^^^. Animal models have shown a reduction in 
macrophage adherence^^^, opsonisation and tumour cell killing with age^ "^ ’^^ ^^ .
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In old humans with chronic bronchitis macrophage phagocytosis is also 
reduced^^®. The decline in phagocytic capacity of macrophages is thought to 
occur in parallel with a reduction in the production of macrophage-derived 
chemokines MIP-1a, MIP-1p and MIP-2 in a model of dermal injury^^^.
The phagocytic capacity, synthesis of reactive oxygen intermediates and 
intracellular killing efficiency of neutrophils is impaired with ageing^^®. In 
addition, NK and NKT cell production of cytokines such as IFN-y and 
chemokines are reduced with age^^®. Ogata et al have demonstrated an 
association between low NK cell activity and infection with short life 
expectancy due to infection^^°.
Shifts in the production of cytokines in the elderly may alter the maturation 
and balance of DC subsets. In particular, the documented increase in IL-10 
production in old may affect the maturation of DC subsets. It has also been 
proposed that a reduction in IL-12 production may have an impact on DC 
antigen presenting function in frail elderly^^\ There is conflicting evidence 
regarding the function of antigen presenting cells with ageing^^^. Whilst some 
studies have shown a reduction in the ability of APCs from frail elderly to 
induce T cell proliferation, other studies have shown that DCs from the old do 
not have impaired capacity to induce T cell responses^^^’^ "^^ . Castle et al found 
that APCs isolated from the peripheral blood of healthy old individuals had an 
enhanced ability to stimulate T cells from young individuals compared with 
APCs isolated from the young^^^. These differences may be due to selection 
of either healthy or old individuals, in addition to the subtype of APC used for 
the in vitro stimulation assay used.
To date, research on the effects of ageing on professional antigen presenting 
cells in the skin has focused almost exclusively on the Langerhans cell 
population. It is well recognized that the number of Langerhans cells in 
photoaged skin is reduced^^®. The clinical improvement in inflammatory skin 
diseases such as psoriasis following ultraviolet light exposure is thought, in 
part, to be related to depletion in the Langerhans cell population^^^. Change
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in the number of Langerhans cells within sun-protected skin, however, 
remains controversial with some studies reporting a decrease in cell numbers 
238;239ap,(j others reporting no change with age^ "^ ®. The morphology of 
Langerhans cells is also thought to alter with ageing with a reduction in the 
number of dendrites and Birbeck granules^^^V
Alterations in the function of Langerhans cells been reported. The migration 
of Langerhans cells in response to the intradermal injection of TNF-a has 
been shown to be reduced in the old^ ^® and this may be secondary to a 
reduction in IL-1p within the epidermis^^^  ^ The capability of Langerhans cells 
to present antigens to sensitized T cells and to stimulate proliferation of 
allogeneic T cells has also been shown to be reduced in mice^^^ ^
1.5.4 Effects of ageing on skin structure
Cutaneous ageing is a complex process and comprises both intrinsic ageing, 
thought to be genetically determined, and extrinsic ageing caused by 
environmental factors such as exposure to ultraviolet irradiation. Although 
there are microscopic differences between intrinsically and extrinsically aged 
skin, similar changes at a macroscopic level are seen with increased skin 
fragility, loss of elasticity, increased transparency, wrinkling and increased 
laxity^ "^ "*. These changes are thought to occur as a result of reduced 
proliferative capacity, cellular senescence and reduced biosynthetic capacity 
of skin-derived cells such as fibroblasts in addition to the increased production 
of degradative enzymes including the matrix metalloproteinases (MMPs) '^^^-
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Collagen is most abundant extracellular component of the skin, accounting for 
80% of dry weight, and provides the strong tensile properties of the dermis. 
An elastic fibre network provides elasticity accounts for 2-4% of extracellular 
matrix of sun-protected skin. Glycosaminoglycans/ proteoglycan 
macromolecules play a role in hydrating the skin and biological signalling. All 
three of these components are affected by ageing. In intrinsic skin ageing a 
reduction in the number and biosynthetic capacity of fibroblasts is observed
r*® o w )
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with an associated gradual loss of elastic tissue in the papillary dermis and a 
reduction in collagen content '^^®. In extrinsic skin ageing there is an 
accumulation of elastotic material, with thickened, tangled granular 
amorphous structures thought to be degraded elastic fibres, and dysregulation 
of elastin and fibrillin production. This results in an associated gross distortion 
of the dermal matrix '^^^’^ '^ ®. As with intrinsic ageing, a reduction in the collagen 
network is also seen.
1.5.5 Effects of ageing on cutaneous vasculature
The cutaneous vasculature is responsible for maintaining tissue viability, 
supplying oxygen and nutrition, and also allows for trafficking of cells in and 
out of the skin. The capillary network in the skin is made up of two main 
horizontal plexuses^"*^’^ ®^: the superficial plexus just below the epidermis, 
where arterial capillaries rise to form the papillary capillary loops, and a 
deeper plexus at the junction between the dermis and subcutis. Ascending 
arterioles and descending venules connect the superficial and deep plexuses. 
The superficial capillary papillary loops are thought to be important for 
providing nutritional supply. In addition, perivascular infiltrates are seen in this 
site during DTH response. The deeper vessels are thought to contribute to 
the colour of skin and also thermoregulation^"^®.
Various non-invasive imaging techniques including videocapillaroscopy^^^ and 
laser doppler flowmetry^^® have been employed to directly visualise the 
microcirculation in the skin. Patterns of blood flow in the microcirculation of 
the skin during the course of the Mantoux test have previously been studied 
using these techniques'^®. Maximal arteriolar vasodilatation was shown to 
occur during first 2 days of the reaction with rapid blood flow in the congested 
capillaries of the dermal papillae followed by engorgement of the deeper 
venous plexus in the resolving response at 72-96 hours®®®.
Cutaneous disorders such as purpura®®"*, telangiectasia®®®, palor^ ®®, angioma 
and venous lake formation are seen more commonly in old individuals and 
indicate that age related changes in skin microvessels may occur®® .^ The 
density of superficial capillary loops decreases with age in association with
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atrophy of the superficial dermis, however overall blood flux has been shown 
to increase with an expansion of the parallel vasculature in the deeper 
dermis^^°’^ ®^. In one study, old individuals (60-74 years) were found to have a 
66% reduction in capillary density on the volar (photoexposed) aspect of the 
forearm compared with the young group^^°. Similar findings have been 
demonstrated in mice^^®. However, marked variability in vasculature has been 
described according to the site studied and the degree of 
photoexposure^®°’^ ®^ .
Physiological changes in skin microvessels have also been observed 
including decreased vasoreactivity^®^’^ ®^ , decreased thickness of vessel 
basement membrane and decreased numbers of perivascular cells^® .^ In 
addition, ageing has been shown to result in a decreased expression of 
eNOS, the constitutive isoform of nitric oxide (NO) synthetase, responsible for 
endothelium derived NO synthesis^^. NO is thought to be a potent inhibitor of 
cellular adhesion, in particular monocytes and leukocytes, by the inhibition of 
the expression of adhesion molecules such as VCAM-1^®^. A reduction in 
endothelial nitric oxide production in the old has been proposed as a possible 
mechanism for development of atherosclerosis^^. Other factors influencing 
vasodilatation may also be altered including sympathetic nerve responses^®® 
increased rigidity of the skin around blood vessels due to fibrosis^®^ and 
impaired regulation of vascular calcium homeostasis/flux and sodium pump 
activity^®®.
The effects of ageing on lymphatics in the skin are poorly understood although 
lymphatic involution with age within the main lymphatic trunks has been 
reported in addition to changes in the surrounding elastin fibre network in the 
skin that may increase rigidity with a resulting impairment of lymphatic 
drainage^®®.
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1.6 Models used to study immune responses in the skin
1.6.1 Differences between human and murine models.
Murine models are generally considered to be the mainstay of in vivo 
immunological experimentation as they allow for elegant manipulation of the 
immune system and in many ways mirror the human immune system. In 
addition, recent advances in light microscopy have allowed for direct in vivo 
visualization of evolving immune responses using intravital imaging in live 
animals^®®. Sequencing the human and mouse genome has shown 
remarkable conservation between the 2 species with only 300 genes that are 
unique to either species. Despite this, however, there are significant 
differences between mice and men in both the innate and adaptive immune 
s y s t e m s ^ a n d  so caution needs to be employed when extrapolating data 
from murine experiments to humans.
In the context of examining immune responses in the skin, DTH responses 
are assessed by the measurement of either footpad or ear swelling in mice 
compared with the forearm in humans. Previous experiments in humans have 
shown variation in the DTH response according to anatomical site^^^’^ ^^  and 
therefore comparison of a forearm in a human and a footpad or ear in a 
mouse is difficult. In rats the resident T cells in the skin are also different with 
gamma delta TCP bearing T cells compared with alpha beta TCP in 
humans^^^. The duration of the response is altered in mice with a peak 
response at 12 hours compared with 2-3 days in humans^^. This may be 
reflective of differences in antigen presentation and time required for antigen 
to be transported to the draining lymph nodes. Whereas the response consists 
primarily of lymphocytes in humans, it is neutrophil rich in mice^ "^ .^ Elicitation 
of the response also requires much higher concentrations of antigen in mice 
compared with humans^^.
The use of murine models to study ageing is also controversial^^®. Mice and 
men have dramatically different lifespans and although differences in T cell 
function have been found in both species this may be representative of 
different ageing mechanisms. Importantly, mice have significantly (10X) 
longer telomeres^^^ and do not lose CD28 expression on T lymphocytes with
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cellular differentiation^^®, important for telomerase induction and therefore the 
restraints on immunity in humans due to telomere length may not be relevant 
in mice. Mice also have a reduced antioxidant defence and therefore may be 
more susceptible to the effects of oxidative stress with ageing compared with 
humans^®^.
One of the difficulties with analyzing data from human studies is the presence 
of confounding factors due to poor standardization of the groups studied. The 
SENIEUR protocol was designed as a result of consensus form the EURAGE 
concerted action program on ageing^^^ with a view to standardizing the 
population under study and excluding endogenous and exogenous influences 
on the immune system. The aim was to isolate pure ageing from that 
secondary to environment and disease. The SENIEUR protocol is based on 
the exclusion of disease based on clinical history, absence of biochemical 
abnormalities and absence of prescribed medication for known diseases or 
that with known influence on the immune system (including non-steroidal anti­
inflammatory drugs). The use of the SENIEUR protocol in multiple studies 
has subsequently shown that it is a reliable instrument for the selection of 
volunteers, and that differences can be identified in immune parameters 
between the very healthy and the almost very healthy. In the very healthy, 
however, only very modest changes in the immune response have been 
identified up to an advanced age^®^  and the clinical relevance of these 
changes has not been clarified.
However, it has been postulated that the SENIEUR protocol excludes over 
90% of the aged population^^® and therefore is selecting a group of individuals 
poorly representative of the aged population as a whole. The study of 
individuals who are excluded by the SENIEUR protocol but well characterized 
in terms of clinical co-morbidity may be more relevant to the development of 
strategies to enhance quality of life with ageing. In this thesis, a modified 
version of the SENIEUR protocol was employed with a view to excluding 
significant comorbidity but selecting a representative group of old individuals.
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1.7 Aims and objectives
It is known that there is a decline in immunity with age^^  ^ that is thought in part 
to explain the observed increased frequency of infection and malignancy. 
Previous studies in old subjects, predominantly performed on nursing home 
residents, have indicated an increase in the percentage of negative DTH 
reactions in the skin to the Mantoux test and other antigens^®°’ ®^^ ’^ ^^ . It has 
been assumed that this is reflective of a generalized decline in cell-mediated 
immunity with increasing age. However, it is unclear whether the previously 
reported decline in DTH responses in the old was related to associated co­
morbidity or was a true reflection of reduction in their cutaneous immunity as a 
result of intrinsic ageing.
Previous studies have focused on clinical responses to the injection of antigen 
in the skin or cellular response in the peripheral blood, however it is not known 
how these parameters correlate with each other or if the skin is reflective of 
immunity in other compartments. Our laboratory has previously shown that 
there is dissociation between the peak clinical and peak cellular response in 
the skin during the course of a DTH response^ and therefore the absence of 
a visible clinical response in the old may not be indicative of an absent 
immune response in the skin.
Given the demographic increase in age in the population it is essential that we 
have not only the tools to assess immunity but also have an understanding of 
the changes that occur in immunity with ageing.
AIM
To characterize the effects of ageing on the immune system in the skin in 
healthy old individuals.
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OBJECTIVES
The objectives of this project were to:
1. Study the correlation between clinical DTH responses to the 
intradermal injection of antigen in the skin and peripheral blood 
responses to antigen in the old and young.
2. Characterize the lymphocytic response to the intradermal injection of 
antigen in the old.
3. Examine the skin homing capacity of memory T cells in the peripheral 
blood in the old.
4. Investigate the production of chemokines and cytokines at the site of 
the immune response in the old.
5. Evaluate cell types involved in the initiation of DTH responses in the 
skin.
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2. Materials and Methods
2.1 Volunteer recruitment
Healthy young individuals under the age of 40 and old individuals over 70 
were recruited for the study. Exclusion criteria based on a modified version of 
the Senieur protocol were used in order to prevent confounding factors due to 
co-morbidity and other factors that may influence the immune status of an 
individual (Table 2.1). All volunteers were Caucasian and living in the Greater 
London area. A total number of 53 old and 39 young individuals were 
recruited for the study. The age range for old volunteers was 70-91 years with 
a mean age of 79 years. The age range for young volunteers was 23- 37 
years with a mean age of 28 years.
TABLE 2.1 (Exclusion criteria)
• Past history of TB
• Significant comorbidity (renal impairment or failure, heart failure, 
diabetes)
• Past history of inflammatory skin disorder
• Past history of neoplasia in the last 10 years
• Previous treatment with chemotherapy or radiotherapy
• Immunosuppressive medication
• Recent infection or immunization (within last month)
• Pregnancy and breast feeding
• Previous history of hypersensitivity to skin testing
Ethics
The study was approved by the Ethics committee of the Royal Free Hospital.
2.2 Skin testing
2.2.1 Mantoux tests
Mantoux test reactions were induced on the volar aspect of the forearm by the 
intradermal injection of 0.1ml of lOU/ml tuberculin purified derivative (PPD)
56
(Evans Vaccines Ltd., Liverpool, UK). Intradermal injection was confirmed by 
the induction of a distinct, sharply defined bleb at the skin test site. As a 
control, injection of the carrier solution for PPD (Evans Vaccines Ltd., 
Liverpool, UK) was also injected in the opposite forearm.
2.2.2 Candida skin testing
0.02ml of Gandin skin test solution (Allermed Laboratories Inc, San Diego, 
CA) was injected intradermally as for the Mantoux test. As a control 0.02ml of 
sterile saline was injected, as the carrier solution for the Gandin solution was 
not available commercially.
2.2.3 Varicella zoster virus (VZV) skin testing
0.02ml of VZV skin test solution (Gift from M. Takahashi, Osaka University) 
was injected as for the other antigens.
2.2.4 Assessment of skin test responses
Baseline skin erythema at the site of antigen injection was measured using a 
DermaSpectrometer (Gortex Technology, Hadsund, Denmark). This is a 
portable, handheld device that allows the measurement of the skin erythema 
index (El) by measuring light absorption coefficients (Figure 2.1 B). The mean 
of 3 measurements was recorded. At Day 3 and at the time of sampling (if 
different from Day 3) the change in El from baseline, palpability and size of 
induration were measured. The change in El was calculated by subtracting 
the baseline measurement from the El taken when measuring the response. 
The size of induration was determined by measuring the maximum diameter 
of the response. The change in El, induration and palpability were then 
scored according to Table 2.2 and the sum of the scores was combined to 
give an overall clinical score. Non-responding individuals were defined as 
having a clinical score of less than 1 at Day 3 and at any time point up to 
sampling.
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TABLE 2.2 Assessment of skin test responses
Clinical Score 0 1 2 3 4 5 Score
Erythema-index (El) 0 1-5 6-10 11-15 >16
Size of induration (mm) 0 1-5 6-10 11-15 16-20 >21
Palpability Nil Justpalpable Easily Marked
Very
marked
Total
The change in El from baseline, size of induration and palpability were scored 
and added together to give an overall clinical score.
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2.3 Skin sampling
Skin suction blisters were raised or 5mm punch biopsies were taken from the 
site of skin testing. Samples were collected at various time points between 0 
and 21 days after injection of antigen. Each volunteer was allotted to a 
specific sample time-point and either paired skin suction blisters and punch 
biopsies or blisters or biopsies alone were taken (Figures 2.1 and 2.2). 
Repeated skin testing to the same skin test antigen in the same individual was 
avoided in order to prevent boosting of the immune response from repeated 
antigenic exposure.
2.3.1 Suction blisters
Suction blister induction (Figure 2.2)
Skin suction has previously been shown to result in the formation of a split 
between the epidermis and dermis at the level of the lamina lucida. Suction 
blisters were induced by the application of negative pressure of 25-40kPa 
(200-300mmHg below atmospheric pressure) via a suction chamber (Medical 
Engineering, Royal Free Hospital, UK) centred over the site of testing for 2-4 
hours using a clinical suction pump (VP25, Eschmann, Lancing, UK) (Figure 
2.2). Skin suction chambers with apertures of 15mm, 12.5mm and 10mm 
were used according to the size of the response and skin elasticity. In all 
cases, the size of suction chamber aperture selected ensured that the whole 
of the area of induration was sucked up in to the chamber with minimal 
incorporation of normal surrounding skin.
Suction was applied at warm room temperature (~22°C) until a unilocular 
blister measuring 10-15mm was formed over the site of the skin test. The 
blister was then protected overnight with a rigid adhesive dressing assembled 
using a Comfeel plus ulcer dressing (Coloplast, Peterborough, UK), a 
universal top (Sterilin, Fisher Scientific UK Ltd, Loughborough, UK), Micro pore 
tape (3M healthcare, Loughborough, UK) and Tubigrip bandaging (Seton 
Healthcare Group pic, Oldham, UK).
Blister fluid was aspirated from the blister at 18-24 hours after induction using 
a sterile 23G needle and a 2ml syringe (Tyco Healthcare UK Ltd, Gosport,
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UK). The fluid was aspirated at the 18-24 hour time point in order to ensure 
maximal accumulation of cells within the blister fluid from the site of antigenic 
challenge in the skin. The recorded time of sampling was the time from skin 
injection to blister fluid aspiration. The volume of fluid recovered from the 
blister was recorded and suspended in 1.5ml conical tubes (Alpha 
Laboratories Ltd, Eastleigh, UK). The aspirated blister site was dressed with 
Betadine dry powder spray (Seton Healthcare Group pic, Oldham, UK) and a 
Mepore dressing (Molnlycke Health Care Ltd., Dunstable, UK). Volunteers 
‘ were advised to leave the dressing in place and to keep it dry for 24 hours 
before removing it and leaving the wound open to the air. The suction cups 
were dismantled after use and disinfected in Barrycidal 36 (Heraeus 
Instruments Ltd, Brentwood, Essex, UK) for a minimum of 24 hours.
Suction blister cell isolation
The blister fluid was microcentrifuged at BSOxg (3000 rpm) for 4 minutes 
(Microcentaur, MSE, Sanyo) to pellet the cellular contents. The supernatant 
was removed and aliquotted in to 1ml cryogenic tubes (Nunc, Thermofisher 
Scientific, Roskilde, Denmark) and stored at -70°C until analysed. The blister 
cell pellet was resuspended in SOOpI of RPMI 1640(GIBCO, BRL Life 
Technologies, Paisley, UK) containing 10% human AB serum, lOOU/ml 
penicillin, lOOpg/ml streptomycin and 2mM L-glutamine (all from Sigma 
Aldrich, Gillingham, Dorset, UK).
Counting of blister cells
Blister white and red cell numbers were quantified using a haemocytometer. 
Cellular viability was assessed by trypan blue exclusion. A lOpI aliquot of 
blister cell suspension was mixed 1:1 with Trypan blue (Sigma- Aldrich, 
Gillingham, Dorset, UK) and viable non-stained cells were counted.
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FIGURE 2.1 The clinical DTH response In the skin and skin sampling.
A. The skin test response to the intradermal injection of antigen is
characterized by the development of erythema and induration at the 
site of injection, reaching a peak at 2-3 days.
B. The erythema index at the site of the response was measured at
baseline, at day 3 and at the time of sampling using a
DermaSpectrometer. The mean of 3 measurements was recorded.
C. Following skin testing on the inner aspect of the forearm, skin samples 
were collected at various time points from 0-15 days after injection. 
Skin suction blisters were raised primarily to obtain either cutaneous 
lymphocytes or monocytes.
D. Skin biopsies were also taken. Whenever possible paired biopsies and 
blisters were taken from opposite forearms. Venous blood was also 
taken for PBMC isolation.
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FIGURE 2.2 Skin suction blister induction.
A. A clinical grade suction pump (VP25 Eschmann suction pump) was
used for skin suction blister induction. The pump has a guage that 
allows for constant negative pressure to be applied to the skin. The 
pump has sterile disposible tubing and liners that were changed in 
between volunteers.
B. Suction cups were made of 3 main components: A template, a cup 
made of nylon and a see through Perspex lid. Rubber 0-rings were 
fitted around the lid and template to allow an airtight seal to be formed 
between all 3 components when fitted together. The size of the 
template used was adjusted according to the size of the response and 
the amount of skin sucked up in to the skin after application of negative 
pressure.
C. Skin suction blisters were induced over the site of skin testing (1). A 
suction cup was centred over the site of injection (2) and a negative 
pressure of 25-40kPa (200-300 mmHg) below atmospheric pressure 
was applied until a unilocular blister (3) was formed. The blister was 
dressed with a 5X5cm Comfeel dressing (3), a trimmed universal 
container top (4), micropore tape (5) and a tubigrip bandage (6). 
Blister fluid was aspirated the following day using a sterile 23G needle 
and a 2ml syringe (7).
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2.3.2 Skin biopsy 
Biopsy procedure
A 5mm punch biopsy was taken either from the centre of the site of injection 
of antigen or control solution or normal skin (Figure 2.1 D). The surrounding 
skin was infiltrated with 2% lignocaine/ 1:80, 000 adrenaline local anaesthetic 
(Astra Pharmaceuticals Ltd, Kings Langley, UK) prior to biopsy. The wound 
was closed with 4/0 Surgipro polypropylene suture (Tyco Healthcare UK Ltd., 
Gosport, UK). The skin was transported as quickly as possible to the lab in 
sterile saline.
Biopsy storage and sectioning
Biopsies were mounted in Cryo-M-Bed (Bright Instrument Company Ltd., 
Huntingdon, UK) on cork disks, orientated so that the epidermis was 
perpendicular to the cork disk, and snap frozen in isopentane (Sigma-Aldrich, 
Gillingham, Dorset, UK) cooled in a bath of liquid nitrogen. The samples were 
then stored in a freezer at -80°C. 6pm frozen sections were cut at -20°C 
using a Bright 5040 microtome (Bright Instrument Company Ltd., Huntingdon, 
UK) on to poly-L-lysine coated glass slides (Sigma-Aldrich, Gillingham, 
Dorset, UK). Poly-L-lysine coated slides were used in order to promote strong 
adhesion of the skin section to the slide. Two sections were mounted on to 
each slide. The sections were then left overnight to air-dry and then fixed in 
fresh acetone for 10 minutes, followed by 99% Ethanol for 10 minutes. The 
sections were air-dried for 10 minutes and then cling-filmed wrapped and 
stored until use in a freezer at -80°C.
2.4 Blood samples
Blood was taken from all volunteers prior to skin testing and at the time of skin 
sampling for the isolation of peripheral blood mononuclear cells (PBMCs) and 
serum separation. The serum sample was refrigerated for 30 minutes and 
then centrifuged at 800xg for 20 minutes. The supernatant was aliquotted in 
to 1ml cryogenic tubes and stored at -80°C.
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2.4.1 PBMC isolation
Heparinised blood was mixed 1:1 with Hanks Balanced Salt Solution (HBSS) 
(GIBCO, BRL Life Technologies, Paisley, UK) and layered on to Ficoll-Paque 
(Amersham Biosciences UK Ltd, Chalfont St. Giles, UK) in 50ml Falcon tubes. 
This was centrifuged for 20 minutes at 800xg with no brake. The buffy coat at 
the interphase layer was harvested and then washed twice for 10 minutes in 
excess HBSS by centrifugation at 650xg for the first wash and 300xg for the 
second wash. The cells were finally resuspended in complete medium as for 
the blister cells (RPMI 1640 (GIBCO, BRL Life Technologies, Paisley, UK) 
containing 10% human AB serum, lOOU/ml penicillin, lOOpg/ml streptomycin 
and 2mM L-glutamine (all from Sigma Aldrich, Gillingham, Dorset, UK)). 
Typically, 1-2 xIO® cells were isolated per 1ml of venous blood.
2.5 Flow cytometry
Flow cytometry was used in order to identify and analyse specific subsets of 
cells. The technique allows for the rapid measurement of individual cells as 
they flow in a fluid stream one by one through a laser beam. Cells are 
analysed on the basis of cell size and granularity in addition to labeling with 
antibodies conjugated to different fluorochromes. A FACSCalibur flow 
cytometer (Becton Dickinson, Oxford, UK) was used for all experiments. This 
machine has 2 lasers (488nm and 600-650nm), enabling the simultaneous 
measurement of 4 different coloured fluorochromes (channels FL1-FL-4). 
Acquisition and analysis of all data was undertaken using CellQuest software 
(Becton Dickinson, Oxford, UK). Single colour fluorochrome controls were 
used prior to the start of sample acquisition in order to compensate between 
different channels to correct for overlapping emission spectra that can occur 
between different fluorochromes. The optimum concentration of each 
antibody was determined by preliminary titration.
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FLOW
CYTOMETRY
Staining
Specificity/
fluorochrome Clone Isotype/source Company
Direct/surface
CXCR4 PE 12G5
Mouse antihuman 
lgG2a
R&D
Systems
OCRS PE 191704 Rat antihuman lgG2b
R&D
Systems
CXCR3 (CD183) 
APC 1C6/CXCR3 Mouse antihuman IgGIk
BD
Pharmingen
CCR4 PE 1G1 Mouse antihuman IgGIk
BD
Pharmingen
CLA FITC HECA-452 Rat IgM k
BD
Pharmingen
CD11a Him Mouse antihuman IgGIk
BD
Pharmingen
CD4 PerCP SK3
Mouse antihuman 
IgG-hlgGIk
BD
Pharmingen
CD4 PECy5.5 Caltag
CD3 APC UCHT-1 Mouse antihuman IgGIk
Dakocytomat
ion
CD69 PE L78 Mouse antihuman IgGIk
BD
Pharmingen
CD27 PE M-T271 Mouse antihuman IgGIk
BD
Pharmingen
CD28 FITC CD28.2 Mouse antihuman IgGIk
BD
Pharmingen
Direct/
intracellular
Ki67 FITC 856 Mouse antihuman IgGI
BD
Pharmingen
Ki67 isotype control
CTL-MOPC-
21
IFN-gamma APC 827 Mouse antihuman IgGI
BD
Pharmingen
All antibodies shown are monoclonal.
FITC: Fluoroscein isothiocyanate
PE; Phycoerythrin
PerCP: Peridinin clorophyll protein
PECy5.5: Phycoerythrin- cyanin 5.5
APC: Allophycocyanin
TABLE 2.3 Antibodies used for flow cytometry.
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Analysis was performed by gating on either the live cell (lymphocyte or 
monocyte) populations using forward and side scatter profiles with exclusion 
of dead cells and debris. Isotype and negative controls were used to 
delineate positive populations where positive and negative populations were 
not clearly distinguishable. The antibodies used for flow cytometry are shown 
in Table 2.3.
2.5.1 Surface staining by direct immunofluorescence
The expression of cell surface markers was determined using monoclonal 
antibodies directly conjugated to a specific fluorochrome with a single 
incubation step. The use of a combination of different fluorochromes such as 
FITC, PE, PerCP and APC allowed for the detection of up to 4 different 
antigens simultaneously. lOOpI of blister or PBMC cell suspensions in culture 
medium were aliquotted in to 5ml FACS tubes (Falcon, Becton Dickinson 
Labware, New Jersey, USA) together with pre-determined optimal 
concentrations of directly conjugated antibodies. The tubes were vortexed 
and incubated in the dark at room temperature for 15 minutes. The cells were 
then washed in excess PBSA (1% w/v bovine serum albumin and 0.02% 
sodium azide (both Sigma- Aldrich, Gillingham, Dorset, UK) in phosphate 
buffered saline (PBS)) and centrifuged at 650xg for 5 minutes. The 
supernatant was decanted and the cells resuspended and fixed with 200 pi of 
2% paraformaldehyde (Sigma- Aldrich, Gillingham, Dorset, UK) in PBS and 
stored for at least 1 hour in the dark at 4°C until analysed.
2.5.2 Intracellular staining
In order to stain for intracellular antigens such as Ki67 or cytokines, cells were 
fixed and permeabilised to allow for the access of antibodies to intracellular 
structures whilst maintaining the morphological scatter characteristics of the 
cells. A modified protocol of the Caltag Fix and Perm Cell Permeabilisation kit 
(Caltag Laboratories, Burlingame, California, USA) was used. If a combination 
of both cell surface and intracellular antigen staining was required, cells were 
first incubated with the cell surface antigen antibodies as per protocol above, 
washed with PBSA and centrifuged at 650xg for 5 minutes. The supernatant
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was decanted and the cell pellet was resuspended with lOOpI of reagent A 
(Fixation medium containing formaldehyde). The tubes were vortexed and left 
to incubate in the dark at room temperature for 10 minutes. The cells were 
washed with PBSA and centrifuged at 650xg for 5 minutes. The cell pellet was 
then resuspended with 100pl of reagent B (Permeabilisation medium) and 
optimal concentrations of directly conjugated antibodies to intracellular 
antibodies were added. The tubes were vortexed and left to incubate in the 
dark at room temperature for 15 minutes. Finally the cells were washed with 
PBSA, centrifuged at 650xg for 5 minutes and fixed with 2% 
paraformaldehyde as described for the direct immunofluorescence method.
2.5.3 Detection of antigen specific cells
Antigen specific CD4+ lymphocytes were identified using flow cytometry to 
detect the intracellular accumulation of interferon gamma following short term 
in vitro stimulation with antigen in the presence of brefeldin A. Brefeldin A is a 
fungal metabolite that enhances the staining of intracellular cytokines, 
preventing their secretion by interfering with their transport in vesicles from the 
rough endoplasmic reticulum to the Golgi complex. PBMCs (1x10®) or blister 
cells in complete medium were added to sterile FACS polypropylene tunes 
(Kendall, Tyco Healthcare Group, Massachusetts, USA). The cells were 
stimulated with PPD (Statens serum institute, Copenhagen, Denmark) at a 
final concentration of lOpg/ml for 15 hours at 37°C in a humidified 5% CO2 
atmosphere. Brefeldin A (Sigma- Aldrich, Gillingham, Dorset, UK) was added 
at a final concentration of 5|ig/ml after 2 hours of incubation. The same 
protocol was used to detect CMV antigen specific cells with the substitution of 
PPD antigen for CMV lysate (Virusys Corporation, Sykesville, MD, USA) at a 
final concentration of lOOpl/ml.
A modified protocol, with prolonged incubation prior to the addition of brefeldin 
A, was used to detect lymphocytes specific for Candida and VZV antigens in 
order to maximize the detection of interferon gamma positive cells. PBMCs 
and blister cells were incubated with Candida antigen (Greer laboratories, 
Nuway Circle, Lenoir, USA) at a final concentration of 40pg/ml and VZV
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antigen (Virusys corporation Sykesville, MD, USA) at a final concentration of 
20|il/ml for 15 hours followed by the addition of brefeldin A at 15 hours and 
then staining for interferon gamma at 20 hours. For experiments where CLA 
expression on antigen specific cells was analysed, unsupplemented X-Vivo 
medium (Biowhittaker, Cambrex Bioscience, Walkersville.) was used rather 
than complete medium to culture the cells as this was found to prevent the 
down-regulation of CLA upon cell stimulation.
For both protocols unstimulated PBMC and blister cell controls were used to 
verify the staining specificity and as a guide for delineating positive and 
negative populations. As a positive control, the superantigen Staphylococcal 
exotoxin B (SEB) was added to PBMCs and blister cells at a final 
concentration of Ipg/ml (Sigma- Aldrich, Gillingham, Dorset, UK). Gating was 
set on the live lymphocyte population using forward and side scatter profiles.
2.5.4 Enumeration of T lymphocytes
Absolute cell counts of T lymphocytes in PBMCs and blister cells were 
performed using TruCOUNT^'^ tubes (BD Biosciences, San Jose, California, 
USA) and flow cytometric analysis. This technique was used to determine the 
absolute number of cells extracted from the skin following suction blister 
induction and the number of cells that had migrated in the transwell migration 
assay experiments. A known volume of cell suspension was added to a 
known number of fluorescent beads contained within the TruCOUNT tube. 
During sampling the absolute number of cells in the sample was determined 
by comparing the number of acquired gated cellular events and the gated 
fluorescent bead events. Cells added to the tube were also labeled with 
fluorescent surface markers in order to calculate the absolute number of 
different types of cells.
lOOjil of the PBMC or blister cell samples in complete culture medium was 
carefully pipetted in to a TruCOUNT tube to which the required antibodies to 
surface antigens were added at concentrations as for direct 
immunofluorescence staining. The tubes were vortexed and incubated in the
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dark at room temperature for 15 minutes. After, incubation 200fil of 1X FACS 
lysis buffer (BD Biosciences, San Jose, California, USA) was added and the 
tube was vortexed. The sample was stored for a minimum of 1 hour in the 
dark at 4°C prior to acquisition and analysis. The absolute number of cells 
was calculated using the equation below:
X gated cell events x Y beads per TruCOUNT tube x sample volume 
Z gated bead events x Trucount volume
2.6 In vitro cell culture
2.6.1 Measurement of cellular proliferation by [^H] thymidine 
incorporation
PBMCs were suspended in complete culture medium (RPMI (GIBCO, BRL 
Life Technologies, Paisley, UK) containing 10% human serum supplemented 
with lOOU/ml penicillin, 10Opg/ml streptomycin and 2mM L-glutamine (all from 
Sigma- Aldrich, Gillingham, Dorset, UK)). The PBMC concentration used was 
1x10® cells/ml. lOOpI aliquots of cell suspension were pipetted in to the wells 
of 96 well round bottomed cell culture plates (Falcon, Becton Dickinson 
Labware, New Jersey, USA) and incubated at 37°C in a humidified 5% CO2 
atmosphere. lOOpI of antigen diluted in complete medium was added in a 
range of concentrations to wells, with each concentration performed in 
triplicate. The range of final well antigen concentrations were as follows: 
PPD antigen (Statens serum institute, Copenhagen, Denmark) 0-5pg/ml, 
Candida antigen (Greer laboratories, Lenoir, NC, USA) 0-20pg/ml and VZV 
antigen (Virusys corporation, Sykesville, MD, USA) 0-20pl/ml. The cells were 
incubated for 5-6 days (5 days for PPD antigen, 6 days for Candida and VZV 
antigens) before adding lOpI of 0.0025MBq [®H] thymidine (Amersham 
Biosciences UK Ltd, Chalfont St. Giles, UK) to each well and incubating for an 
additional 16 hours. Optimal incubation times were determined by initial 
visual assessment of wells for signs of cell proliferation and then 
measurement of proliferation by [®H] thymidine incorporation at different time 
points. Cells were harvested onto glass microfibre filter strips using a cell 
harvester (Cambridge Technology, Watertown, Massachusetts, USA) and
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counts per minute (cpm) from incorporated pH] thymidine were determined by 
liquid scintillation counting. The mean of triplicate wells was calculated and 
used for the purpose of data analysis.
2.7 Cytokine/ chemokine assays
2.7.1 Multiple cytokine assay by cytometric bead array Cytometric 
Bead Array (GBA) Cell Signalling Flex Set System)
Concentrations of cytokines and chemokines (IL-6, IL-8, IL-10, TNF, IFN-y, 
RANTES, MCP-1, MIP-1a) in blister fluid and serum were analysed using the 
BpTM Cytometric Bead Array (GBA) Cell Signalling Flex Set System and were 
analysed using a BD FACSArray^*^ bioanalyzer with FCAP Array Software (all 
BD Biosciences, San Jose, California, USA). This technique employs the use 
of particles with discrete fluorescent intensities and sizes to detect soluble 
analytes and enables multiplexed quantitative analysis of multiple proteins 
from a single sample using flow cytometry.
The assay was performed in a 96 well round bottomed plate (Falcon, Becton 
Dickinson Labware, New Jersey, USA). 50pl of mixed capture beads each 
coated with a cytokine- specific antibody was mixed with 50pl of mixed 
cytokine-specific PE-conjugated antibodies in addition to 50|il of blister fluid, 
serum or dilution series of analyte recombinant protein. The plate was gently 
vortexed and then incubated at 4 hours in the dark, at room temperature, in 
order for sandwich complexes to form. The plate was then centrifuged and 
the supernatant aspirated from each well. 150pl of wash buffer was then 
added to each well and the plate was then inserted in to the BD FACSArray^*^ 
bioanalyzer for analysis. This machine automatically assigns an alpha­
numeric position on a grid for each bead population using the NIR and Red 
channels. A standard curve for each analyte is created based on bead size 
and PE- fluorescence intensity for the dilution series of the recombinant 
protein samples. This enables the quantitative calculation of the concentration 
of the analytes from the test samples bound to the beads.
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All samples were analysed in one experiment in order to minimize variation in 
measured concentrations due to different experimental conditions on different 
days. In addition, blister and serum samples were stored at -70°C 
immediately after collection from volunteers and were only defrosted for the 
purpose of analysis in order to minimize changes in cytokine/chemokine 
concentration due to repeated freeze thaw cycles.
2.7.2 Multiplex bead immunoassay (Luminex technique)
Analysis of the chemokines CCL27 (CTACK), CCL17 (TARC), CCL1 (1-309) 
and SDF was performed by Dr. John Curnow (Division of Immunity and 
Inflammation, MRC Centre for Immune Regulation, University of Birmingham, 
UK.). Cytokine Beadlyte and Luminex 100 assay kits were used (both from 
Upstate Biotechnology, Lake Placid, New York, USA.). The technique is very 
similar to that described for the other cytokine/chemokine assays and was 
selected for the analysis of some chemokine concentrations due to the lack of 
availability of reagents using the BD™ Cytometric Bead Array (CBA) Cell 
Signalling Flex Set System.
The technique is based on the use of sets of polystyrene microspheres, each 
internally dyed with ratios of two spectrally distinct fluorochromes that are 
distinct for each set of microsphere. Each set of microspheres is conjugated 
with a specific cytokine capture antibody. A biotinylated antibody that binds to 
streptavidin labeled with a third fluorochrome binds to captured chemokines, 
present on the surface of the microspheres. The Luminex 100 flow cytometer 
and software is able to calculate the concentration of chemokines by 
separating pools of microspheres with different specificities in to individual 
bead sets and by determining the amount of the analyte bound to the surface 
of each microsphere.
2.7.3 Transwell chemotaxis assays.
In vitro cell migration assays were used to quantify the ability of CLA-k 
lymphocytes to migrate in response to selected chemokines. Cell migration in 
response to IP-10 (1-309) and SDF recombinant peptides (both Peprotech Inc,
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New Jersey, USA) was measured. SDF was used as a positive control as 
large numbers of cells have previously been shown to migrate in response to 
this chemokine in vitro. 400pl of complete medium with 500ng/ml of either 
recombinant IP-10 or SDF was added per well in to 26 well flat- bottomed 
plates. 6.5-mm diameter, 3-pm pore transwell inserts (Greiner Bio-one Ltd, 
Stonehouse, UK) were placed in to each well. As a negative control complete 
medium alone was added in to wells. 200pl of PBMC suspension in complete 
medium at a concentration of 2.5x10® cells/ml was pipetted in to the top 
chamber. Triplicate wells were used for each volunteer and chemokine. The 
plates were incubated for 3 h at 37°C in a humidified 5% CO2 atmosphere. 
Cells were then collected in to FACS polypropylene tubes (Kendall, Tyco 
Healthcare Group, Massachusetts, USA) from both top and bottom chambers. 
All chambers were rinsed twice with complete medium in order to maximize 
cell retrieval. The cells were then centrifuged at 650xg for 5 minutes, the 
supernatant was discarded and the pellet was re-suspended in lOOpI of 
complete culture medium. This was transferred to a TruCOUNT™ tube, 
stained with anti-CLA, CD3 and CD4 antibodies, acquired and analysed 
according to the protocol described in section.
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HISTOLOGY
Indirect Immunoperoxidase
(HRP- Polyclonal rabbit antimouse- CD1a NA1/34 Mouse antihuman lgG2ak Dakocytomation
Dakocytomation) Ki67 Ki-67 Mouse antihuman IgGIk Dakocytomation
4pl per slide CD3 UCHT-1 Mouse antihuman IgGIk Dakocytomation
CD68 EBM11 Mouse antihuman IgGIk Dakocytomation
CD8 DK25 Mouse antihuman IgGIk Dakocytomation
CD14 TUK4 Mouse antihuman lgG2ak Dakocytomation
CD4 (Pure Leu-3a) Mouse antihuman IgGIk BD Pharmingen
Indirect immunoperoxidase HLA-DR (biotin) Immunotech
(Streptomycin HRP kit BD) DC-SIGN (CD209) biotin DCN46 lgG2b BD Pharmingen
Negative controls lgG2b Dakocytomation
lgG2a DAK-G05 Dakocytomation
IgGIk 107.3 BD Pharmingen
lgG2ak BD Pharmingen
TABLE 2.4 Antibodies used for immunohistochemistry
2.8 Immunohistoloqy
The study employed the use of both indirect immunoperoxidase and 
biotin/streptavidin alkaline phosphatase techniques. The characteristics of the 
monoclonal antibodies used are documented in Table 2.4.
2.8.1 Indirect Immunoperoxidase technique
The indirect immunoperoxidase technique was used to detect numbers and 
distribution of T cells, monocytes/ macrophages, dendritic cells and to detect 
cellular proliferation in the skin biopsies. In this technique a primary 
unconjugated antibody is bound to the antigen of interest in the tissue section. 
A second horseradish-peroxidase conjugated antibody, raised in another 
animal host that is specific for the animal and immunoglobulin class of the 
primary antibody, is then bound to the primary antibody. The complex that is 
formed is visualized following incubation with an appropriate chromagen or 
substrate. In this study, the chromagen 3, 3’-diaminobenzidine 
tetrahydrochloride (DAB) was used. This is converted by horseradish- 
peroxidase into an insoluble brown substrate, identifying the cell/ antigen of 
choice.
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Frozen tissue sections were defrosted and placed in to a moist staining 
chamber containing water soaked tissue. The sections were ringed with 
polysiloxane (Dakocytomation, Glostrup, Denmark) as a water repellent. 50pl 
of 1x phosphate buffered saline (PBS) (GIBCO, Invitrogen, Paisley, UK) 
containing 10% human serum (Sigma Aldrich, Gillingham, Dorset, UK), 10% 
Aprotinin (Sigma- Aldrich, Gillingham, Dorset UK) and a pre-titrated 
concentration of primary antibody was carefully pipetted on to each slide. The 
antibodies used are listed in Table 2.4. Non-specific antibody binding was 
minimized by the addition of 10% human serum. 10% Aprotinin (a protease 
inhibitor derived from bovine lung) was added to block any endogenous 
immunoperoxidase activity within the tissue. The slides were then left to 
incubate for 45 minutes at room temperature. The fluid on the sections was 
removed by gently tapping the slide and the sections were then washed with 
fresh IxPBS for 5 minutes, followed by formalin buffered saline (4.5g sodium 
dihydrate phosphate, 6.5g di-sodium hydrogen orthophosphate, 100ml of 40% 
formaldehyde and 900ml of 1x PBS) for 10 minutes and finally IxPBS for 5 
minutes. 4pl of horseradish peroxidase conjugated rabbit anti-mouse 
secondary antibody in 50pl of IxPBS with 10% human serum was then added 
to each section. The sections were incubated at room temperature for a 
further 45 minutes and then washed as previously.
1 drop of Filtered Nickel DAB solution (95 mg of 3.3’diaminobenzidine, 1.6g 
NaCI, 0.136g Imidazole, 2g nickel sulfate dissolved in 180ml of Tris/HCL 
buffer with pH corrected to 7.4 with 1M TRIS) containing Ipl/ml of 10% H2O2 
(added immediately prior to use) was then added to each section using a 
Pasteur pipette. This was left for up to 7 minutes prior to rinsing with PBS for 
3 minutes. Slides were then placed in Tris Cobalt to intensify the stain (1.2g 
TRIS base, 1g Cobalt Chloride dissolved in 180ml distilled H2O with pH 
corrected to 7.2 with HCI) for 5 minutes and then rinsed in tap water. Sections 
were counterstained with 0.1% Nuclear fast red for 5 minutes, rinsed in tap 
water and then dehydrated by washing for 10 seconds in 70% ethanol, 90% 
ethanol, twice in neat ethanol and then cleared in 50:50 Citroclear/ ethanol 
mix and finally neat Citroclear (HD Supplies, Aylesbury, Bucks, UK). Sections
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were left in the neat Citroclear for a further 10 minutes and then mounted in 
styrolite.
2.8.2 Control slides
Three control preparations were used each time staining was performed. As 
a negative control, a section of both tonsil and skin tissue was incubated with 
normal mouse serum instead of primary antibody. In addition, where possible, 
a negative isotype control antibody for the same animal species as the 
primary antibody was also used at the same concentration on single sections 
of skin and tonsil (Table 2.4). Tonsil tissue was also stained as a positive 
control. Tonsil provides a rich source of cells including those stained for in the 
skin sections and allows for the distribution and staining of cells to be tested 
against tissue architecture.
2.8.3 Biotin/streptavidin/horseradish peroxidase technique
An indirect biotin/ streptavidin method was used to detect DC-SIGN 
expression on skin tissue sections. In this technique, the primary antibody is 
allowed to bind with specific antigen in the tissue sections. A secondary 
biotinylated antibody is then applied. This is raised in a different species to 
the primary antibody and is specific for the primary antibody species and 
immunoglobulin class. A third layer consisting of streptavidin conjugated to 
horseradish peroxidase is then added. Streptavidin has a strong affinity for 
biotin. Up to 150 biotin molecules can be complexed to a single second layer 
antibody, allowing for amplification of the staining signal and a greater 
sensitivity than the indirect immunoperoxidase technique. As for the indirect 
immunoperoxidase technique, DAB is then added which acts as a substrate 
for horseradish peroxidase.
Frozen sections were placed in to 1x PBS for 2 minutes. The sections were 
then ringed with polysiloxane and incubated with 50pl of 1x PBS containing 
10% human serum, 10% aprotinin and a pre-tritrated concentration of primary 
mouse antihuman DC-SIGN antibody. The sections were incubated for 1 hour 
at room temperature in a moist chamber with a lid and then washed in 1x PBS
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for 5 minutes, formalin buffered saline (made up as described previously) for 
10 minutes and then IxPBS for 5 minutes. The sections were incubated with 
50|il of IxPBS with 10% human serum and secondary biotinylated antibody 
(description and supplier) for 30 minutes and then washed as previously. The 
DAB, counterstaining, dehydration, clearing and mounting steps were 
performed in precisely the same way as for the indirect immunoperoxidase 
technique.
Staining for HLA-DR on sections was performed using a primary pre- 
biotinylated mouse anti-human antibody to HLA-DR. The protocol was 
therefore amended for this antigen, with omission of the addition of the 
secondary biotinylated antibody. The protocol was otherwise identical to that 
stated above.
2.8.4 Quantification of Immunohistochemistry
A single observer using coded slides carried out all measurements. The slides 
were visualized using a light microscope (Nikon Eclipse E600) and a digital 
camera (Nikon DXM 1200F camera with Eclipse Net software version 1.16.3 
for Nikon). High-resolution colour images taken of the required fields were 
saved in tif (uncompressed file) format and then analysed using Image J 
software (downloaded from NIH website). In all cases, a frame with a 
predetermined area of 15 X 10cm was centred on the digital image and the 
number of cells within it was counted by clicking on the image with a mouse 
linked to the computer. For each section, 5 representative fields were 
selected for analysis and the mean value of the cell count was recorded. 
When counting the numbers of cells in perivascular infiltrates, the 5 largest 
perivascular infiltrates present in the upper and mid dermis were selected for 
analysis. Cell numbers were expressed as the absolute number of cells 
counted within the frame. For the assessment of Langerhans cell numbers 
the cell number was expressed as cells per epidermal unit area. The area 
within which cells were counted was measured by drawing around the outline 
of the epidermis and then analysed using Image J software.
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2.9 Statistics
Statistical analysis was performed using Graph Pad Prism version 3.00 for 
Windows (GraphPad Software, San Diego, California, USA). Non-parametric 
tests were predominantly utilised as the data could not be assumed to be 
normally distributed. The Kruskall-Wallis test was used to compare three or 
more unpaired groups and the Mann- Whitney was used when comparing only 
two unpaired groups. The Wilcoxon matched pairs test was used when 
comparing two groups of matched data. Asterixes are shown on some graph 
figures to indicate the p value and are rated as follows: p<0.05 *, p<0.01 ** 
and p<0.001***.
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3. Cutaneous and peripheral blood 
responses to antigen in the young and 
oid.
3.1 Introduction
The delayed-type hypersensitivity response to the intradermal injection of 
antigen is traditionally thought to be a memory T cell mediated response, 
representative of underlying cell-mediated systemic immunity. DTH testing in 
the skin therefore potentially provides a useful clinical technique for assessing 
an individual’s immunity to different infections. The cutaneous response to 
the injection of tuberculin purified protein derivative (PPD), known as the 
Mantoux test (MT), is the standard method for determining immunity to 
tuberculosis (TB) and screening individuals for latent TB (NICE guidelines, 
March 2006). It is also used widely in research as the prototypic model for 
delayed type hypersensitivity responses (DTH) in the skin.
In humans, a positive clinical response to the injection of PPD antigen in to 
the skin is typically characterised by erythema and swelling that peaks at 48- 
72 hours and resolves within 14 days. Previous studies in old subjects, 
predominantly performed on nursing home residents, have indicated an 
increase in the percentage of negative DTH reactions to the Mantoux test 
(MT) and other antigens^®°’ ®^^ ’^ ^^ . It has been assumed that this is reflective 
of a generalised decline in cell- mediated immunity with increasing age. 
However, individuals of all ages with diseases such as rheumatoid arthritis^®®, 
chronic renal failure^®\ and malnutrition^®^ have also been observed to have a 
decreased cutaneous responsiveness to the MT. It is therefore unclear 
whether the previously reported decline in DTH responses in the old is related 
to associated co-morbidity or is a true reflection of reduction in their immunity 
as a result of intrinsic ageing.
Previous studies have focused on clinical responses to the injection of antigen 
in the skin or cellular responses to antigen in the peripheral blood, however it
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is not known how these parameters correlate with each other or if the skin is 
reflective of immunity in other compartments. Responses to a variety of 
antigens both in the peripheral blood and skin of old and young individuals 
were therefore investigated in order to assess whether DTH skin test 
responses are truly representative of global immunity to infection.
3.2 The Mantoux test
3.2.1 Clinical responses to the Mantoux test
A total of 35 old and 20 young individuals were tested with the intradermal 
injection of 1 unit of PPD (0.1ml of a 1:10000 solution of PPD skin test 
solution) into the inner aspect of the upper forearm. In previous studies both 
10 and 1 unit doses of PPD have been used in order to elicit DTH responses. 
It has been shown, however, that no difference in clinical response was seen 
between the 2 doses in young individuals who respond after the first test with 
PPD (Unpublished data, Reed JR). The lower dose of PPD was therefore 
chosen for the purpose of this study in order to more readily identify any 
potential differences between the young and old groups.
In all individuals who developed a response, the peak clinical response 
occurred between 48 and 72 hours as demonstrated previously (Figure 2.1). 
At 72 hours the diameter of the response, palpability and change in erythema 
from baseline in the skin were measured and a clinical score was assigned 
(Table 2.2). Previously, the clinical score has been found to parallel the 
degree of erythema and the diameter of the lesion (Unpublished data, Cate 
Orteu). The inclusion of a measurement of palpability (induration) in the 
clinical score was added as this was thought to be a more representative 
reflection of the degree of inflammation in the lesions. In this study, the 
degree of induration was also found to correlate with the clinical score in both 
the young and old groups.
The sum of the clinical scores for the old and young groups was used to 
calculate a mean score for both groups. Overall there was a significantly 
reduced clinical score (P<0.0001 Mann Whitney test) in the old group (Mean: 
0.19, Median: 0) compared with the young (Mean: 6.4, Median: 7.5) (Figure
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3.1). Only 4 old individuals (11% of old people tested) developed a detectable 
clinical response to the MT. The peak and duration of the clinical response in 
these 4 old individuals did not differ from the clinical response in the young 
group.
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FIGURE 3.1 Clinical response to the Mantoux test in the young and old.
The clinical response to the intradermal injection of 1 unit of PPD was
assessed in the young and old at Day 3. This showed a significant reduction 
in clinical score (Mann Whitney test p<0.0001).
3.2.2 Peripheral blood responses to the Mantoux test
We next investigated whether the lack of response in the skin reflected a 
global loss of reactivity to the PPD antigen. The ability of peripheral blood 
mononuclear cells to proliferate in response to antigen is thought to be 
reflective of an individual’s ability to mount a response to systemic infection. 
We therefore examined the functional ability of PBMGs isolated from the blood 
to respond to the PPD antigen using proliferation assays. Purified PBMGs 
were stimulated with a range of doses of PPD antigen from O-IO^ig/ml and 
proliferation was measured by tritiated thymidine incorporation at Day 5. In 
vitro PBMG proliferation assays with PPD showed no statistical difference in
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the ability of cells to proliferate in the young and old groups at concentrations 
of antigen at both 1 pg/ml (Mann Whitney p=0.105) and 10pg/ml (Mann 
Whitney p=0.514) (Figure 3.2)
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FIGURE 3.2 PBMC proliferation in response to PPD antigen (10pg/ml) 
in the young and old.
Following 5 days of culture with PPD, the ability of young and old PBMGs to 
proliferate in response to PPD at a concentration of 10ng/ml was assessed 
using tritiated thymidine incorporation. No difference was found in the ability 
of young and old PBMGs to proliferate in response to antigen (Mann Whitney 
p=0.514).
3.2.3 Correlation of clinical score with peripheral blood responses
The proliferative responses of PBMGs were then correlated with clinical score 
in order to determine whether skin responses are reflective of peripheral blood 
responses (Figure 3.3). In young individuals, good PBMG proliferative 
responses (>10,000 cpm) were associated with a good clinical response to 
the MT. All young and old individuals who had a poor PBMG proliferative 
response (<10, OOOcpm) to PPD at a dose of lOpg/ml had an absent clinical 
response. However, in the old group, there was dissociation between the 
observed absent clinical response in the skin and PBMG responses. In spite 
of good proliferative PBMG responses (equivalent to those seen in the young) 
old individuals failed to develop a clinical response to the MT (Figure 3.3).
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This indicates that, in the old, the absent clinical response to the MT may not 
be reflective of global immunity to the antigen and may be reflective of age- 
specific changes in cutaneous immunity.
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FIGURE 3.3. Correlation of the clinical score following the Mantoux test 
with PBMC proliferation.
The proliferative response of young and old PMBOs to PPD, as assessed by 
tritiated thymidine incorporation at Day 5, was correlated with the clinical 
score in the skin. In young individuals, good proliferative PBMC responses 
(>10000 cpm) were associated with a clinical response in the skin. However 
a large number of old individuals failed to develop a clinical response in the 
skin in spite of good PBMC responses (circled).
Another explanation for the observed differences between the young and old 
could be that all individuals in the young group had been immunised with the 
BCG (Bacillus of Calmette and Guerin) vaccine whereas only one individual in 
the old group had been vaccinated. Previous studies have demonstrated that 
the route of primary exposure to antigen may determine the ability of different 
tissues to subsequently develop memory responses to that antigen. PPD 
comprises of a complex mixture of peptides and carbohydrates derived from 
M. tuberculosis and immunity can be acquired in several ways; namely 
previous and/or latent infection with TB, BCG vaccination and exposure to 
environmental mycobacteria. The young individuals were most likely to have
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developed immunity to the PPD antigen as a result of BCG vaccination 
(administered percutaneously) whereas immunity in the old group was likely to 
be due to previous exposure to tuberculosis or environmental mycobacteria. 
The BCG immunisation program in the UK did not start until the 1940s and 
therefore most individuals over the age of 70 will not have routinely been 
vaccinated. Of interest, however, one old individual in this study had been 
vaccinated and did not have a clinical response to the Mantoux test in spite of 
good peripheral blood response to the antigen. This suggests that 
percutaneous administration of the BCG vaccine may not determine 
subsequent ability to respond to the antigen in the skin in the old.
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3.3 Candida skin testing
3.3.1 Clinical and peripheral blood responses to Candida antigen
In order to exclude differences in exposure to antigen between the young and 
old groups it was decided to skin test individuals with Candida albicans 
antigen as it was thought that the route and degree of exposure to this antigen 
was likely to be equivalent in both groups. Although Candida albicans is 
rarely recovered from normal skin, it is a common inhabitant of the mucosal 
surfaces of the oropharynx and gastrointestinal tract. Serological studies also 
indicate that a significant proportion of individuals negative for Candida 
colonisation at the time of testing have been exposed to Candida in the past. 
Superficial cutaneous infections of the skin are common in healthy individuals, 
in particular in occluded sites such as the axillae, toe web spaces, 
inframammary skin and groins where a warm, moist environment encourages 
colonisation and infection. Reduced cell mediated immunity, such as that seen 
in individuals with congenital T cell defects, further increases the risk of 
Candida infection as seen in chronic mucocutaneous candidiasis where 
extensive, multiple sites become infected^®^’^ ®"^ .
3.3.2 Clinical response to Candida antigen
A total of 27 young and 23 old individuals were tested with the Candin skin 
test with intradermal injection of Candin skin test solution into the inner aspect 
of the upper forearm. A dose of 0.02ml of the Candin skin test solution was 
selected for use in the study as this was the smallest dose/volume that could 
be administered accurately intradermally without the need for diluting the 
commercial preparation with an associated risk of contamination of the skin 
test preparation. Once again, a clinical score was assigned for each 
individual tested based on erythema, diameter and palpability of the clinical 
response (Figure 2.2). In both young and old groups, a peak in clinical 
response to the Candin skin test was seen at 48- 72 hours. As with the MT, 
the clinical score was found to correlate with each individual parameter 
measured in both the young and old groups.
A marked reduction in clinical response to antigen injection was observed in 
the old (Mean: 1.65, Median.O) compared with the young (Mean: 5.52,
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Median: 5) at Day 3 (Mann Whitney test P=0.0004) (Figure 3.4) and at all time 
points following the injection of 0.2ml of Candin skin test solution.
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FIGURE 3.4. Clinical response to the injection of Candin skin test 
solution in the young and old.
There was a marked reduction in the clinical score at Day 3, following the 
injection of 0.02ml Candin skin test solution, in the old compared with the 
young (Mann Whitney p<0.0001).
Repeated testing of the skin with the PPD antigen has previously been 
reported to have a boosting effect on cutaneous responses^®®. One old 
volunteer was tested on 3 separate occasions with 0.02ml of Candin skin test 
solution, at separate sites on both forearms, several months apart. No clinical 
response was seen after the first skin test with 0.02ml Candin, in spite of good 
PBMC proliferative responses. However, on subsequent testing a positive 
clinical response was observed (clinical score=2) and this response increased 
further following the third skin test (clinical score=3). In view of these findings, 
intradermal injection of antigen was performed only once per individual for 
each skin test antigen.
It is also possible that there may be a threshold effect in the old, in that if 
sufficient quantities of antigen are injected into the skin a clinical response can 
be induced. The use of a higher dose of antigen, however, may not be truly
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reflective of antigen load in vivo. In 3 old individuals with good PBMC 
responses to Candida, a higher skin test dose of 0.1ml of Candin was used for 
skin testing. Of the old individuals tested, 2 of 3 developed a clinical response 
(Mean clinical score=4.3).
3.3.3 Peripheral blood response to Candida antigen and correlation with 
clinical response
The ability of old and young volunteers’ PBMCs to proliferate in response to 
Candida antigen in vitro was assessed for a range of concentrations of 
Candida antigen up to 20 pg/ml. No statistical difference was found between 
young and old PBMC proliferation at all concentrations of Candida antigen 
tested including the 20 pg/ml concentration (Mann Whitney p= 0.69) (Figure 
3.5A). The clinical response to the skin test was then correlated with PBMC 
proliferative responses. This demonstrated that, as with the MT, there were 
significant numbers of old volunteers who failed to respond clinically to 
Candida antigen injection in spite of good peripheral blood responses (Figure 
3.5B). The majority of young individuals tested had both good peripheral 
blood responses and skin responses to the Candida antigen. Only one 
individual in the young group failed to develop a clinical response in spite of 
good peripheral blood responses. No specific reason for this could be 
identified.
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FIGURE 3.5. Proliferation of PBMCs In response to Candida antigen and 
correlation with the clinical response to the Candin skin test In the 
young and old.
A. Proliferative PBMC responses were assessed by tritiated thymidine 
incorporation after 6 days in culture with the Candida antigen at a 
concentration of 20pg/ml. No difference in PBMC proliferation was found 
between the young and old groups (Mann Whitney p=0.69). )Linear scale 
shown for proliferation.
B. As for PPD, the clinical response in the skin at Day 3 to the injection of 
Candin skin test solution was correlated with PBMC proliferative responses to 
Candida antigen (20^g/ml). In the young a good PBMC response was 
associated with a good clinical response in the skin. In the old however there 
was a group of individuals who failed to develop a clinical response in the skin 
in spite of good PBMC responses (circled).
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3.4 Varicella zoster virus (VZV) skin testing
3.4.1 Clinical and peripheral blood responses to the Varicella Zoster 
Virus (VZV)
Having demonstrated reduced clinical responses in spite of good peripheral 
blood responses to testing with both bacterial (PPD) and fungal (Candin) 
antigens in the old, we decided to investigate whether this observation could 
also be extended to viral antigens. VZV is a herpes virus that infects 98% of 
the adult population. As a primary infection, usually seen in children less than 
10 years of age, VZV causes chickenpox with a widespread vesicular eruption 
over the skin. During primary infection lifelong infection within the cutaneous 
dorsal root sensory ganglia is established. The reactivation of latent virus in 
later life results in both pain and a vesicular eruption within a dermatome in 
the skin, known as shingles^®®. Shingles is particularly problematic in the 
older population with greater than 66% of the population over the age of 50 
years affected. Pain in the skin following shingles, known as post herpetic 
neuralgia, causes considerable morbidity and often persists long term^"^\ The 
increased incidence of shingles in the older population has previously been 
attributed to an overall decline in cell- mediated immunity with age. A previous 
study has observed reduced responses in the skin of old individuals to testing 
with a VZV skin test antigen comprising of a heat inactivated OKA strain of 
VZV^® .^ However clinical responses in the skin were not correlated with 
underlying responses to VZV antigen in the peripheral blood.
0.02ml of VZV skin test solution was injected intradermally into the inner 
aspect of the forearm in 8 young and 10 old individuals. As for the Candida 
skin test, the 0.02ml volume of skin test solution was selected on the basis 
that this was the smallest volume that could accurately be injected into the 
skin. A reduction in the clinical score was observed in the old group 
(Mean=1.7, Median:0) compared with the young (Mean= 6.38, Median:6.00) 
(Mann Whitney Test p=0.0021) (Figure 3.6A). PBMC responses to VZV 
antigen were also assessed using proliferation assays. Purified PBMCs were 
cultured with VZV antigen over a range of concentrations up to 4pl/ml for 6 
days and proliferation was then assessed using tritiated thymidine
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incorporation. Unlike proliferative responses to Candida and PPD antigens, 
there was a reduction in PBMC proliferation in the old for a range of 
concentrations of VZV antigen, including proliferation at a peak concentration 
of 4|il/ml Figure 3.6B)(Mann Whitney test p=0.04) This suggests that older 
individuals lose systemic immunity to the VZV virus and this may explain the 
increased frequency of viral reactivation in the old.
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FIGURE 3.6 Proliferation of PBMCs In response to VZV antigen and 
correlation with the clinical response to the VZV skin test In the young 
and old.
A. A significant reduction in the clinical score in the skin was seen in the old 
compared with the young at Day 3 after injection of 0.02ml of the VZV skin 
test solution (p=0.0021). Only one young individual, who had no previous 
history of chickenpox, failed to respond to the VZV skin test (circled).
B. Following 6 days of in vitro culture of PBMCs with the VZV antigen, PBMC 
proliferation was assessed using tritiated thymidine incorporation. A reduction 
in proliferative responses at a peak concentration of 4pl/ml was observed in 
the old compared with the young (Mann Whitney test p=0.04).
C. PBMC proliferative responses to VZV antigen were correlated with the Day 
3 clinical score following injection of VZV skin test antigen. One old individual 
was found to have an absent skin response in spite of good PBMC 
proliferative responses to VZV antigen (circled).
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It is possible that individual variation in the timings of exposure to and 
infection with VZV may have been responsible for the observed results. As 
chickenpox is predominantly a childhood infection, primary VZV infection 
would have occurred more recently in the young group with less time for 
immune responses to diminish. Of the subjects tested, only one young 
individual had no previous history of chickenpox and this person failed to 
develop either a clinical or peripheral blood response to the VZV antigen. Two 
of the old subjects were unsure if they had had chickenpox as children and 
had no history of shingles, however both of these individuals had good 
peripheral blood responses and clinical responses to the VZV antigen. The 
rest of the old and young recruits had a history of chickenpox as children. Five 
old individuals and no young individuals had a history of shingles. No 
statistically significant difference was found for PBMC proliferation (Mann 
Whitney test. p=0.76) or clinical responses (Mann Whitney. p= 0.48) to VZV 
antigen in individuals with or without a past history of shingles. No one had a 
recent history (within the last year) of shingles or close contact exposure to 
individuals with chickenpox or shingles.
Correlation of clinical score with PBMC proliferation revealed that, as for the 
other skin test antigens, all young individuals with a good blood response to 
VZV antigen developed a good clinical response to the VZV skin test (Figure 
3.6C). Four old individuals had a detectable clinical response to injection with 
the VZV antigen in addition to good peripheral blood responses however 
these scores were significantly reduced compared with the young responder 
group (Mann Whitney test. p=0.006). One old individual failed to develop a 
clinical skin response in spite of a good PBMC proliferative response to VZV 
antigen (Figure 3.6C). Due to the limited numbers of subjects tested it is 
difficult to conclude what proportion of old individuals are unresponsive to skin 
testing with VZV skin test antigen in spite of good peripheral blood responses, 
however a skin-specific loss of immunity in the old to VZV may in part explain 
the prediliction for cutaneous involvement following viral reactivation in 
shingles.
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3.5 Effects of cytomegalovirus (CMV) infection on immune responses
Loss of immunity to certain antigens, for example VZV, with ageing may be 
related to infection with other chronic latent viral infections such as human 
cytamegalovirus (CMV). CMV infection is thought to be one of the indicators 
of the so-called immune risk phenotype seen with ageing^^^. The massive 
clonal expansion of CMV specific T cells seen in individuals with chronic latent 
infection is thought to crowd out T cells with other antigenic specificities with a 
resulting restriction in the memory T cell pool repe r to i re^ I t  has previously 
been demonstrated that there is a reduction in telomere length of antigen- 
specific I  lymphocytes for a variety of antigens including VZV and PPD in 
individuals with latent CMV i n f e c t i o n ^ O n c e  telomeres have reached a 
critical length the cell will undergo apoptosis. A reduction in telomere length 
therefore implies that there is a reduced replicative capacity and therefore 
reduced immunity to the antigen for which the T cells are specific.
CMV positive individuals in this study were identified on the basis of the ability 
of their PBMCs to produce IFN-y after overnight incubation in vitro with CMV 
antigen. Purified PBMCs were stimulated overnight with CMV antigen at a 
final concentration of 100 pl/ml in the presence of Brefeldin A. IFN-y 
producing cells were then identified using fluorescently labelled antibodies 
and analysis by flow cytometry. (Figure 3.8). We have previously established 
that individuals with a positive IFN-y overnight incubation response to antigen 
also have serum IgG antibodies to CMV, indicating that these individuals have 
persistent latent viral infection.
The clinical DTH response to Candin skin test solution (Figure 3.7A) and PPD 
in the skin did not appear to be affected by a positive CMV status in the young 
or old groups. Of the 4 old individuals that had a clinical response to testing 
with PPD, 50% were CMV positive. However, a higher proportion of CMV 
positive compared with CMV negative individuals failed to develop a clinical 
response to VZV in the old group (83% of CMV positive individuals versus 
25% of CMV negative individuals)(Figure 3.7B). This result may also reflect 
the fact that overall PBMC responses were reduced in the CMV positive group
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compared with the CMV negative group (mean cpm 11154 vs 20481 
respectively). The number of individuals tested was too small for the results 
to reach statistical significance. CMV status did not influence response to VZV 
testing in the young, however it is thought that chronicity of CMV infection is 
important for exerting detrimental effects on the immune system and so the 
young individuals’ immunity may as yet be unaffected by CMV infection.
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FIGURE 3.7 Effect of CMV Infection on the clinical response to Candin 
and VZV skin test responses In the old.
A. No difference in clinical score at Day 3 following Candin skin test injection 
was found between old individuals with and without CMV infection. Infection 
with latent CMV in the individuals studied was determined by ability of CD4+ T 
lymphocytes to produce IFN-y in response to overnight stimulation with CMV 
antigen in the presence of brefeldin A, as determined by flow cytometry 
(Figure 3.8). B. The clinical score at Day 3 following VZV skin test injection 
was compared in old individuals with and without CMV infection. No 
statistically significant difference was identified between CMV positive and 
negative individuals (Mann Whitney p=0.11), however a larger proportion of 
old individuals with CMV had an absent response to VZV skin test (83%), 
compared with the CMV negative (25%) Individuals.
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FIGURE 3.8 PBMC- derived CD4+ T lymphocyte Intracellular IFN-y 
expression following culture with CMV antigen.
PBMCs were incubated for 15 hours with or without CMV antigen in the 
presence of Brefeldin A that was added after the first 2 hours of culture. The 
cells were then stained with CD4 PercP and IFN-y APC following fixation and 
permeabilisation (Caltag Fix and Perm Cell kit). The cells were examined for 
IFN-y expression by gating on live lymphocytes based on FSC/SSC profile (A) 
and then CD4 expression (R2 and R3 gates). The dot plots show 
representative expression of IFN-y in CD4+ cells in the un stimulated control 
sample (B) and following addition of the CMV antigen (C) (The percentage of 
IFN-y+ cells in this representative individual is shown). Percentages of antigen 
specific cells were calculated by subtracting the percentage of IFN-y positive 
cells present in the un stimulated cell sample (B) from the CMV stimulated 
sample(C).
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3.6 Discussion
This work has demonstrated that, although in the young DTH skin testing is a 
good indicator of immunity to the antigen being tested, in the old group the 
diminished DTH response in the skin is not reflective of a comparable decline 
in all compartments of the immune system. In spite of good peripheral blood 
responses to bacterial (PPD) and fungal (Candida) antigens, old individuals do 
not respond clinically to the injection of these antigens into the skin. 
Furthermore, this finding may also be applicable for viral recall antigens in that 
the same dissociation between skin and blood responses was seen in one 
individual following skin and blood testing with VZV antigen. Although the 
possibility of differences in the route of exposure and immunisation to the PPD 
antigen was considered as a possible cause for the observed differences 
between the young and old groups for the Mantoux test, our findings 
demonstrated that these results were not confined to testing with PPD antigen 
alone and were therefore unlikely to be due to differences in the route of 
immunisation. We therefore felt justified in using data from both Candida and 
Mantoux skin testing for the purpose of further studies discussed in this thesis.
It is well recognised that certain groups of young individuals who are 
immunosuppressed, such as those with HIV, may have a negative MT in spite 
of acute infection with Numerous studies have documented age-
associated changes in different types of immune cells including T cells, B cells 
and antigen presenting cells that may result in defective immunity with 
ageing^^V In particular, changes in the memory T cell pool may result in the 
loss of immune memory^^^. However, the equal ability of young and old 
PBMCs to proliferate in response to both PPD and Candida antigens suggests 
that healthy old individuals used in this study were not significantly 
immunocompromised. It is possible that PBMC proliferation is not totally 
representative of an individuals' ability to respond to infection. However, 
previous studies investigating global parameters of immunity in healthy old 
individuals also indicate that the decline in immunity is modest in this 
population^®®. This data is further supported by the prior observation that 
anergic old individuals have been able to mount an adequate secondary
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immune response following infection witfi acute A negative skin test
response to cutaneous challenge with antigen in the old is therefore not 
necessarily reflective of globally reduced immunity.
The use of the Mantoux test to assess for BCG vaccine efficacy as a correlate 
of protective immunity is questionable. A previous study has indicated that 
some individuals that have been vaccinated with BCG whilst young lose their 
ability to respond to skin testing with time^®. With the increase in worldwide 
tuberculosis infection and the advent of immunomodulatory anti- IN F  a drugs 
to treat disease such as rheumatoid arthritis and psoriasis, where there is a 
risk of reactivation of latent it is essential that we have the tests
available to be able to accurately assess old individuals’ immunity to TB. 
These findings show that the Mantoux test greatly underestimates immunity in 
healthy old individuals and therefore this study has wide reaching implications 
for the use of the Mantoux test as a screening test.
The diameter of the response (>15mm) is often used to determine the 
likelihood of a positive response due to BCG vaccination versus acute or 
latent TB infection. Our findings suggest that this method may not be reliable 
in old individuals. More recently, the use of Elispot assays assessing IFN-y 
peripheral blood responses to 2 antigens specific for the human tuberculosis; 
early secretory antigenic target 6 (ESAT 6) and culture filtrate protein 10 
(CFP10)) have been developed^^"^ and may represent a more accurate and 
reliable method for screening individuals of all ages for infection with TB.
One of the major limitations to longevity with a good quality of life is likely to 
be related to the ability of the immune system to function adequately^®^ and 
therefore tests providing accurate information on immunity to infection are 
going to become increasingly important as the proportion of individuals over 
the age of 70 within the population increases. In view of limited financial 
resources, the identification of individuals that would benefit from boosting of 
their immunity to specific infections, for example by immunisation to influenza
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or VZV, is desirable. However, this work indicates that skin testing is not 
suitable for this purpose in the old.
The apparent dissociation between cutaneous and blood responses to antigen 
suggests that there is a skin specific reduction in immunity that occurs with 
ageing. These findings have wide reaching implications in that they may 
explain the observed increase in cutaneous malignancy^^°, infection and 
reduction in severity of atopic dermatitis with age^®^ . The potential 
mechanisms for skin-specific reduction in immunity are the focus of further 
investigation discussed in this thesis.
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4. Characterising the lymphocytic 
response to antigen in the old.
4.1 Introduction
In humans, the skin represents an accessible organ in which we can readily 
study dynamic immune responses. Immunohistochemistry and flow cytometry 
techniques were used in this study in order to characterise the in vivo 
dynamics of lymphocytic responses in the skin during the course of a DTH 
response to both the MT and Candin. Both techniques are complimentary, in 
that whilst immunohistochemistry permitted the morphological and quantitative 
investigation of cell types present in the skin, flow cytometry allowed for more 
accurate multiparameter phenotyping of cells in addition to assessment of 
functional characteristics.
Various cell isolation techniques, such as enzyme digestion and mechanical 
disaggregation, have been employed by different investigators in the past in 
order to retrieve skin cells suitable for flow cytometric analysis. However, 
reduced expression of CD3, CD4 and CDS in addition to integrins and 
selectins on lymphocytes has been reported with the use of such techniques. 
Skin explant cultures can also be used to extract lymphocytes from the skin, 
however this requires 5 days or longer of in vitro culture with possible resulting 
changes in cell phenotype, limiting the study of dynamic responses in the skin. 
In this study, a skin suction blister technique was used to extract viable T 
lymphocytes accumulating at the site of the DTH response for the purpose of 
flow cytometry. This technique allowed for direct ex-vivo study of cell 
phenotype and function in addition to the collection of fluid in order to study 
chemical mediators present at the site (discussed in Chapter 5).
The lymphocytic response during the course of the Mantoux reaction in the 
young has been characterised. This has revealed that the lymphocytic 
response comprises predominantly of CD4+ memory (CD45RA-) T 
lymphocytes that proliferate and accumulate at the site of the response, 
reaching a peak at Day 7^. In addition, there is an expansion and contraction
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of an antigen specific cell population of CD4+ T lymphocytes during the 
course of the response®®. Interestingly, there is dissociation between the 
peak clinical response (seen at 48-72 hours) and the peak lymphocytic 
response (seen at Day 7)®^ . Although other cell types, such as macrophages 
and neutrophils are seen in abundance in the skin at early time points, a 
clinical response is only seen in those with immunity to the antigen indicating 
that adaptive, cell mediated immunity is essential for a clinical response to 
develop in the skin. This suggests that T lymphocytes must play a crucial and 
early role in the development of the clinical response following the intradermal 
injection of recall antigens.
We therefore investigated whether the observed reduction in clinical response 
to antigen injection in the old was also associated with a reduced lymphocytic 
response in the skin.
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4.2 Number of T lymphocytes at site of response in skin
4.2.1 Cell numbers retrieved from skin suction biisters foliowing the MT
using the Trucount technique.
Skin suction blisters were raised over the site of the MT in 3 old and 3 young 
volunteers at Day 7. The Day 7 time point was chosen as this has previously 
been shown to be the time of peak lymphocytic infiltration into the skin 
following the MT in the young^. The old volunteers selected for the study had 
no clinical response to the MT in spite of good peripheral blood responses to 
PPD. The young group had good clinical responses to the MT in addition to 
good peripheral blood responses to PPD.
Cells were separated from the blister fluid by microcentrifugation and total 
numbers of GD3+ and CD4+ lymphocytes were calculated using the Trucount 
technique. A reduction in the number of CD3+ and CD4+ T lymphocytes 
retrieved from the blister fluid was seen at Day 7 in the old subjects compared 
with the young (Figure 4.1) (Mann Whitney p=0.02) for both CD3 and CD4 T 
lymphocytes.
^ 8 75000
^  100000 
"6
i i
50000
25000-
YOUNG OLD YOUNG OLD 
CD3 CD4
FIGURE 4.1 Numbers of CD3+ and CD4+ lymphocytes In young and old 
blisters at the site of the MT.
Skin suction blisters were raised over the site of the MT at Day 7 in young and 
old. Cells isolated from blister fluid were stained with cell surface antibodies 
to CD3 and CD4 and counted using the Trucount technique. A significant 
reduction in both numbers of CD3 and CD4 T lymphocytes were found in the 
old compared with the young (Mann Whitney p=0.02 for both CD3+ and CD4+ 
T lymphocytes).
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4.2.2 Cell numbers counted from skin biopsies following Candin skin 
test (CD3+, CD4+, CD8+ cells)
In order to assess whether a similar reduction in cell number was observed 
with other antigens, we decided to investigate the cellular response to Candin 
skin tests. Although we had demonstrated a reduction in numbers of 
lymphocytes isolated from skin suction blisters in the old for the MT, we were 
unable to exclude the possibility that not all of the cells present in the skin 
were retrieved using the skin suction blister technique. In view of this, it was 
decided to analyse cell numbers on the basis of analysis of skin biopsies. 
5mm skin punch biopsies were taken from the site of injection of 0.02ml 
Candin skin test solution at day 0, 1, 3 and 7 in young and old individuals. 
The clinical score was recorded at day 3 and at the time of biopsy. A 
minimum of 4 young and 4 old individuals were tested at each time point. In 
the young and old groups there was no significant difference in the mean 
clinical response scores obtained at 72 hours for the groups at each of the 
time points, confirming that similar clinical responses were obtained 
regardless of the time of the biopsy (Kruskal-Wallis young: p=0.48, old: 
p=0.32)
Fresh frozen skin biopsies were sectioned and stained with antibodies for 
CD3, CD4 or CD8 using the indirect immunoperoxidase technique. The 
numbers of positive subtypes were then identified using light microscopy and 
counted using the Image J software. For each section, 5 frames with a 
predetermined area were centred on the 5 largest perivascular infiltrates 
within the dermis. Each frame was counted and the mean value of the cell 
count for the 5 frames was calculated.
Normal skin was found to contain small numbers of lymphocytes, 
predominantly seen around blood vessels, in both the young and old groups 
(Figure 4.2). No significant difference was found between numbers of cells in 
the young and old (Mean young vs old: CD3:1.56 cells(SD±1.88) vs 1.64 
cells(SD±1.87), CD4:0.56 cells(SD±0.71) vs 1.56 cells(SD±1.39), CD8: 0.13 
cells(SD±0.14) vs 0.25 cells (SD10.23). In both groups CD4+ cells 
outnumbered CD8+ cells (ratio of 4.6:1 CD4:CD8 cells combined data from
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old and young groups). It is possible that a proportion of the CD4+ cells 
stained represented resident tissue macrophages, however the sum total of 
CD4+ and CD8+ T cells equalled the number of CD3+ T lymphocytes in most 
cases, suggesting the number of non- lymphocytic cells expressing CD4 in 
normal skin were negligible.
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FIGURE 4.2 Numbers of CD3+, CD4+ and CD8+ in normal skin in young 
and old.
Skin biopsies taken from normal skin on the forearm were stained with 
antibodies for CD3, CD4 or CD8 using the immunoperoxidase technique in 
young (Y) (Photo plate 1) and old (O) individuals. Cell numbers are expressed 
as the mean number of cells counted for 5 representative frames for each 
individual. No significant difference in the numbers of cells was found for all 
cell types (Mann Whitney CD3: p=0.69, CD4: p=0.22, CD8: p=0.42) between 
the young and old groups. In both young and old groups a higher numbers of 
CD4+ cells were seen compared with CD8+ cells.
4.2.3 Numbers of CD3+ and CD4+ cells
In the young, after the injection of intradermal Candin, CD3+ and CD4+ cells 
were seen to accumulate perivascularly within the dermis (Photo plate 1). 
Perivascular CD4+ and CD3+ cell numbers had risen significantly from 
baseline by 24 hours (p=0.0079 for both CD3+ and CD4+ cells) with 
subsequent increases in the number of cells at day 3 (mean=CD4+:52.6 cells 
SD±21.93, CD3+:77.0 cells SD±39.68) and day 7(mean=CD4+ 70.68 cells
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SD±36.69, CD3+ 92.25 cells SD±46.43). Although the majority of infiltrating 
cells were within perivascular areas, small numbers of cells were seen within 
the interstitium and the epidermis (Photo plate 1) in some individuals. This 
was particularly evident where the total number of lymphocytes infiltrating the 
skin was large.
A reduced mean number of CD4+ and CD3+ T cells was seen over all time 
points studied in the old compared with the young (Fig 4.3A+B). For 
individual time points, however, the 24 hour time point was the only time that a 
reduction in CD4+ T cells present in old skin was significant between the 
young and old groups (Mann Whitney p= 0.0079). For both young and old 
biopsies the number of CD3+ (Spearman r=0.774, p=0.017) and CD4+ cells 
(Spearman r=0.928, p=0.0007) present at day 7 (the peak of the cellular 
response) correlated well with the clinical score at day 3 (the peak of the 
clinical response (Figure 4.3C). Given that we have demonstrated reduced 
clinical score in the old group as a whole it is therefore likely that cell numbers 
present in the skin are reduced overall in the old group.
105
CDS, CD4 and CD8 
STAINING
:''y:
w f m»t : ,r,
i
PHOTO PLATE 1. Infiltration of CD4, CD3 and CD8+ cells at the site of 
antigen injection in the young with good clinical responses.
Fresh frozen sections of skin biopsies taken from the site of injection were 
stained with antibodies for CD4, CD3 and CD8 using the indirect 
immunoperoxidase technique. Sections were counterstained with Nuclear 
Fast Red.
1. Skin section at low power (x10 magnification) stained with anti- CD3 
antibodies showing perivascular infiltrates (example circled). Biopsy 
taken at Day 7 from individual with good clinical response. CD3-k cells 
within the interstitium and epidermis can also be seen (arrowed).
2. Perivascular infiltrate CD34- cells (x40 magnification).
3. Perivascular infiltrate CD8+ cells (x40 magnification).
4. Skin section at low power (x10 magnification) stained with anti- CD4 
antibodies showing perivascular infiltrates (example circled). Biopsy 
taken at Day 7 from individual with good clinical response.
5. Perivascular infiltrate CD4-f- cells (x40 magnification).
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FIGURE 4.3 Numbers of CD3+ and CD4+ perivascular cells in skin 
biopsies from young and old individuals after Candin skin testing.
Skin biopsies were taken at 1 ,3  and 7 days after skin testing with Candin in 
young and old individuals. Fresh frozen skin biopsies were sectioned and 
stained with antibodies for either CDS or CD4 using the indirect 
immunoperoxidase technique. For each individual biopsy one section of 
tissue was analysed. The mean number of cells for 5 frames, centred around 
the 5 largest perivascular infiltrates within the section, was calculated. 5 
individuals in both the young and old age groups were biopsied for each of the 
time points. Graphs A and B show the mean numbers of cells within 
perivascular infiltrates for each individual. Error bars show the SEM. In the 
young and old, the peak cellular infiltrate for CD3+ (A) and CD4+ cells (B) 
was seen at Day 7. A reduction in the numbers of CD3+ and CD4+ cells was 
seen for all time points in the old compared with the young, although this only 
reached statistical significance for CD4+ cells (B) at the 24 hour time point 
(Mann Whitney test p=0.0079). However correlation between the clinical 
score at Day 3 and number of cells at Day 7 showed a significant correlation, 
for both CD3+ cells (C) (Spearman r=0.774, p=0.017) and CD4+ cells 
(Spearman r=0.928, p=0.0007) (D).
4.2.4 Numbers of CD8+ ceils
Although the number of CD8+ T cells initially increased at 24 hours from 
baseline in the young and old (Wilcoxon ranked pairs test p=0.002), the 
numbers of infiltrating CD8 cells then remained constant up to the Day 7 time 
point (Figure 4.4). There was no significant difference in the numbers of 
CD8+ cells in skin between young and old at each timepoint measured. The 
numbers of CD8 cells in the young were low in comparison with the numbers 
of CD4+ cells, highlighting the fact that the response in the skin is a 
predominantly CD4+ T cell response. Overall the ratio of CD4+ to GD8+ T 
lymphocytes in the old group was low compared with the young group. This 
suggests that initially in the DTH response both CD4+ and CD8+ cells are 
recruited to the skin in the young and old. In the young, however, there is 
subsequent accumulation of CD4+ but not CD8+ T lymphocytes at the site, 
such that CD8+T lymphocytes are outnumbered in later phases of the 
response. The reduction in CD4+ cell numbers in the old may therefore be 
reflective of a lack of expansion of CD4+ T lymphocyte population during the 
course of the response.
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FIGURE 4.4 Numbers of CD8+ perivascular cells in skin biopsies taken 
from young and old individuals after Candin skin testing.
Skin biopsies were taken at 0 ,1 ,3  and 7 days after skin testing with Candin in 
the old and young. 4-5 different individuals were tested for both groups at 
each time point. Biopsies were sectioned and stained with an antibody for 
CDS using the indirect immunoperoxidase technique. For each individual, 5 
frames centred around the 5 largest perivascular infiltrates were counted per 
section and the mean number of cells was calculated. Although at 24 hours 
there was a significant increase in the number of CD8+ cells in the skin in 
both the young and old groups (Wilcoxon ranked pairs test p=0.002 for 
combined data from both groups), the number of CD8+ cells then remained 
relatively constant up to the Day 7 time point. No difference in the number of 
CD8+ cells was found for each time point between young and old groups.
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4.3 Number of perivascular infiltrates seen during course of response to 
Candin in the young and old.
Although data is conflicting, some studies have shown a reduction in the 
number of capillaries within ageing skin^^®. The actual number of perivascular 
infiltrates seen in the skin in the old and young was therefore calculated in 
order to exclude a reduction in the actual numbers of blood vessels in old skin 
as a reason for the observed reduction in lymphocyte numbers. Skin sections 
stained for CD3 were used for the purpose of counting the numbers of 
perivascular infiltrates at days 1, 3 and 7 after the injection of Candin skin test 
solution into the skin. The number of infiltrates within 3 representative low 
power fields was counted for each skin section and the mean of the 3 counts 
was calculated (Figure 4.5). No significant change in the number of 
perivascular infiltrates present in the skin biopsies over the time course 
studied was found in either the old (Kruskall Wallis test p=0.8) or the young 
groups (Kruskall Wallis test p=0.9). In addition, no significant difference in the 
number of perivascular infiltrates was found between young and old skin, 
suggesting that there was no significant reduction in the actual number of 
blood vessels within the skin in the old.
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FIGURE 4.5 Numbers of perivascular Infiltrates in skin biopsies from 
young and old individuals
Skin biopsies were taken at 1 ,3  and 7 days after skin testing with Candin in 
the old and young. Biopsies were sectioned and stained with an antibody for 
CDS using the indirect immunoperoxidase technique. Sections were also 
counterstained with Nuclear Fast Red. For each individual, 3 representative 
low power frames were selected and the number of perivascular infiltrates 
within each field was counted. The mean number of perivascular infiltrates 
per field was then calculated for each individual. In both young (Y) and old 
(O) individuals no change in the actual number of perivascular infiltrates seen 
occurred throughout the response (Kruskall Wallis test p=0.8 old, p=0.9 
young). No significant difference in the number of perivascular infiltrates was 
found between old and young individuals. (Mann Whitney p>0.5 for all time 
points).
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4.4 Activation of lymphocytes (CD69 expression) isolated from site of 
MT response.
We then decided to investigate whether the observed decrease in cell number 
present at the site of skin testing seen in the old was also correlated with a 
reduction in cellular activation. CD69 is expressed on a range of activated 
cells including B and T lymphocytes, macrophages and NK cells and is an 
early activation antigen. Upon activation, T lymphocytes produce an array of 
pro-inflammatory mediators, such as IFN-y and TNF-a. These cytokines are 
critical for both the amplification of immune response in addition to inducing 
cutaneous vasodilatation and extravasation contributing to erythema and 
induration observed as part of the clinical response. A lack of activation of 
cells in the old could therefore explain reduction in the clinical score and 
reduced numbers of lymphocytes.
Lymphocytes isolated from blisters in the young and old were stained with 
antibodies immediately ex vivo for CD3, CD4 and CD69 and analysed by flow 
cytometry in order to establish whether the cells present in the blister fluid 
were activated (Figure 4.6). Analysis of CD69 expression on CD4-i- T 
lymphocytes at Day 7 following the MT revealed a significant reduction in the 
percentage of CD4+ T lymphocytes expressing CD69 in the old compared 
with the young (Mann Whitney p=0.0357), indicating a reduction in cellular 
activation in the skin in the old (Figure 4.7). Levels of CD69 expression on 
lymphocytes isolated from blisters were significantly higher than in peripheral 
blood in both young and old (p=0.01 and p= 0.001 respectively).
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FIGURE 4.6 T lymphocyte intracellular KI67 and CD69 expression in skin 
suction blister cells and PBMGs collected at day 7 after the Mantoux test 
following culture with PPD antigen.
Skin suction blister cells and PBMGs were stained immediately ex-vivo with 
CD3 ARC, CD4 PercP, Ki67 FITC and CD69 PE. Live lymphocytes were 
gated on the basis of the FSC/SSG profile in order to exclude cell debris (A) 
and then gated on the basis of GD4+GD3+ expression in the blood (B) and 
blister (not shown) cell populations. Dot plots show the expression of GD69+ 
(G) and Ki67+(D) GD4+ cells from the PBMG and skin suction blister cells. 
Numbers in the upper right quadrants indicate the percentage of GD4+ Ki67+ 
or GD4+ GD69+ cells. The cell samples shown were from a representative 
young individual at Day 7 with a good clinical response following the injection 
of PPD into the skin.
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FIGURE 4.7. Percentage of CD4+CD69+ T lymphocytes in the old 
compared with the young at the site of the MT and in peripheral blood at 
Day 7.
Cells isolated from skin suction blisters induced at Day 7 after the MT and 
peripheral blood were stained with antibodies for CD3, CD4 and CD69 
immediately ex v/Vo and analysed by flow cytometry. A significant reduction in 
the percentage of CD69+CD4+lymphocytes was found in the old compared 
with the young (Mann Whitney p=0.0357). Low percentages of cells isolated 
from peripheral blood were found to express CD69 compared with blister cells 
in both the young and old.
4.5 KI67 expression in the skin
4.5.1 Proliferation of lymphocytes isolated from skin suction blisters at 
the site of the Mantoux Test (Ki67 expression)
Previously it has been proposed that cells proliferate locally at the site of the 
response to the MT in the skin in humans, accounting for increasing cell 
numbers observed rather than ongoing recruitment of T cells to the site from 
the blood. Reduced proliferation of CD4-I- T lymphocytes within the skin in the 
old may explain the observed reduced numbers of lymphocytes present. We 
therefore investigated whether the cells present at the site of testing were 
proliferating using Ki67. Ki67 is a marker of cell proliferation that is expressed 
in the G1, S, G2 and M phases of the cell cycle.
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In order to establish whether a reduction in proliferation of cells at the site 
could explain the reduced cell numbers present in the old, suction blisters 
were raised over the MT at day 7 in 5 young and 5 old individuals. As 
previously, all individuals tested had good peripheral blood responses to the 
PPD antigen, however none of the old group had a clinical response to the MT 
whereas the entire young group had a good clinical response. The day 7 time 
point was chosen as this had previously been shown to be the time of peak 
Ki67 expression for the MT in young individuals®®. Cells were isolated from 
the blister and stained with antibodies for CD3, CD4 and Ki67, in order to 
determine the percentage of cells proliferating by flow cytometry (Figure 4.7). 
In the young group, around 30% GD4+ T lymphocytes were found to be in cell 
cycle as indicated by Ki67 expression, (mean: 28.01% SD±14.81) (Figure 
4.8). Minimal blood GD4+ and GD8+ T lymphocyte proliferation occurred 
during the course of the MT. In addition, only small numbers (<2%) of GD8+ 
SB T cells expressed KI67. This confirmed previous findings (unpublished 
data, Reed JR). In the old group, mean Ki67 levels were reduced at Day 7 
compared with the young however this did not reach statistical significance 
(Mann Whitney p=0.095) (Figure 4.8A).
In order to determine whether proliferation in the skin could be induced by the 
trauma of injection alone, 0.1ml of Mantoux control solution was injected in to 
the forearm skin in 4 old and 3 young volunteers (Figure 4.88). The Mantoux 
control solution was obtained from the same suppliers as the Mantoux test 
solution and contained the diluent of the tuberculin purified protein derivative 
only. Suction blisters were induced at Day 7 and isolated skin suction blister 
cells were stained as for the MT SB cells. KI67+ GD4+ T cells were identified 
in skin suction blister cells isolated from the site of the injection of control 
solution. Although in the young group there was a reduction in the percentage 
of proliferating cells following the injection of the control solution compared 
with the MT (Wilcoxon ranked pairs test p=0.04), no difference was found 
between the MT or control skin tests in the old group (Mann Whitney test 
p=0.21). This implies that the level of Ki67 expression seen in old PPD
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blisters is probably representative of that induced by trauma rather than due to 
an antigen-specific response to the PPD antigen (Figure 4.8).
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FIGURE 4.8 Percentage CD4+ KÎ67+ lymphocytes in peripheral blood 
and SB at Day 7 after the MT and injection of the Mantoux control 
solution.
A. Skin suction blisters were induced at Day 7 after the MT in young and old 
volunteers. Suction blister cells and PBMCs were isolated and stained with 
antibodies for CD4 and Ki67 in order to identify CD4+ Ki67+ T lymphocytes by 
flow cytometry (Figure 4.7). A reduction in the mean number of Ki67-i- CD4+ T 
lymphocytes was seen in the old compared with the young, although this did 
not reach statistical significance (Mann Whitney test p=0.095).
B. Skin suction blisters were also induced at Day 7 at the site of injection of 
Mantoux control test solution in the young and old. SB cells were isolated and 
stained as for the cells in Figure 5a. In the young, a reduction in the 
expression of Ki67 on CD44- T lymphocytes was seen at the site of control 
solution injection compared with the MT test site (p=0.04). However, in the 
old, no significant difference in the expression of Ki67 was found between the 
MT test site and the control test site (p>0.5).
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4.5.2 Proliferation of cells identified in skin biopsies at site of Candin 
skin test (Ki67 expression)
In order to establish whether similar levels of proliferation were found following 
Candin injection, skin biopsies were taken at different time points after skin 
testing and stained with antibodies for Ki67 using an indirect 
immunoperoxidase technique. All individuals tested had good peripheral blood 
proliferative responses to the Candida antigen. Ki67+ cells were identified by 
light microscopy and counted as previously described. In all samples, Ki67+ 
cells were seen within the basal layer of the epidermis (Photo plate 2 (1+2)) 
consistent with constitutive proliferation of the epidermal kératinocytes. Small 
numbers of Ki67+ cells only were seen in the dermis up to day 7 when 
numerous Ki67+ cells were seen in perivascular infiltrates (Photo plate 2 
(2+3)).
As with the MT, in the young the percentage of Ki67+ cells within the 
perivascular infiltrate was around 20% suggesting that levels of proliferation 
were similar to those observed for the MT using the skin suction blister 
technique (Figure 4.9). For the old group, the majority of the old individuals 
had reduced numbers of Ki67+ cells (Mean; 4.867 cells) compared with the 
young (Mean: 20.92 cells)(Figure 4.9) although this did not reach statistical 
significance (Mann Whitney p=0.06). One old individual was found to have 
markedly higher numbers of cells expressing Ki67 (circled Figure 4.9A) 
compared with the rest of the old group. This old individual had a good 
clinical score in the skin (clinical score =6), in addition to high numbers of 
infiltrating perivascular T cells present at day 7 (mean number perivascular 
CD4+ T cells: 80.8 cells vs overall mean for old group: 33.24), indicating that 
this individual was not representative of the old population as a whole. 
Correlation of clinical score at Day 3 with the number of Ki67+ cells in both 
young and old groups however showed a positive correlation with increasing 
numbers of Ki67 cells with increasing clinical score (Spearman r=0.863, 
p=0.0045). It therefore seems likely that there is reduced Ki67 expression in 
the old with absent or poor clinical responses to the Candin skin test.
119
NORMAL SKIN
YOUNG SKIN DAY 7
OLD SKIN DAY 7
PHOTO PLATE 2
120
PHOTO PLATE 2. KI67+ cells in the skin following Candin skin testing.
Fresh frozen skin biopsies were stained with Ki67 using an indirect
immunoperoxidase technique. Sections were counterstained with Nuclear
Fast Red.
1. Biopsy of normal skin (x10 magnification). Showing Ki67+ cells within 
epidermis and around hair follicles.
2. Biopsy of normal skin (x40 magnification). Showing Ki67+ cells along 
basement membrane of epidermis
3. Biopsy of skin at day 7 following Candin injection in young individual 
with good clinical response showing Ki67+ cells within perivascular 
infiltrates.
4. Perivascular infiltrate (x40 magnification) from biopsy shown in 3
showing Ki67+ cells (arrowed).
5. Biopsy of skin at day 7 (x10 magnification) following Candin injection in
old individual with no clinical response to Candin injection.
6. Perivascular infiltrate (x40 magnification) from biopsy shown in 5
showing reduced numbers of Ki67+ cells.
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FIGURE 4.9 Numbers of KI67 cells in perivascular infiltrates in young 
compared with old at Day 7.
Skin biopsies were taken at Day 7 following the injection of the Candin skin 
test in the young and old. Biopsies were stained using antibodies for Ki67 and 
the indirect immunoperoxidase technique. Ki67+ cells were seen 
predominantly within the perivascular infiltrates. Ki67+ cells within frames 
centred over the 5 largest perivascular infiltrates per section were counted 
and the mean number of Ki67+ cells per frame per individual was calculated.
A. There was a reduction in the mean number of Ki67 cells in the 
old)compared with the young although this did not reach statistical 
significance (Mann Whitney test p=0.06). One old individual had a relatively 
large number of KI67+ cells (circled), however they had a good clinical and 
lymphocytic response to the Candin skin test and were therefore not 
representative of the old group as a whole.
B. The number of Ki67+ cells at Day 7 as calculated in Figure 6a was 
correlated with the clinical score seen at Day 3 (the peak of the clinical 
response) in the young and old. This showed a strong positive correlation 
between clinical response and the number of Ki67+ cells counted in the 
perivascular infiltrates (Spearman r=0.863, p=0.0045).
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4.6. Antigenic specificity of cells present at site of response in skin
The proportions of antigen-specific cells present in the skin following the MT
and the Candin skin test were compared at different time points using the skin 
suction blister technique. In the young, peripheral blood T cell responses to a 
particular antigen are a prerequisite for developing a clinical response to 
injection of that antigen into the skin. This suggests that the ability to develop 
a clinical response to any particular antigen in the skin is specific and involves 
antigen specific T cells. The absence of a clinical response in the skin in the 
old, in spite of good peripheral blood T cell responses may therefore be due to 
failure of T lymphocytes specific for the injected antigen to accumulate at the 
site in the skin.
Although antigen-specific cells can be identified using tetramers, MHC class II 
technology is currently poorly established. In addition, both PPD and Candida 
antigens have multiple epitopes that would require the use of multiple 
tetramers in order to identify cells of different specificities. We therefore used 
flow cytometry to detect the intracellular accumulation of the effector cytokine 
IFN-y following overnight incubation of blister cells with the antigen in the 
presence of brefeldin A in order to identify cells that were antigen specific. 
Skin suction blister cells contain a population of antigen- presenting cells and 
therefore the addition of antigen alone is sufficient to allow for antigen 
presentation to specific T lymphocytes. This was confirmed by previous 
experiments that demonstrated that the addition of additional APCs as 
irradiated autologous PBMCs to the skin suction blister cells did not augment 
IFN-y production (unpublished work, Reed JR).
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4.6.1 Antigenic specificity of skin suction blister T lymphocytes isolated 
at the site of the MT in young and old.
Initially, skin suction blister cells from blisters induced at days 7, 15 and 21 
after the MT were assessed for antigenic specificity in the young group 
(Figure 4.11). Earlier time points were not investigated for the MT as previous 
work had shown that only very small percentages of antigen specific T 
lymphocytes are present before 7 days In this experiment, in the young, 
the percentages of antigen specific, IFN-y producing, SB CD4+ T lymphocytes 
increased during the course of the MT response with a peak in the percentage 
of antigen specific cells at day 15, confirming previous findings. An increase 
in antigen specific cells was seen from Day 7 to day 15 (mean 15 to 30 % 
respectively) and then a reduction at day 21 (mean 26%) (Figure 4.10 A). At 
all time points the percentage of antigen specific T cells in the blood remained 
low (<1.4%) and relatively constant (Kruskall Wallis test p=0.09) and was 
significantly lower than the percentages of antigen specific cells isolated from 
the skin (Figure 4.1 OA). Background IFN-y expression in CD4-i- cells in the 
unstimulated blister control samples was also low and remained constant 
during the course of the MT (range of means 0-0.64%).
Previously it has been demonstrated that stimulation of skin blister cells 
isolated from the site of a MT with tetanus toxoid resulted in minimal IFN-y 
expression (<1%), indicating that the accumulating I  cells in the skin are 
specific for the injected antigen. As an additional control, 2 young individuals 
had paired suction blisters on opposite forearms, one with Mantoux control 
solution and the other with the MT. In both individuals a small percentage of 
cells specific for antigen were recruited in to the skin at the site of Mantoux 
control solution injection (MTvs Mantoux control: 32.4%vs6.62% and 
25.51 %vs2.81%), indicating that non-specific recruitment of antigen-specific T 
cells can occur at sites of trauma in the skin. This is advantageous as it may 
allow for T cells with a variety of antigenic specificities to enter wounds that 
are potentially infected with a variety of pathogens.
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In the old, a dramatic reduction in the number of antigen-specific cells within 
the SB was seen for all time points compared with the young (Mann Whitney 
Day 7 p=0.0013, Day 15 p=0.0028, Day 21 p=0.001) (Figure 4.1 OB). 
Although a slight increase in the mean number of antigen specific cells 
between day 7 and 15 was seen in the old, this did not reach statistical 
significance (Wilcoxon ranked pairs test p=0.2). There was no significant 
difference between the number of antigen specific cells in the blood and 
blister for all time points. In contrast to the young group, in the old group there 
is no expansion of the antigen specific T cell population during the course of 
the MT response and this may account for the observed reduction in clinical 
response in addition to reduced numbers of lymphocytes present.
125
35 - 
30 -
10 -
0 5 10 15 20 25
BLISTER
BLOOD
DAY
751
* * *
* * *
♦  ♦0)  —  r  H
I  .  25- 
— Q
à? Ü
FIGURE 4.10 The kinetics of PPD-specific T cell Infiltration In the skin 
following the MT In young and old.
The percentage of Candida specific CD4+ T cells in the peripheral blood and 
skin was determined in the old (O) and young (Y) by examining for 
intracellular cytokine staining using flow cytometry (Figure 4.11). Skin blister 
and PBMC were stimulated with PPD antigen overnight in the presence of 
brefeldin A. Unstimulated controls were also performed. Live CD3+CD4+ 
cells were gated and at least 10,000 CD4+T cell events were acquired. A. 
The percentage of CD4+ T lymphocytes positive for IFN-y expression 
following the MT in skin blister cells and peripheral blood in the young was 
determined. The data points show the mean ±SEM of 7-10 experiments 
performed at each time point. A peak in the percentage of PPD- specific cells 
in the blister was found at day 15. At all time points measured the percentage 
of antigen specific (CD4+ IFN-y) cells was significantly higher in the SB cell 
population compared with the blood.
B. There was a significant reduction in the percentage of antigen- specific 
slom blister cells in the old compared with the young for all measured time- 
points after the MT (Mann Whitney Day 7 p=0.0013, Day 15 p=0.0028, Day 21
p=0.001)
126
LYMPHOCYTE GATE CD4+ LYMPHOCYTES QUADRANT STATISTICS
KWSL 14/4^4.006
200 400 600 800 1000
FSC-Htight
KB/SL 14/4/4 007
;?'"To2
FNgwrmaAPC
32 .43%
io‘  10'' lo"'
A. DAY 7 PPD BLISTER CELLS + PPD YOUNG
§1
KB/SL 14/4/4.007
200 400 600 800 1000fSCMà^
KB/SL 14MM.006
FNganm APC
B. DAY 7 PPD BLISTER CELLS CONTROL SAMPLE
KB/ SL 14/4/4.006
0%
IFN gamma APC
19/02/04.003
200 400 600 800 1000
FSC-Héght
19rt)2/04.003
10' 1(T 10" 10
FNgammaAPC
C. DAY 7 PPD BLISTER CELLS + PPD OLD
19/02/04.003
mlÊ
0 .06%
FIGURE 4.11 T lymphocyte intracellular IFN-y expression in day 7 
Mantoux test blister cells in young, old and control samples.
Skin suction blister cells from the site of PPD injection were incubated for 15 
hours with or without PPD in the presence of Brefeldin A, which was added 
after the first 2 hours of culture. The cells were stained with CD4 Cy5.5 and 
IFN-y APC. Live lymphocytes were identified and gated on the basis of the 
FSC/SSC profile in order to exclude cell debris. Representative dot plots 
show the expression of IFN-y in CD4-t- cells in A. skin suction blister cells from 
a young individual with a good clinical response following PPD stimulation in 
vitro, B. in skin suction blister cells isolated from the site of the response 
without PPD stimulation in vitro and C. skin suction blister cells isolated from 
the site of PPD injection from an old individual without a clinical response. The 
figure in the right upper quadrant of the quadrant statistics column represents 
the percentage of CD4+ T cells positive for IFN-y expression.
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4.6.2 Antigenic specificity of skin suction blister T lymphocytes isolated 
at the site of Candin skin test in young and old.
In order to establish whether a similar phenomenon was observed in the skin 
for the Candin skin test, skin suction blisters were raised at days 3 (n=6), 7 
(n=4) and 15 (n=2) after testing with Candin in the young. This demonstrated 
a significant increase in the percentage of CD4+ IFN-y+ T cells in the skin 
from Day 3 to Day 7 (Wilcoxon ranked pairs test p=0.0095) with an apparent 
reduction in percentage cells at day 15 (Figures 4.12, 4.13). At all time points, 
the percentages of antigen specific cells in the skin (CD4+ IFN-7+ I  
lymphocytes) were higher than that in peripheral blood. As with the MT, only 
a small percentage of CD8+ (CD3+CD4-) T lymphocytes produced IFN-y after 
overnight stimulation with antigen. At all time points the actual percentages of 
IFN-y+ CD4+ T SB cells following Candin injection were significantly lower 
compared with that seen following the MT.
A significant reduction in the percentage of CD4+ IFN-y+ cells was observed 
at day 3 (Mann Whitney p=0.04) and day 7 (Mann Whitney p=0.02) time 
points in the old compared with the young. Although a significant difference 
in the percentage of IFN-y-n CD4+ cells in the SB cell population versus the 
blood was found at day 3 in the old (Wilcoxon ranked pairs test p=0.0078), no 
difference was found at Day 7 (Wilcoxon ranked pairs test p=0.25). No 
significant difference was found between young and old peripheral blood cells 
to produce IFN-y upon stimulation with the PPD or Candida antigens both 
prior to skin testing and after skin testing for the day 3, 7 and 14 time points 
(data not shown).
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FIGURE 4.12 Kinetics of candida-specific T cell infiltration in the skin 
following Candin skin testing in young and old.
The percentage of candide specific CD4+ T cells in the peripheral blood and 
skin was determined by examining for intracellular cytokine staining using flow 
cytometry (Figure 4.13). Skin suction blister cells and PBMCs were 
stimulated with Candida antigen overnight. Unstimulated controls were also 
performed. Live CD3+CD4+ cells were gated. At least 10,000 CD4+T cell 
events were acquired. A peak in the percentage of IFN-y+ CD4+ T 
lymphocytes was seen at Day 7 in the young (A), with percentages of cells 
significantly higher than PBMCs at all time points. The data points in A show 
the mean ±SEM of 2-5 experiments performed at each time point. A 
significant reduction in the percentages of Candida specific (CD4+IFN-Y+) SB 
cells was seen at Day 3 (B) (Mann Whitney p=0.04 and Day 7 (C) (Mann 
Whitney p=0.02) in the old compared with the young.
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FIGURE 4.13 T lymphocyte intracellular IFN-y expression in day 3, 7 and 
15 Candin skin test blister cells in young individuals.
Skin suction blister cells from the site of Candin injection at 3, 7 and 15 days after injection 
were incubated for 20 hours with Candida antigen in the presence of Brefeldin A, which was 
added after the first 15 hours of culture. The cells were stained with CD4 PerCP and IFN-y 
APC. Live lymphocytes were identified and gated on the basis of the FSC/SSC profile in 
order to exclude cell debris. Dot plots show expression of IFN-y in CD4+ cells (R2 and R3 
gates) from skin suction blister cells collected from representative young volunteers at the 
measured time points. The percentage of CD4+ IFN-y+ cells is shown in the upper left 
quadrant.
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4.7 Discussion
The investigation of human immune responses in tissues is made difficult by 
both ethical and practical considerations. For this reason, most studies 
investigating both normal immunity and the effects of ageing on this have 
focused on peripheral blood-derived populations of cells rather than the cells 
at the actual sites where immune memory responses are occurring. The 
effects of ageing on lymphocytic responses in human skin in vivo therefore 
remain poorly defined. Both skin suction blisters and punch biopsies are 
minimally invasive techniques that were well tolerated by all participants in the 
study and left minimal residual long term scarring on the skin after the 
procedure. The two techniques used allowed a detailed functional analysis of 
cells accumulating at the site following antigen injection, in addition to 
quantification and identification of the location of T lymphocytes within the 
skin. Although previous studies have studied both clinical and peripheral 
blood responses in response to antigen, this study is the first to investigate the 
kinetics of an immune response in the skin in the old in correlation with the 
clinical response to the injection of antigen.
The MT has previously been used extensively to investigate cutaneous 
memory CD4-h T cell responses. However, many of these studies have 
focused on the immune response in the skin up to 4 days, over the time 
course where a visible clinical response is present in the skin. It has 
subsequently been demonstrated by our laboratory however that whilst the 
peak clinical response occurs at day 3, the peak cellular lymphocytic response 
is not reached until day 7 when the clinical response is markedly reduced. In 
addition, significantly increased numbers of lymphocytes are still present in 
the skin as late as 3 weeks after skin testing^" ’^®®. Many investigations have 
therefore significantly underestimated the role of lymphocytes in DTH 
responses in the skin.
In view of the dissociation between clinical and cellular responses seen in the 
young the aim of this study was to establish whether the reduced clinical 
response in the skin in the old was truly reflective of reduced lymphocytic 
responses at the site of the response. A reduction in the numbers of
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lymphocytes was seen for the MT response at day 7 in the old group when 
peak numbers of lymphocytes are seen in the skin in the young. A reduction 
in cell numbers was also seen at 1, 3 and 7 days after skin testing with 
Candin. Importantly, a positive correlation between clinical response and 
numbers of cells within perivascular infiltrates for both young and old 
individuals was demonstrated with reduced numbers of lymphocytes in all 
individuals who failed to develop a clinical response to the injection of antigen. 
This data is important as it further indicates that the clinical DTH responses in 
the skin are dependent on T lymphocyte responses at the site. We have 
however only studied lymphocytic responses at a set number of time points. It 
remains possible that lymphocyte numbers peak after day 7 in the old due to a 
slower response time. In the future it would therefore be advantageous to 
study all phases of the response, in particular at later time points.
Although the majority of studies would suggest that there is no age related 
decrease in the total number of CD3+ T lymphocytes in old humans or mice, 
some studies have indicated that this is the case. The age related decline in 
the number of T cells present in the skin during the response could therefore 
be related to an overall decline in the circulating number of T cells in the old. 
In our study, however, there was no evidence that any of the volunteers in the 
old age group had reduced cell counts in peripheral blood based on PBMC 
counts isolated from whole blood. The overall phenotype of T lymphocytes is 
also thought to change with ageing with a shift of cells with a naïve phenotype 
(CD45RA+, CD45RO-) to a memory phenotype (CD45RA-CD45RO+)^®^’ ®^^. 
Previously our laboratory has established that, in the young, the predominant 
CD4+ T cell phenotype during the course of the response is CD45RA-, 
CD45RO+. The older group was therefore likely to have had increased 
circulating numbers of lymphocytes with a memory phenotype compared with 
the young group. However, a reduction in memory T cell receptor repertoire 
also occurs with ageing^ '^^. The presence of peripheral blood T lymphocyte 
responses in the old to both PPD and Candida suggests that the old 
population investigated in this study did have a population of cells within 
peripheral blood that had the specific T cell receptors for these antigens.
132
Previous studies on old humans have observed that there is an increase in 
the frequency of CD4+ T cells compared with CD8+ T cells in peripheral blood 
resulting in the increased CD4:CD8 ratio. It is therefore of interest that a 
reversal of this ratio was seen during the course of the response in the skin in 
the old, with a reduced CD4:CD8 ratio compared with the young at later time 
points. This observation suggests that although there is an initial recruitment 
of both CD8 and CD4+ T lymphocytes to the site of injection occurred in both 
young and old individuals, the overall increase in lymphocyte numbers during 
the DTH response seen in the young is dependent on the expansion of the 
CD4+ T lymphocyte population alone.
Reduced functional capacity of T lymphocytes present in the skin may be 
responsible for reduced cellular response. In particular, a lack of cellular 
proliferation at the site may be responsible for the reduced expansion of the 
CD4+ T lymphocyte population in the skin. Conventionally it is thought that, 
during a secondary immune memory response, memory T cells resident in the 
draining lymph node are activated and divide following interaction with antigen 
presenting cells that have migrated from the skin to the lymph node. These 
memory T cells are then recruited to the skin at the site of antigenic challenge. 
This model has been proposed based on data from murine studies that have 
shown that although antigen specific memory cells are present in both non­
lymphoid and secondary lymphoid organs, they do not proliferate within non­
lymphoid organs during primary or secondary immune responses®" ’^®^. 
However, published data from human studies has in fact indicated that a 
significant proportion of the expansion of lymphocyte numbers within the skin 
is mediated by localised T cell proliferation®®. This model is further supported 
by the results from this study that show that there is a marked increase in the 
percentage of Ki67 positive T cells at day 7 in the skin, at the time when 
lymphocyte numbers reach their peak, without any detectable increase in Ki67 
positive cells within the peripheral blood population.
Previous studies have indicated reduced peripheral blood cell proliferative 
responses to mitogens or antigens in ageing mice and humans^^®^^^. In this 
study, however, we have not found any differences in the proliferative capacity
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of peripheral blood cells to respond to either the PPD or Candida antigens 
(discussed in Chapter 3), suggesting that any observed reduction in the 
proliferative capacity of cells within the skin is related to either the population 
of cells recruited or the local microenvironment in the skin. We have 
demonstrated a small, but non-statistically significant, reduction in the 
percentage of Ki67 + CD4+ T lymphocytes present in the skin for both the MT 
and Candin skin test in the old compared with the young at all time points. 
Importantly, comparable levels of Ki67 expression in the CD4+ T lymphocyte 
population were seen in the old following the injection of control solution and 
the MT, suggesting that proliferation observed in the old is due to trauma 
rather than that driven by an antigen-specific response. Thus a lack of ability 
of antigen specific T cells to proliferate at the site would result in a failure of 
the CD4+ T cell population in the skin to expand appropriately with a resulting 
reduction in clinical and cellular response.
In this study we have demonstrated a marked reduction in the percentage of 
antigen-specific cells present in the skin during the Mantoux and Candin skin 
tests in the old compared with the young. The lack of antigenic specificity of 
cells present at the site in the old may also explain why there was a reduced 
level of T cell activation, as shown with a reduction in CD69 expression on 
suction blister cells. Antigen specific cells were identified on the basis of 
intracellular production of IFN-y production after overnight stimulation with 
antigen. Both the MT and Candin skin test are thought to induce Th1 type 
lymphocytic responses in the skin with the production of predominantly IFN-y. 
Some studies have shown a change in cytokine profiles after cellular 
activation in the old. It is therefore possible that cytokines other than IFN-y, 
such as IL-2, may be produced by antigen specific cells in the old. However, 
in old mice lymphocytes have been shown to produce less IL-2 and more IFN- 
ythan T cells from young mice^^^’ ®^®. These results may have been biased by 
the larger numbers of memory T cells in the old mice as memory T cells are 
known to produce more interferon gamma than their naïve counterparts. 
Studies where individual cell phenotypes have been investigated have
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subsequently shown no difference in cytokine production in young and old 
mice.
It is also possible that the observed reduction in antigen specific cells in the 
old may not be due to a reduction in antigen-specific cells per se but rather an 
inherent inability of these cells to produce IFN-y. Although no difference in 
IFN-y production was found for peripheral blood CD4+ T lymphocytes in the 
young and old groups, the skin microenvironment in the old could render T 
lymphocytes refractory to restimulation with antigen and also affect their ability 
to produce IFN-y. It is also possible that the old skin suction blister cells may 
have contained reduced numbers or defective antigen presenting cells, 
required for restimulation of T cells by the antigen in our in vitro model. 
Further investigation, using autologous irradiated APCs from PBMCs added to 
the skin suction blister cells, would help to exclude absent or defective antigen 
presenting cells within the skin suction blister cell population as a reason for 
the apparent reduction in antigen specific cells.
Significantly lower percentages of antigen specific cells were identified during 
the course of the response to the Candin skin test compared with the MT in 
the young. Although this may be reflective of differing responses in the skin to 
different types of antigen, the reduced percentage of antigen specific cells 
was not reflective of a reduction in the clinical response to the Candin skin test 
compared with the MT. For both skin tests it was not possible to use the same 
reagent for in vitro work. This was thought to be attributable to the presence 
of preservative agents within the skin test that were toxic to the SB cells in 
vitro. It is therefore possible that the agent used to test for in vitro responses 
did not contain the full range of epitopes that were present in the skin test 
resulting in an underestimation of the actual number of antigen specific cells 
present. Previous studies have indicated that intracellular cytokine staining 
only detects between 30 to 90% of tetramer positive cells^^® and it is therefore 
possible that our data represents an underestimate of the percentage of 
antigen specific cells present in the skin. Of interest, other studies have found 
that less than 1% of cells infiltrating the skin are antigen specific^®®. The
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variability in published data may be explained by differing skin tests and in 
vitro agents used to identify antigen specific cells.
It is of interest that at the peak of the clinical response there are very few 
antigen specific cells present at the site of the response. In spite of this, 
clinical responses are only seen in those who have antigen specific cells 
within the peripheral blood, suggesting that antigen specific T cells have to be 
involved early in the response. Clinical response in some individuals is seen 
after a matter of hours indicating that memory response is rapid following 
injection of antigen. It is possible that non-antigen specific mechanisms such 
as trauma or activation of innate pathway is sufficient to allow for the flux of a 
large number of T cells through the skin, of which only a very small number 
have to be antigen specific in order to mediate a response. Using this model, 
we have demonstrated the recruitment of antigen-specific cells to the sites of 
trauma alone in the skin in humans.
Another possibility is that an early, antigen specific response in the skin is 
mediated by memory T cells already resident within the skin. Large numbers 
of T cells are present in normal skin® ’^®®. These cells have diverse T cell 
receptor repertoires, an effector memory phenotype®^ and are in close 
proximity with APC in the skin^®’®°. Thus, all components are present in the 
skin that should enable a rapid, antigen specific response to antigen in the 
skin. Although similar numbers of resident CD3, GD4 and CD8+ T cells were 
identified within both young and old skin in this study a functional defect in the 
resident lymphocyte skin cell population in the old could explain the observed 
reduction in both clinical and cellular responses to antigen injection in to the 
skin.
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5. Skin homing receptor expression on 
peripheral blood lymphocytes and the 
production of cytokines and 
chemokines at the site of antigenic 
challenge.
5.1 Introduction
In Chapter 4 we demonstrated that there is a reduction in the number of 
lymphocytes at the site of the DTH response to both the MT and Candin skin 
test in the old compared with the young. In addition, we have shown that 
there are reduced cellular and clinical responses to the intradermal injection of 
a variety of antigens in the old in spite of the presence of antigen specific 
memory T cells within the peripheral blood. A possible explanation for the 
reduced number of lymphocytes present in the skin during the course of the 
DTH response, in spite of apparent immunity to the injected antigen in the 
peripheral blood compartment, is that in the old there is a defect in the 
recruitment of lymphocytes from the blood into the skin.
The migration of circulating T lymphocytes in to tissue- specific sites of 
inflammation is a complex process involving a range of adhesion molecules, 
cytokines, chemokines and the expression of their respective receptors on 
different cell types. In addition to the regulation of recruitment of cells to sites 
of inflammation, mechanisms are also in place to allow for routine 
immunosurveillance of non- inflamed tissues. Lymphocyte trafficking is a 
highly coordinated process and thus a breakdown of the underlying 
mechanisms involved may either result in inappropriate inflammation, as seen 
in inflammatory skin diseases such as psoriasis, or conversely immune 
suppression. The observation that the frequency of cutaneous infection^^® 
and neoplasia^"^^ increases with age could potentially be explained by defects
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in lymphocytic recruitment in to the skin. In addition, atopic dermatitis (an 
inflammatory skin condition) improves with age^®  ^ and this may again be 
explained by alterations in lymphocyte trafficking. Selective targeting of skin 
specific molecules involved in process of cellular migration and retention have 
become potential therapeutic targets for inflammatory disease.
Chemokines and cytokines produced during the course of the DTH may also 
play an important role not only in the recruitment of cells but also the retention 
of cells at the site, resulting in accumulation of cells. Recent evidence in 
humans suggests that the induction of chemokine receptors on CD4+ T cells 
following their entry in to inflamed tissue might play an important role in 
lymphocyte accumulation and also subsequent migration out of the skin 
resulting in resolution of the immune response.
5.2 Adhesion molecule expression on circulating T cells
The recruitment of lymphocytes into inflamed skin is dependent on the 
expression of a variety of cell surface receptors that enable lymphocyte 
interaction with the endothelium of cutaneous blood vessels and then 
subsequent transendothelial migration into the skin.
5.2.1 Cutaneous lymphocyte antigen expression on T lymphocytes in 
peripheral blood.
OLA expression on circulating T cells in the young and old was investigated in 
order to determine whether alterations in CLA expression could be 
responsible for the observed reduced lymphocytic response in the skin. 
Memory T lymphocytes localising to the skin express the cutaneous 
lymphocyte antigen (CLA) which functions as a ligand for E-selectin^^°. In 
inflamed skin, the expression of E-selectin on endothelium allows for transient 
reversible binding of endothelial cells with CLA+ lymphocytes from the 
peripheral blood, resulting in a process known as rolling where lymphocytes 
are seen to move in a linear direction along the endothelium. Upregulation of
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expression of E-selectin is mediated by the pro-inflammatory cytokines IFN-y 
and TNF-a'“®.
PBMCs from young and old individuals were stained for CD3, CD4 and CLA 
and analysed using flow cytometry (Figure 5.3). No significant difference was 
identified between the groups for percentage CLA expression on total CD4+ T 
lymphocytes (Mann Whitney p=0.054) although a small increase in the 
expression of CLA on the total CD3+ lymphocyte population was seen in the 
old (Mann Whitney: p=0.01)(Figure 5.1 A). CLA is expressed predominantly 
on memory rather than naïve T lymphocytes. In view of the higher proportions 
of memory versus naïve cell populations observed in the old it is possible that 
the higher proportions of memory T lymphocytes may compensate for an 
overall relative reduction in CLA expression which would not be identified by 
assessing CLA expression on the total T lymphocyte population. In view of 
this, CLA+ CD45RO-I- memory CD4-H T lymphocytes were identified in the 
young and old groups using flow cytometry (Figure 5.2). No difference in 
CLA expression on CD4+CD45RO-I- T lymphocytes was found between the 
young and old groups (Mann Whitney p=0.89) (Figure 5.1 B).
CLA expression on antigen specific T lymphocytes in the young and old was 
also investigated. CLA is expressed only on T lymphocytes that have 
undergone primary activation in the draining lymph nodes in the skin^®. It is 
therefore possible that different routes of initial exposure to the PPD antigen 
(ie via BCG vaccination in the young versus environmental exposure in the 
old) could result in changes in CLA expression on antigen-specific T 
lymphocyte expression of CLA in the young and old groups studied. PBMCs 
were cultured overnight in X-Vivo 15 medium with PPD antigen in the 
presence of brefeldin A. The cells were then stained for CD3, CD4, IFN-y and 
CLA. As previously, antigen specific cells were identified on the basis of the 
intracellular production of IFN-y after overnight stimulation with antigen. CLA 
expression was then compared for old and young groups on the antigen- 
specific (CD4-H IFN-y +) T lymphocyte populations (Figure 5.3). No difference 
was found for CLA expression on PPD- specific cells in the young and old
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(Mann Whitney p=0.89) (Figure 5.1C), demonstrating that percutaneous 
administration of PPD antigen in the young group did not result in increased 
CLA expression compared with the old who had not received vaccination.
CLA expression on CD4+ T cells specific for other antigens was also 
compared (Figure 5.1C). As for PPD, no significant difference was found for 
CLA expression on T lymphocytes specific for Candida and VZV in the young 
and old. It is of interest however that there was an overall reduction in the 
percentage of CLA positive antigen specific cells for the PPD compared with 
Candida antigens (Mann Whitney old p=0.01, young p=0.036)). This may 
reflect the fact that Candida is a predominantly cutaneous pathogen whereas 
PPD is likely to be mucosal, respiratory pathogen.
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FIGURE 5.1 Expression of CLA on T lymphocytes in young and old: CD3 
and CD4+ subsets, CD4+CD45RO subsets and CD4+ antigen specific 
cells.
PBMCs were collected from young and old were collected and the expression 
of CLA on different T lymphocyte subsets was determined using flow 
cytometry (Figure 5.3). The percentage of CLA-i- lymphocytes within the total 
CD3-I- and CD4-t- lymphocyte populations was determined. No difference was 
found between the young and old for CD4-H lymphoctyes (Mann Whitney 
p=0.054) although a small increase in CLA expression on CD3-H lymphocytes 
was found in the old (Mann Whitney p=0.01) T lymphocyte subsets (A). The 
percentage of CLA-n lymphocytes within the CD44-CD45RÜ4- (memory T cell) 
population was also determined using flow cytometry (Figure 5.2). No 
difference was found between the young and old (Mann Whitney p=0.89) (B). 
The percentage of CLA-k cells within the PPD, VZV and Candida antigen- 
specific CD4-I- T lymphocyte populations was determined (C). Antigen 
specific cells were identified by staining for IFN-y production after overnight 
stimulation of PBMCs in vitro with antigen (Figure 5.3). No difference was 
found between the young and old groups, although higher percentages of 
CLA-i- cells were present within the Candida compared with the PPD specific 
population (Mann Whitney old p=0.01, young p=0.036) (C).
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FIGURE 5.2 CLA expression on the CD4+CD45Ro+ T lymphocyte 
population.
PBMCs from young and old individuals were stained with GD3APC, CD4 
PercP, and CD45RO PE and analysed by flow cytometry. Live lymphocytes 
were gated on the basis of the FSC/SSC profile in order to exclude cell debris
(A) and then gated on the CD4+ population on the basis of CD4+CD3+ 
expression (B). The representative dot plot C shows the expression of 
CD45RO and CLA on the CD4+ lymphocyte population. The percentage of 
CLA+ cells within the CD45RO+ population was calculated using quadrant 
percentage statistics (30% in this individual).
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FIGURE 5.3 T cell intracellular IFN-y expression in CLA+ CD4+ 
lymphocytes
PBMCs from young and old individuals were incubated with PPD, Candida or 
VZV antigens (shown here following incubation with PPD antigen for 15 hours 
the presence of Brefeldin A, which was added after the first 2 hours of 
culture.) The cells were stained with CD4 PerCP, IFN-y APC and CLA FITC 
and analysed by flow cytometry. Live lymphocytes were identified and gated 
on the basis of the FSC/SSC profile in order to exclude cell debris (A). 
Representative dot plots show expression of IFN-y in CD4+ cells (gate R3)
(B), CLA+ cells in the total lymphocyte population (C), and within the 
CD4+IFN-y+ cell population (D) (gated on R3 shown in B). The percentage in 
the right upper quadrant in D represents the percentage of CLA+ antigen- 
specific CD4+ T lymphocytes within the peripheral blood.
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5.2.2 CD11a (LFA-1) expression on peripheral blood T lymphocytes.
After selectin mediated rolling on the endothelium, lymphocytes attach firmly 
to the endothelium through the adhesion of beta 2 integrins, including LFA-1, 
expressed on the lymphocyte cell surface and adhesion molecules such as 
ICAM expressed on the endothelium. The expression of CD11a, a subunit of 
LFA-1, on both CLA+ and CLA- circulating peripheral blood CD4+ T 
lymphocytes was compared in young and old using flow cytometric analysis. 
(Figure 5.5). No difference was found for GDI la  expression between young 
and old CLA positive (Mann Whitney p=0.21) and negative cells (Mann 
Whitney p=0.48) (Figure 5.4). A statistically significant reduction was found 
for LFA-1 expression on CLA negative cells compared with CLA positive cells 
in the young group (Wilcoxon matched pairs test: p=0.002). The reasons for 
this are unclear.
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FIGURE 5.4 Expression of CD11a on CLA+ and CLA- CD4+ T 
lymphocytes in the young and old.
PBMCs isolated from young and old individuals were stained with antibodies 
for CD3, CD4, CLA and GDI la  and analysed using flow cytometry (Figure 
5.5). CD44- lymphocytes were identified and the percentage of GDI la  cells 
within the CD4+ lymphocyte population was calculated for CLA-f and CLA- 
populations. No significant difference was found for the percentage of 
CD11a+ cells within the CD44-CLA- (Mann Whitney p=0.21) or CD4-t-CLA-L 
cell populations (Mann Whitney p=0.48) for the old and young groups.
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FIGURE 5.5 CD11a expression on CD4+CLA+ and CD4+CLA-T 
lymphocytes
PBMCs collected from young and old individuals were stained with anti- CD4 
PercP, CD3PE, CLA FITC and CD11a APC. Live lymphocytes were identified 
and gated on the basis of the FSC/SSC profile in order to exclude cell debris 
(A). CD4+ cells were gated on on the basis of CD3-t-and CD4+ staining on the 
lymphocyte gate (B). CLA+CD4+ cells (R3 gate) and CLA-CD4+ cells (R4 
gate) were identified (C). The median fluorescent intensity (MPI) was 
calculated for both CLA-CD4+ cells (R3 gate) (D) and CLA+CD4+ cells (R4 
gate) (E). The figures on D and E are the calculated MFIs for the 
representative individual shown.
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5.3 Chemokines and integrin triggering
Although no difference in CD11a expression could be detected in the young 
and old groups this does not exclude differences in integrin function and 
avidity for the endothelium. Previous work has shown that integrin activity is 
regulated independently of the level of cell surface expression and that 
immune cells are able to modify their avidity of binding to ligands on 
endothelial cell surfaces. Maintenance of integrins in a non-adhesive state 
therefore prevents non-specific binding to the endothelium. The triggering of 
the avidity of leukocyte integrins is thought to be mediated by chemokines, a 
superfamily of small molecular weight proteins. In inflamed skin, endothelial 
adherence and subsequent transendothelial migration of CLA+ cells in to the 
skin is thought to be critically dependent on the interactions between the 
chemokines CCL17 (TARC) and CCL27 (CTACK) with their receptors CCR4 
and CCR10 respectively®^.
5.3.1 CCR4 expression
CCR4 expression was compared on both CLA+ and CLA- CD4-i- T 
lymphocytes isolated from the peripheral blood in the young and old by flow 
cytometry (Figure 5.8). In both groups, CCR4 expression was found to be 
significantly higher on the CLA-h T cells, confirming previous findings (Mean 
old: 70.37% vs 22.45%; mean young: 60.65%vs13.7% for CLA-h and CLA- 
cells respectively). No difference was found for CCR4 expression between 
the young and old groups (Mann Whitney CLA-k cells: p=0.15, CLA- cells 
p=0.2) (Figure 5.6). Unfortunately, it was not possible to stain cells for CCR10 
as a reliable monoclonal antibody was not commercially available at the time 
of this study.
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FIGURE 5.6. Expression of CCR4 on CLA+ and CLA- CD4+ T 
lymphocytes in the young and old.
PBMCs isolated from young and old individuals were stained with antibodies 
for CD3, CD4, CLA and CCR4 and analysed using flow cytometry (Figure 
5.8). CD4+ lymphocytes were identified and the percentage of CCR4+ cells 
within the CD4+ lymphocyte population was calculated for CLA+ and CLA- 
populations. No significant difference was found for the percentage of 
CD11a+ cells within the CD4+CLA- (Mann Whitney p=0.2 or CD4+CLA+ cell 
(Mann Whitney p=0.15) populations for the old and young groups.
5.3.2. CCL17 and CCL27 concentrations
In order to determine whether levels of CCL17 and CCL27 expression within 
the skin differed in young and old subjects, skin suction blisters were raised 
over the site of Candin antigen injection at day 3. The levels of CCL17 and 
CCL27 within skin suction blister were then determined using a luminex 
technique. The luminex assays were performed by a collaborator (John 
Curnow) at Birmingham University. The day 3 time point was chosen for 
suction blister fluid analysis as this had previously been shown to be the time 
at which peak levels of the chemokines were present for the MT.
No difference was found for levels of CCL17 (Mann Whitney p=0.92B) or 
CCL27 (Mann Whitney p=0.717) in the blister fluid from blisters induced over 
the site of the Candin skin test in young or old groups (Figure 5.7). Of note, 
no correlation was found between the clinical score measured in the skin at 
day 3 and the level of chemokine detected in either group (CCL17:Spearman r 
old=-0.31 p=0.356, Spearman r young=-0.4B p=0.2667; CCL27: Spearman r 
old= 0.36, p=0.27, Spearman r young=0.4B, p=0.2667).
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FIGURE 5.7. Concentrations of CCL27 and CCL17 In blister fluid.
Concentrations of the chemokines CCL27 (A) and CCL17 (B) were
determined in blister fluid aspirated from blisters induced at Day 3 over the 
site of Gandin injection in the young (n=7) and old (n=11). The concentrations 
of chemokines were calculated using a multiplex bead immunoassay 
(Luminex technique), performed by collaborator Dr. John Curnow at 
Birmingham University. No significant difference in the concentrations of 
either CCL27 (Mann Whitney p=0.717) or CCL17 (Mann Whitney p=0.929) 
were identified between the old and young. Error bars represent the SEM.
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FIGURE 5.8. CCR4+ expression on CLA+ and CLA- CD4+ T lymphocytes
PBMCs collected from young and old individuals were stained with anti- CD4 
PercP, CD3 APC, CLA FITC and CCR4 PE. Live lymphocytes were identified 
and gated on the basis of the FSC/SSC profile in order to exclude cell debris 
(A). CD4+ cells were gated on the basis of CD3+and CD4+ staining on the 
lymphocyte gate (B). CLA+CD4+ cells (R3 gate) and CLA-CD4+ cells (R4 
gate) were identified (C). Histograms were constructed based on gating for 
CLA-CD4+ cells (R3) (D) and CLA+CD4+ cells (R4) (E). The Ml gate was 
used to determine the percentage of CCR4+ cells for both cell populations 
(shown on histograms) and was set according to a negative isotype control for 
PE.
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5.4 CXCR3 and IP-10 expression
We next investigated the expression of CXCR3 on peripheral blood 
lymphocytes in the young and old in addition to the levels of IP-10 within 
blister fluid following Candin skin testing. CXCR3 is expressed on memory 
CD4 T cells in addition to the majority of CD8 T cells in the peripheral blood 
and is thought to attract cells to Thi -type reactions including sites of 
inflammation in the skin^^ '^^^ .^ The inflammatory chemokines IFN-y inducible 
protein (IP-10), monokine induced by IFN-y (Mig) and IFN I  cell a 
chemoattractant (l-TAC) act as ligands for CXCRO^ "^^ . IP-10 production in the 
skin is thought to be stimulated by IFN-y and previous studies have 
demonstrated production from both kératinocytes and dermal fibroblasts^®^.
5.4.1 CXCR3 expression
The expression of CXCR3 on both CLA positive and negative CD4-i- T 
lymphocytes isolated from peripheral blood was analysed using flow 
cytometry (Figure 5.9). This showed that although there was no difference in 
the percentage of CXCR3+ cells in the CLA-CD4+ T lymphocyte population 
(Mann Whitney p=0.4), there was a significant reduction in the percentage of 
CXCR3 positive cells in the CLA positive CD4+ T lymphocyte population in 
the old compared with the young (Mann Whitney p= 0.023) (Figure 5.10A.) It 
is therefore possible that there is defective recruitment of CLA positive cells 
into the skin via the CXCR3- IP10 chemokine axis resulting in reduced 
immunity to Thi type immune responses such as those seen for the MT and 
Candin skin test used in this study.
5.4.2 IP-10 concentrations
IP-10 levels were analysed in skin suction blister fluid from blisters raised over 
the Candin skin test and also after the injection of saline. No significant 
difference was found for the blister fluid levels of IP10 in both young and old 
after Candin skin testing (Mann Whitney p=0.34). (Figure 5.1 OB) Low levels of 
IP-10 only were found at sites of saline injection. No correlation was found 
between the clinical score at day 3 and the levels of IP-10 in either young 
(Spearman r=0.33, p=0.44) or old (Spearman r=0.57, p=0.07) groups.
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FIGURE 5.9. CXCR3 expression on CLA+ and CLA- CD4+ T lymphocytes
PBMCs collected from young and old individuals were stained with anti- CD4 
PercP, CD3 PE, CLA FITC and CXCR3 APC. Live lymphocytes were 
identified and gated on the basis of the FSC/SSC profile in order to exclude 
cell debris (A). CD4+ cells were gated on on the basis of CD3+and CD4+ 
staining on the lymphocyte gate (B). CLA+CD4+ cells (R3 gate) and CLA- 
CD4+ cells (R4 gate) were identified (C). Histograms were constructed based 
on gating for CLA-CD4+ cells (R3) (D) and CLA+CD4+ cells (R4) (E). The M1 
gate was used to determine the percentage of CXCR3+ cells for both cell 
populations (shown on histograms) and was set according to a negative 
isotype control for APC.
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FIGURE 5.10 Expression of CXCR3 on CLA+ CD4+ T cells in young and 
old and levels of IP-10 In blister fluid at day 3 following Candin or saline 
injection.
A. PBMCs isolated from whole blood in young and old were stained with 
antibodies for CD3, CD4, CLA and CXCR3 and analysed using flow 
cytometry. Lymphocytes were selected for analysis on the basis of forward 
and side-scatter profiles. CD4+ lymphocytes were then identified and the 
percentage of CXCR3+ cells within the CD4+ lymphocyte population was 
calculated for CLA+ and CLA- populations (Figure 5.10). No significant 
difference was found for the percentage of CXCR3+ cells within the 
CD4+CLA- cell population (Mann Whitney p=0.023), however a reduction in 
the percentage of CXCR3+ cells was found in the CD4+CLA+ lymphocyte 
population in the old compared with the young (Mann Whitney p=0.4). B. IP- 
10 concentrations were measured in blister fluid from blisters raised at Day 3 
following either Candin (n=6 young, n=11 old) or Saline injection (n=3 for both 
groups). Levels of IP-10 were determined using the BD™
Cytometric Bead Array (CBA) Cell Signalling Flex Set System. No significant 
difference was found in the levels of IP-10 following injection of Candin (Mann 
Whitney p=0.34) or saline in the young and old groups. Error bars represent 
tthe SEM.
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5.5 Transwell migration assays: migration of CLA+ CD4+ T lymphocytes
Transwell migration assays were used in order to establish whether the
reduced expression of CXCR3 on CLA+CD4+ T cells isolated from the 
peripheral blood in the old had an effect on their ability to migrate in response 
to IP10, one of the ligands for CXCR3. A signficant difference in the migratory 
capacity of both total CD4+ T lymphocytes and CLA+CD4+ lymphocytes was 
detected between young and old in response to IP-10 (Mann Whitney P=0.4 
and p=0.4 respectively) (Figure 5.13). However, the percentage cell migration 
for the IP-10 wells was not significantly different compared with the control 
wells where no IP-10 had been added (Wilcoxon ranked pairs test p>0.5). 
This suggests that there was no active migration in response to IP-10 in this 
assay. A range of concentrations of the IP-10 recombinant peptide and 
different culture times were tried in order to optimise the assay. In addition, 
pre-activation of cells with anti-CD3 prior to their use in the migration assay 
was tried as CXCR3 known to be important for migration of activated T cells. 
Unfortunately none of these approaches resulted in significantly increased 
migration in the IP-10 containing assay compared with the control assay 
where no peptide had been added. This may have been due the small 
number of CXCR3+CLA-I- cells present in the migration assays.
The migration of total CD4+ and CLA+CD4+ lymphocyte populations in 
response to SDF was assessed. This assay was used as a positive control as 
the majority of T lymphocytes are known to express the CXCR4 receptor. 
Using flow cytometric analysis, the expression of CXCR4 on CLA+ CD4+ cells 
from the peripheral blood was compared in the young and old (Figure 5.11). 
No significant difference in CXCR4 expression on CLA+CD4+ T lymphocytes 
was found (Mann Whitney p=0.16)(figure 5.12A). However, a significant 
increase in the expression of CXCR4 on the CLA- population was found in the 
old compared with the young (Mann Whitney p=0.003), the reasons for which 
are unclear. Analysis of the levels of SDF in suction blister fluid taken from 
blisters at day 3 after Candin injection showed no significant difference in 
levels between young and old (Mann Whitney p=0.277)(Figure 5.12.B). Total 
CD4+ and CLA-I-CD4+ T lymphocytes were found to migrate in response to 
SDF in both young and old individuals with significantly higher numbers of
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cells migrating compared with the control wells where no peptide had been 
added (p>0.5 for all SDF assays). No significant difference in the percentage 
of CLA+CD4+ or total CD4+ cells (Mann Whitney p=1 and p=0.4 respectively) 
migrating in response to SDF was found between the young and old (Figure 
5.13 B+D), suggesting that the migratory capacity of CLA+CD4+ T 
lymphocytes in the old is not impaired in vitro.
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FIGURE 5.11. CXCR4 expression on CLA+ and CLA- CD4+ I  
lymphocytes
PBMCs collected from young and old individuals were stained with anti- CD4 
PercP, CD3 APC, CLA FITC and CXCR4 PE. Live lymphocytes were 
identified and gated on the basis of the FSC/SSC profile in order to exclude 
cell debris (A). CD4+ cells were gated on on the basis of CD3+and CD4+ 
staining on the lymphocyte gate (B). CLA+CD4+ cells (R3 gate) and CLA- 
CD4+ cells (R4 gate) were identified (C). Histograms were constructed based 
on gating for CLA-CD4+ cells (R3) (D) and CLA+CD4+ cells (R4) (E) and the 
median fluorescent intensity (MFI) was calculated for both cell populations 
(values shown in this representative individual on histograms D and E )._
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FIGURE 5.12 Expression of CXCR4 on CLA+ CD4+ T cells In young and 
old and levels of SDF In blister fluid at Day 3 following the Candin skin 
test.
A. PBMCs isolated from whole blood in young and old were stained with 
antibodies for CDS, CD4, CLA and CXCR4 and analysed using flow cytometry 
(Figure 5.11 ). CD44- lymphocytes were identified and the percentage of 
CXCR44- cells within the CD44- lymphocyte population was calculated for 
CLA-k and CLA- populations. No significant difference was found for the 
percentage of CXCR44- cells within the CD44-CLA-t- cell population (Mann 
Whitney p=0.16), however a reduction in the percentage of CXCR4-L cells was 
found in the CD4+CLA- lymphocyte population in the young compared with 
the old (Mann Whitney p=0.003).
B. SDF concentrations were measured in blister fluid from blisters raised at 
Day 3 following Candin injection in young (n=7) and old (n=11) individuals. 
The concentrations of chemokines were calculated using a multiplex bead 
immunoassay (Luminex technique), performed by collaborator Dr. John 
Curnow at Birmingham University. No significant difference was found in the 
levels of SDF in blister fluid in the young and old groups (Mann Whitney 
p=0.277). Error bars represent the SEM
156
%TOTAL CD4+ LYMPHOCYTE POPULATION MIGRATION B
3 1
2  - 1
▼fT
OLD YOUNG 
IP10
OLD YOUNG 
CONTROL
ns15
10
%
5
0
OLD YOUNG OLD YOUNG
SDF CONTROL
%
CLA+CD4+ LYMPHOCYTE POPULATION MIGRATION
3 -
2 -
1 -
ns
OLD YOUNG 
IP in
OLD YOUNG 
CONTROi
30 ns
20
%
10
0
OLD YOUNG OLD YOUNG
_SDE_ CONTROL
FIGURE 5.13 Transwell migration assays: Total CD4+ and CLA+CD4+ T 
cell migration in response to IP 10 and SDF.
In vitro cell migration assays were used to quantify the ability of total CD4+ and CD4+CLA+ T 
lymphocytes to migrate in response to IP-10 (1-309) and SDF recombinant peptides. SDF 
was used as a positive control as most cells (>80%) express its ligand CXCR4. As a negative 
control culture medium alone was used. PBMCs were isolated from young and old 
individuals. Chambers containing 3^m size pore Transwell inserts (top chambers) were 
placed into the wells of 26 well flat-bottomed plates (bottom chambers) containing cell culture 
medium and recombinant peptide. PBMCs suspended in culture medium were then added to 
the top chambers. Triplicate wells were used for each individual’s PBMCs and each 
recombinant peptide. The percentage of cells migrating through the Transwell insert from the 
top chamber into the bottom chamber after 3 hours of incubation was calculated. Cells were 
retrieved from the bottom and top chambers and stained with anti-CLA, CD3 and CD4 
antibodies in a Trucount tube, allowing for calculation of cell numbers by flow cytometry. 
There was a reduction in the ability of total CD4 (A+B) and CLA+ CD4+ (C+D) T lymphocytes 
to migrate in response to the IP-10 (A+C) in old compared with young individuals (Mann 
Whitney p=0.04 for both subsets). No difference in the ability of cells to migrate in response to 
SDF (B+D) peptides was found (Mann Whitney p=1 (CLA+CD4+) and p=0.76 (CD4+). For the 
IP-10 peptide similar numbers of cells migrated in the control wells (with no peptide) however 
a significant reduction in cell migration was seen in the control wells compared with SDF.
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5.6 CCR8 and CCL1 (1-309) expression
Recent work has shown that the majority of resident skin T lymphocytes are 
CCR8 positive and respond to its selective ligand CCL1 (1-309)^ ®. CCL1 is 
expressed constitutively within normal non-inflamed skin on endothelial cells 
in addition to epidermal antigen presenting cells. It has therefore been 
hypothesised that CCR8/ CCL1 interactions may be crucial for 
immunosurveillance and homeostatic T cell trafficking in normal skin. In 
addition, CCR8+ T cells have been shown to secrete the cytokines TNF-a and 
IFN-/® both of which are involved in the initiation of Th1 responses. We 
therefore decided to investigate whether a defect in the CCR8- CCL1 
chemokine axis could explain the reduced response to Candin skin testing in 
the old.
5.6.1 OCRS expression on peripheral blood lymphocytes
CCR8 expression on peripheral blood CD4+ T lymphocytes was determined 
using flow cytometry (Figure 5.14). CCR84-CD4-K cells were found to 
represent a very small population of cells in the blood confirming previous 
findings. Although no difference was found for the percentage of cells 
expressing CCR8 in the total CD4+ T lymphocyte population in both young 
(mean: 0.83%) and old (mean:0.68%) individuals (Mann Whitney p=0.12), a 
statistically significant reduction in the percentage of cells with the 
CCR84-CD44-CLA-hphenotype was found in the old (mean: 0.61%) compared 
with the young (mean: 1.65%) groups (Mann Whitney p=0.0007). (Figure 
5.15A). However, due to the very low percentages of positive cells the 
accuracy of this finding is uncertain.
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FIGURE 5.14 CCR8+ expression on CLA+ and CLA- CD4+ T lymphocytes
PBMCs collected from young and old individuals were stained with anti- CD4 
PercP, CD3 APC, CLA FITC and CCR8 PE. Live lymphocytes were identified 
and gated on the basis of the FSC/SSC profile in order to exclude cell debris 
(A). CD4+ cells were gated on on the basis of CD3+and CD4+ staining on 
the lymphocyte gate (B). CLA+CD4+ cells (R3 gate) and CLA-CD4+ cells (R4 
gate) were identified (C). Histograms were constructed based on gating for 
CLA-CD4+ cells (R3) (D) and CLA+CD4+ cells (R4) (E). The M1 gate was 
used to determine the percentage of CCR8+ cells for both cell populations 
(shown for this representative individual) and was set according to a negative 
isotype control for PE.
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FIGURE 5.15 Expression of CCR8 on CLA+ CD4+ T cells in young and 
old and levels of CCL1 in blister fluid.
A. PBMCs isolated from whole blood in young and old were stained with 
antibodies for CD3, CD4, CLA and CCR8 and analysed using flow cytometry 
(Figure 5.14). CD4+ lymphocytes were identified and the percentage of 
CCR8+ cells within the CD4+ lymphocyte population was calculated for CLA+ 
and CLA- populations. No significant difference was found for the percentage 
of CCR8+ cells within the CD4+CLA- cell population, however a reduction in 
the percentage of CCR8+ cells was found in the CD4+CLA+ lymphocyte 
population in the old compared with the young (Mann Whitney p=0.0007).
B. CCL1 concentrations were measured in blister fluid from blisters raised on 
normal skin or at Day 3 following either Candin (n=6 young, n=11 old) or 
saline injection (n=3 in both groups) in young and old individuals. Levels of 
CCL1 were determined using the BD Cytometric Bead Array (CBA) Cell 
Signalling Flex Set System. No significant difference was found in the levels 
of CCL1 in blister fluid from normal skin or following injection of Candin or 
saline in the young and old groups. Error bars represent the SEM.
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5.6.2 CCL1 concentrations
Concentrations of CCL1 within blister fluid from skin suction blisters were then 
analysed. Blisters were induced at day 3 following Candin and saline injection 
and on normal skin. No differences in the concentrations of CCL1 were 
identified in blisters induced on normal skin in young and old individuals 
(Mann Whitney p=0.70), suggesting that constitutive expression of CCL1 in 
skin was likely to be similar in both groups. In addition, no change in CCL1 
expression was found for blisters following Candin skin testing (mean old: 
(Mann Whitney p=0.12) and also following saline injection (Mann Whitney 
p=0.87). No significant difference was found for the concentrations of CCL1 
in blister fluid from blisters induced in skin for the different conditions tested in 
either the young (Kruskal- Wallis test p=0.32) or old (Kruskal- Wallis test 
p=0.43).
5.7 Pro-inflammatory cytokine production within the skin at the site of 
the DTH response
Cytokines play a crucial role in the body's defense against infection and are 
thought to be involved in all phases of inflammation within the skin. Multiple 
cell types in the skin are known to produce cytokines including kératinocytes, 
T and B lymphocytes, monocytes, endothelial cells, fibroblasts, endothelial 
cells, mast cells, dendritic cells, granulocytes and platelets. Although the 
isolation of different cytokines in vitro has enabled the study of individual 
cytokine function, in vivo, a cocktail of cytokines will exert a variety of both 
synergistic and antagonistic effects on different cells within the local 
microenvironment in order to orchestrate an effective immune response. The 
cytokines IN F, IL-6 and interferon gamma have been shown to have pro- 
inflammatory effects on the skin and are likely to be important in the initial 
induction of the response to cutaneous infection, known as the acute phase 
response. We therefore assessed levels of these cytokines in the skin 
following the injection of Candin.
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5.7.1 Tumor necrosis factor (TNF) levels
TNF is secreted by a variety of cells in the skin including monocytes and 
macrophages, T cells, kératinocytes and endothelial cells and is thought to 
have multiple pro-inflammatory activities. TNF has been found to increase 
macrophage and neutrophil chemotaxis, phagocytosis, cytotoxicity and 
respiratory burst activity. TNF-a has important effects on blood vessels, in 
particular venules, to increase blood flow and to increase vascular 
permeability to fluid, proteins and cells. Local release thus results in erythema 
due to vasodilatation in addition to swelling due to influx of fluid in to the 
infected tissue. It also promotes the adherence of T lymphocytes to the 
endothelium by increasing the expression of E-selectin, ICAM-1 and VCAM on 
the endothelial cell surface. TNF-a has also been shown to be important for 
the maturation of dendritic cells in humans and their migration from the 
epidermis in to the dermis and may therefore have an important early role in 
the initiation of immune responses.
TNF levels were measured in skin suction blisters raised over the site of 
Candin and saline injection at Day 3 (Figure 5.16). A significant reduction in 
the level of TNF was noted in the old group compared with the young in the 
skin after Candin injection (Mann Whitney p=0.013). Low levels of TNF were 
found in blister fluid after saline injection indicating that TNF production was 
induced by the injection of antigen rather than by trauma alone in the young. 
In the young and old, no correlation between TNF production and clinical 
score was found (Young: Spearman r=0, p=1.03, Old: Spearman r=0.43,
p=0.18).
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FIGURE 5.16 Concentrations of TNF in blister fluid from blisters induced 
at day 3 following Candin and saline injection.
Concentrations of TNF were determined in blister fluid aspirated from blisters 
induced at Day 3 over the site of Candin injection (n=6 young, n=11 old) and 
following saline injection (n=3 both groups) in the young and old. The 
concentrations of TNF were calculated using the Cytometric Bead Array 
(CBA) Cell Signalling Flex Set System. A significant reduction in the 
concentration of TNF was found in the old following Candin injection 
compared with the young (Mann Whitney p=0.013). Error bars show the 
SEM.
5.7.2 Interferon gamma (IFN-y) levels.
IFN-y is produced predominantly by activated T lymphocytes. It has been 
shown to have several pro-inflammatory effects including the up regulation of 
MHC Class II expression on monocytes^and kératinocytes^^® in addition to 
the activation of monocytes with increased secretion of TNF-a^°" .^
IFN-y concentrations were measured in skin suction blisters as for TNF 
(Figure 5.17). Although there was an increase in the mean concentration of 
IFN-y production in the blister fluid raised over the site of Candin skin testing 
at day 3 in the young compared with the old, this failed to reach statistical 
significance (Mann Whitney p=0.118). This is possibly reflective of the small 
sample size collected. Low levels of IFN-y were detected in blisters following 
saline injection, indicating that trauma alone is not sufficient to induce 
significant production of IFN-y within the skin. IFN-y levels were independent
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of clinical score at day 3 in both young (Spearman r=0.70, p=0.09) and old 
individuals (Spearman r=0.50, p=0.11).
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FIGURE 5.17 Concentrations of IFN-y in blister fluid from blisters 
induced at day 3 following Candin and saline injection.
Concentrations of IFN-y were determined in blister fluid aspirated from blisters 
induced at Day 3 over the site of Candin injection (n=6 young and n=11 old) 
and following saline injection in the young and old (n=3 for both groups). The 
concentrations of IFN-y were calculated using the BD™ Cytometric Bead 
Array (CBA) Cell Signalling Flex Set System. A reduction in the concentration 
of IFN-y was found in the old following Candin injection compared with the 
young but this was not signficant (Mann Whitney p=0.118). Error bars show 
the standard error of the mean. In the old there was no significant difference 
between the blisters following Candin or saline injection (Wilcoxon ranked 
pairs test p>0.5).
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5.7.3 IL-6 levels
IL-6 concentrations were measured in skin suction blisters as for TNF and 
IFN-y. Monocytes are the main producers of IL-6 in the skin, although other 
cell types including kératinocytes, endothelial cells and fibroblasts have also 
been reported to secrete IL-6^® .^ In T cells IL-6 mediates activation, growth 
and d i f f e r e n t i a t i o n ^ a n d  is considered to be an important early pro- 
inflammatory cytokine involved in amplifying the immune response.
No significant difference was found for blisters in young and old over site of 
Candin injection (Mann Whitney p=0.06) (Figure 5.18). Low concentrations of 
IL-6 were found in young and old blisters induced at day 3 after saline 
injection.
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FIGURE 5.18 Concentrations of IL-6 in blister fluid from blisters induced 
at day 3 following Candin and saline injection.
Concentrations of IL-6 were determined in blister fluid aspirated from blisters 
induced at Day 3 over the site of Candin injection (n=6 young and n=11 old) 
and following saline injection (n=3 for both groups) in the young and old. The 
concentrations of IL-6 were calculated using the BD "^  ^Cytometric Bead Array 
(CBA) Cell Signalling Flex Set System. No significant difference in the 
concentration of IL-6 was found in the old following Candin injection compared 
with the young (Mann Whitney p=0.06). Error bars show the standard error of 
the mean. In the old there was no significant difference between the blisters 
following Candin or saline injection (Wilcoxon ranked pairs test p>0.5).
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5.8 Immunosuppressive cytokines: IL-10 levels
IL-10 levels in blister fluid were measured in both young and old. In addition 
to pro-inflammatory cytokines, certain cytokines such as IL10 are able to exert 
potent anti-inflammatory effects. IL-10 has been shown to inhibit the release 
of several cytokines including TNF-a production from monocytes. It is 
produced by both monocytes and lymphocytes including regulatory T cells.
No difference was found for concentrations of IL-10 in blister fluid from blisters 
raised at day 3 over the site of Candin injection in both young and old blisters 
(Mann Whitney:p=0.88) (Figure 5.19). In addition, similar levels of IL-10 were 
found in blisters raised at day 3 after saline injection in young and old (Mean 
young:12.35pg/ml, mean old:9.27pg/ml; Wilcoxon ranked pairs test young 
p=0.5, old p=0.25), suggesting that IL-10 production is not significantly up 
regulated during Candida antigen induced responses in the skin.
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FIGURE 5.19 Concentrations of IL-10 in blister fluid from biisters 
induced at day 3 foliowing Candin and saline injection.
Concentrations of IL-10 were determined in blister fluid aspirated from blisters 
induced at Day 3 over the site of Candin injection (n=6 young, n=11 old) and 
following saline injection (n=3 both groups) in the young and old. The 
concentrations of IL-10 were calculated using the Cytometric Bead
Array (CBA) Cell Signalling Flex Set System. No significant difference in the 
concentration of IL-10 was found in the old following Candin injection 
compared with the young (Mann Whitney p=0.88). There was no significant 
difference between the blister fluids following Candin or saline injection 
(Wilcoxon ranked pairs test p=0.5 young, p=0.25 old). Error bars show the 
standard error of the mean.
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5.9 Chemokines involved in amplification of the immune response:
RANTES. MCP-1. MIP- 1a. IL-8.
Following the acute initiation of the immune response in the skin, a variety of 
cell types secrete a range of chemokines that are able to amplify the response 
by cellular activation and increased cellular recruitment to the site of 
inflammation in the skin as shown in Table 1.2 (Introduction).
A statistically significant reduction in the concentrations of MIP-1a (Mann 
Whitney p=0.008), MCP-1 (Mann Whitney p=0.0057), RANTES(Mann 
Whitney p=0.0182), and IL-8 levels (Mann Whitney:p=0.0056) in suction 
blister fluid raised at day 3 after Candin injection was observed in the old 
(Figure 5.20). High levels of IL-8 were measured in blister fluid from the 
young group after saline injection with no significant difference between levels 
in Candida or saline blisters (Wilcoxon ranked pairs test p=0.5). As with TNF- 
a levels, the clinical score in either the old or young groups did not correspond 
with levels of chemokines measured. Spearman r values for old: RANTES 
(r=0.56, p=0.08), MCP-1 (r=0.06, p=0.86), MIP-1a (r=0.394, p=0.22), IL-8 and 
young: RANTES (r=0.41, p=0.35), MCP-1 (r=0.30, p=0.49), MIP-1a (r=0.59, 
p=0.17).
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FIGURE 5.20 Concentrations of MCP-1, MIP-1a, RANTES, IL-8 In blister 
fluid from blisters Induced at day 3 following Candin and saline 
Injection.
Concentrations of chemokines were determined in blister fluid aspirated from 
blisters induced at Day 3 over the site of Candin injection (n=6 young, n=11 
old) and following saline injection (n=3 in both groups) in the young and old. 
The concentrations of MCP-1, MIP-1a, RANTES and IL-8 were calculated 
using the Cytometric Bead Array (CBA) Cell Signalling Flex Set System. 
A significant reduction in the concentration of all chemokines/ cytokines was 
found in the old following Candin injection compared with the young (Mann 
Whitney p<0.5) for all measured concentrations. Error bars show the SEM.
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5.10 Discussion
In this chapter we have investigated potential mechanisms for the apparent 
reduction in the number of lymphocytes present at the site of immune 
responses in the old. This could be representative of either reduced 
recruitment of cells to the site or reduced activation of cells recruited to the 
skin due to an altered cutaneous microenvironment. The production of 
chemokines and cytokines at the site of the immune response is crucial for 
coordination of immune responses, in particular for the initial recruitment of 
effector memory T cells, their activation in the skin and then down-regulation 
in order to enable resolution. Multiple cell types within the skin produce an 
array of chemokines and cytokines many of which have pleiotropic effects 
creating a complex milieu. Many cytokines and chemokines interact with each 
other and so it is difficult to assertain the precise role of individual factors 
when studying them in isolation in vitro.
We initially investigated whether circulating memory T cells from the 
peripheral blood had any detectable changes in skin homing phenotype. 
Circulating memory T cells can be divided in to tissue-specific subsets based 
on their expression of adhesion molecules and chemokine receptors. Effector 
memory T cells that are specialised for entry in to the skin are characterised 
by the expression of cutaneous lymphocyte antigen (CLA), the ligand for E- 
selectin. We have demonstrated that there is no change in the percentage of 
CLA expression both on the total lymphocyte population and also on the 
memory CD45RO-I-CD4+ T cell population in the young and old. There is 
evidence to suggest that CLA positive cells are a population of cells that do 
not undergo immunosenescence in that although a decrease in CD45RA and 
CD28 expression has been found for CD3+ CLA- cells, there was no change 
in expression of these markers in the CLA+ T cell population. Furthermore, 
telomere length did not shorten in the CLA+ T cell population but shortened in 
the CLA- T cell population^°°.
We have also shown that there is no difference in the percentage of CLA-f- T 
cells that produce IFN-y in response to overnight stimulation with antigen in 
vitro in the young and old, suggesting that function of the CLA+CD4+ T cells is
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not significantly impaired in the old. It is of interest that differences in CLA 
expression were seen for memory T cells of different antigenic specificities 
were seen in both the young and old. It is thought that naïve lymphocytes 
acquire tissue-specific tropism during the primary immune response. This is 
thought to occur within secondary lymphoid tissue associated with a particular 
tissue in which exposure to antigen has occurred^^. This is supported by 
studies that have demonstrated that circulating T lymphocytes specific for 
cutaneous allergens have high levels of CLA expression^°\
All of the young volunteers in this study had received BCG vaccine, 
administered percutaneously, whereas none of the old individuals had been 
vaccinated. The old individuals in this study were likely to have developed 
immunity to the PPD antigen due to the exposure of both respiratory and 
gastrointestinal tract mucosa to environmental mycobacteria. It could 
therefore be predicted that there would be increased CLA expression on PPD- 
specific T lymphocytes in the young group due to administration of the antigen 
through the skin during vaccination. However, no difference was found in 
CLA expression on PPD specific CD4+Tlymphocytes in the young and old 
groups. Increased CLA expression was found for Candida specific CD4+ T 
lymphocytes in both the young and old. This is possibly due to the repeated 
cutaneous exposure and/or colonisation of the skin with Candida, allowing for 
maintenance of skin-specific homing memory T cell population for this 
antigen.
In addition to CLA, the chemokine receptors CCR4 and CCR10 have been 
proposed as critical mediators of skin specific T lymphocyte homing in 
humans and mice. We did not identify any differences in the expression of 
CCR4 expression on CLA+ T lymphocytes in the young and old. In addition, 
the expression of CCL17 and CCL27, the ligands for CCR4 and CCR10 
respectively was also the same in the young and old.
We were unable to assess for CCR10 expression on peripheral blood 
lymphocytes due to the lack of a commercially available monoclonal antibody. 
It is unlikely however that a difference in the expression of CCR10 in the old is
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responsible for the observed reduced immune response. CCR10 is only 
expressed on around 28% of CLA+ memory T lymphocytes and virtually all 
CCR10+ CD4+ T lymphocytes also express CCR4^^^. Whereas CCL17 (the 
ligand for CCR4) expression is found predominantly on dermal venules, 
CCL27 (the ligand for CCR10) is produced mainly by kératinocytes®^. Thus 
while the CCR4-CCL17 axis is likely to be critical in our model, where 
infiltration of cells is predominantly dermal, the role of CCR10- CCL27 
chemokine axis is likely to be redundant in that very few cells are seen to 
infiltrate the epidermis where the majority of CCL27 is expressed.
We did not identify any change in the expression of CD11a in the total 
lymphocyte population and also CD4+CLA+ T lymphocytes in young and old 
individuals. CD11a is a subunit of LFA-1, essential for the adhesion of T 
lymphocytes to the endothelium via binding to ICAM-1- expression of which is 
up regulated in inflamed skin. Both mouse®°^ and human studies®^® have 
shown increase in LFA-1 expression on memory T cells with ageing and we 
would therefore have expected an increase in LFA-1 expression on T 
lymphocytes within the CLA positive (memory) T lymphocyte population. 
Differences in this study may reflect the fact that we were studying a healthy 
aging group of individuals without significant co-morbidity. However, in elderly 
humans there is also evidence for diminished cell-cell binding due to altered 
activation of LFA-1 It is therefore possible that in spite of normal levels of 
LFA-1 in our old group there may be loss of function.
Although we have excluded changes in the expression of specific skin-homing 
receptor expression on peripheral blood CD4-t- memory T lymphocytes as a 
reason for reduced lymphocyte numbers in the old, we have identified a 
reduction in the percentage of CLA+ T cells expressing CXCR3. Although 
not tissue-specific, CXCR3 is thought to be an important skin homing 
receptor®^®, supported by the observations that a significant subset of CXCR3 
positive CD4-I- T lymphocytes also express the skin-specific receptor CCR4^^® 
and that skin derived cells (kératinocytes and monocytes) are able to produce 
the ligands for CXCR3^®^. Thus, a reduction in the expression of CXCR3 on
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CLA+ T lymphocytes may explain the reduction in lymphocyte numbers at the 
site of antigenic challenge in the old.
In contrast to our findings in humans, murine studies using ageing mice have 
identified increase in CXCR3 expression (in addition to multiple other 
chemokine receptors) on peripheral blood CD4+ T cells associated with 
increased migratory capacity to migrate in response to CXCR3 ligands^°®. We 
did not identify any changes in the migratory capacity of CXCR3+ 
lymphocytes from old individuals in this study although this may reflect the 
limitations of the in vitro assay used. CXCR3 expression in the CLA+ T 
lymphocyte subset has not been previously investigated in humans, however 
increased CXCR3 expression on naïve subset of cells with ageing has been 
demonstrated and the authors propose that this may result in the 
inappropriate migration of naïve cells to unorthodox locations^°^. Previous 
studies in mice have shown increased production of the ligands for CXCR3 
with ageing^°®’^ ° .^ In this study the levels of IP-10 measured in young and old 
blister fluid were similar however we did not measure the concentrations of 
the other ligands for CXCR3 (MIG and l-TAC).
CXCR3 also thought to be important for cellular retention at sites of chronic 
inflammation such as rheumatoid arthritis^^° and chronic liver disease^^® with 
up regulation of the receptor on T lymphocytes at sites of chronic 
inflammation. The role of CXCR3 in cellular retention during an acute 
inflammatory response is unknown, however a reduction in CXCR3 
expression in the old may indicate there is impaired T cell retention at sites of 
inflammation in the old. CXCR3 is thought to be up regulated on activated T 
cells^^V The T lymphocytes derived from PBMCs in our study were not 
activated and so we cannot conclude if any differences are present in receptor 
expression at the sites of inflammation where T cells are likely to be activated.
In this study we also identified a possible reduction in the percentage of 
CCR8-I-CLA+ T lymphocytes in the peripheral blood, however this population 
was extremely small in both young and old individuals (less than 5% of T 
cells) making the accurate analysis of this subset of cells difficult. It has been
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demonstrated that the majority of T cells in human skin express the CCR8 
receptor and respond to CCL1 and it has been proposed that the CCL1-CCR8 
chemokine axis provides a mechanism for homeostatic T cell traffic in the 
skin®®. Similar levels of CCL1 were found in blisters induced over normal skin 
in the young and old, indicating that the old do not have deficient CCL1 
production. No increases in the blister fluid concentrations of CCL1 were 
seen at Day 3 and 7 following Candin injection, suggesting that CCL1 has a 
role in homeostasis rather than in acute inflammation. We did not investigate 
the expression of CCR8 on lymphocytes resident in normal skin although we 
have demonstrated that there is no difference in the number of resident CD4+ 
and CD8+ T cells in young and old skin (Chapter 4).
We next went on to investigate whether any detectable changes present in 
cytokines produced as part of the acute phase response could be responsible 
for the reduced clinical and cellular response to antigen injection in the old. 
Variable levels of cytokine and chemokine production were seen in the young 
volunteers with poor correlation between clinical response and production of 
chemokine. The reasons for this are unclear. This may have been due to the 
small number of individuals tested. During acute inflammation, inflammatory 
mediators are not only produced but also consumed during the response and 
it is possible that individual variation in the balance between consumption and 
production of cytokine may have resulted in the observed variety of 
concentrations measured. Certain cytokines and chemokines are known to be 
labile and sensitive to freeze/ thaw cycles and this may have resulted in 
inconsistent deterioration in the samples. All of our blister fluid samples were 
frozen at -80°C immediately after they had been spun down in order to pellet 
the blister cells and the samples were only frozen and defrosted on one 
occasion. However, there was some variation in the time taken following 
aspiration of the blister fluid from the volunteer and freezing the sample that 
may have resulted in variations between samples. All samples were analysed 
for chemokine/cytokine levels in one run in order to minimise variation 
between runs. Certain chemokines were present in high concentrations after 
the injection of saline in to the skin. The induction of blisters in addition to the
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introduction of a needle in to the skin is likely to be traumatic and may induce 
the non-specific release of chemokines.
A reduction in the mean levels of IFN-ywas observed. The injection of IFN-yin 
to the skin of young humans has been shown to increase ICAM -1 expression 
on endothelial cells and kératinocytes with a corresponding infiltration of 
lymphocytes in to the skin^^^. In addition IFN-y is thought to play an important 
role in the activation of monocytes/ macrophages with increased TNF-a 
production, expression of MHC class II molecules and enhanced monocyte 
antigen presenting function. In mice, reduced transcription of MHC Class II on 
macrophages in response to IFN-y with ageing has been demonstrated^^^. 
The effects of ageing in humans on the response to IFN-y injection have also 
been investigated in a previous study. This demonstrated a reduced 
accumulation of monocytes in addition to reduced HLA-DR expression on 
kéra t i nocy tes^^Thus, both a reduction in the production of IFN-y in old skin 
in addition to reduced responsiveness to IFN-y may result in the observed 
reduction in lymphocyte numbers and immune responses seen in our old 
individuals.
IFN-y is predominantly made by memory Th1 effector T cells present in the 
skin at the site of antigen injection following antigen presentation. Our data 
indicates that this may be true in our model in that very little IFN-y was found 
in blister fluid following the injection of saline, thus indicating that IFN-y 
production is dependent on the injection of an antigen rather than due to 
trauma alone.
A significant reduction in the levels of TNF-a was found in old skin following 
Candin injection compared with the young. In addition to IFN-y, TNF-a 
production is also thought to be important in the initiation of immune 
responses in the skin. It also is likely to have a pathophysiological role in the 
development of inflammatory skin diseases as highlighted by the recent 
successful use of biologies targeting TNF for the treatment of diseases such 
as psoriasis^^^. It is secreted by a variety of cells in including monocytes and
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macrophages, T cells, fibroblasts and endothelial cells. Increased serum 
levels of TNF have been consistently reported in old mice and humans^^®’^ ^^ , 
seen in association with increased TNF production by leukocytes after LPS 
stimulation in vitro^^^. It is therefore of interest that in our study reduced 
quantities of TNF-a were produced at the site of Candin injection in the old. It 
has been proposed that increased levels of TNF production may be beneficial, 
by compensating for reduced IL-2 production in the old^^®. However, 
circulating TNF induces a catabolic state and has been shown to be 
associated with increased frailty in the old in addition to increased risk of 
diseases such as dementia, coronary vascular disease and atherosclerosis^^®. 
Studies investigating serum cytokine levels during acute pneumonia however 
have found reduced levels of TNF-a in addition to IL-8 and MIP 1a in the 
old®^°, indicating an impaired production of TNF in response to pathogens in 
the old.
TNF is also required for the maturation of DC and has been shown to have a 
role in promoting the differentiation of CD144- monocytes into cells with 
dendritic cell phenotype^^V Injection of TNF-a intradermally in to humans has 
been shown to induce the migration of Langerhans cells from the epidermis 
and this has been shown to be impaired in the old^ ®®. In mouse studies, 
reduced migration to lymph nodes has been shown in ageing mice following 
TNF injection®^^. Studies on monocytes/macrophages and whole blood have 
shown reduced production of TNF-a after stimulation with LPS in old 
humans®^® and mice®^ ®. In addition, a recent study has shown reduced 
production of TNF by macrophages following stimulation in vitro with Candida 
antigen in mice® '^ .^ These studies indicate that there may be an impaired 
production of TNF-a by monocytes and macrophages with ageing. Reduced 
production of TNF-a by monocytes in our old group may therefore explain the 
observed reduction in immune responses. The effects of ageing on 
monocytes, macrophages and dendritic cells in our old and young groups are 
investigated in Chapter 6.
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The observed reduction in clinical response in the old may also be explained 
by a reduction in TNF-a levels in the old. TNF is thought to induce both 
vasodilatation and increased capillary permeability contributing to both the 
degree of erythema and induration at the site of the immune response 
respectively. Both of these parameters are included in the clinical score used 
in our model. In the young and old groups however, levels of TNF did not 
correlate with the clinical score observed suggesting that additional factors are 
involved in producing the observed clinical response in the skin. TNF also 
stimulates endothelial cells to increased expression of E-selectin, ICAM-1 and 
VCAM^°\ promoting leukocyte adherence and therefore reduction in TNF 
production in old may explain reduced recruitment of lymphocytes in to the 
skin.
TNF also has anti-inflammatory effects and it has been proposed that TNF 
may have an important role in limiting tissue damage during systemic 
infection. TNF receptors belong to a superfamily of death receptors and are 
thought to induce apoptosis in kératinocytes and leukocytes during cutaneous 
inflammation^^^'^^®. Previous studies have shown increased sensitivity in the 
old to TNF induced T cell apoptosis^^^'^^^, indicating that any TNF present at 
the site may have more effective anti-inflammatory effects in the old compared 
with the young, reducing the inflammatory response in the skin. The 
inflammatory effects of TNF can be limited by the production of soluble 
receptors that compete for binding of TNF on cell surfaces. Increased 
production of TNF receptors has been shown in the old^^® and may also 
account for the reduced measured levels of TNF in the old group in this study.
Following initiation of the immune response in the skin the production of 
chemokines/cytokines such as MCP-1, MIP-1a, RANTES and IL8 by various 
cell types is then crucial in order to allow for amplification of the response by 
recruitment of cells to the site and also local activation of cells. (Table 1.2 in 
introduction.) The production of these mediators is thought to be dependent 
on the activation of various cell types by IFN-y and TNF-a^^^. MCP-1, MIP-1a, 
RANTES and IL8 can all be produced by monocytes upon activation and also
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serve to regulate their responses^°. However, resident skin cells also play a 
significant role in the production of chemokines in order to mediate T 
lymphocyte recruitment during inflammation. Activated kératinocytes, 
endothelial cells and dendritic cells have also been shown to produce IP-10, 
MCP-1, IL-8 and RANTES. In addition, dendritic cells have also been shown 
to produce MIP-1a and fibroblasts MCP-1
A significant reduction in the levels of MCP-1, MIP-1a, RANTES and ILS was 
found in the old compared with the young in this study, potentially resulting in 
a reduction in activation and recruitment of monocytes/macrophages, 
neutrophils ^^and lymphocytes^^^^^ during immune responses in the old 
group. The reduced production of these mediators may be reflective of the 
observed reduced levels of lFN-7^ ^®’^ ^  ^ and TNF-a found in this study. 
However, previous studies have indicated an increased production of MIP-1a, 
RANTES from peripheral blood monocytes and T lymphocytes in in
the old, highlighting the need for in vivo investigation of immune responses. 
The previously observed senescence of both fibroblasts and kératinocytes in 
old skin^^ may also explain in part the observed reduction in the production of 
chemokines in response to antigen injection.
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6. Innate Immunity and initiation of the 
immune response in the skin- the 
effects of ageing on macrophages and 
dendritic cells.
6.1 Introduction
Although a clinical response to the intradermal injection of antigen is only 
seen in those with prior immunity, suggesting that antigen-specific cell 
mediated response plays a key role in the DTH response to injection of 
antigen, the initial response to antigen in the skin may depend on non-specific 
immune responses via the innate immune pathway. Previous studies have 
indeed indicated that cellular infiltration into the skin during the course of the 
DTH response is diphasic with an initial infiltration of cells involved in innate 
immunity that occurs in non-sensitised subjects and then second specific peak 
seen only in those who have prior immunity to the antigen. Around 4-6 hours 
after antigen injection neutrophils are seen to infiltrate in to the skin, followed 
by macrophages that reach peak numbers at around 24 hours. It is only after 
48 hours that the predominant cell type seen in the skin is the T 
lymphocyte®^’^ .
The innate immune system plays an essential role in the first line of defence 
against pathogens. Ageing is associated with a breakdown in the epithelial 
barrier to pathogens provided by the skin, placing increased demands on the 
innate immune system in the old. Whilst in the past attention has focused on 
adaptive immunity as a cause for immunosenescence, recent work has 
indicated that cells of the innate immune system are also affected by 
advancing age including monocytes/macrophages, neutrophils, and NKT 
cells.
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Our work has demonstrated a reduction in the numbers of lymphocytes 
present at the site of the DTH response from early time-points, in addition to a 
reduction in the concentrations of the acute inflammatory mediators TNF-a 
and IFN-y, suggestive of a defect in the initiation of the immune response in 
the old. In particular the reduction of cytokines/ chemokines TNF, MCP-1, 
MIP 1a in blister fluid may indicate potential defects in monocyte/macrophage 
function as these factors are both produced by monocytes but also have an 
important role to play in their activation^®^ . Monocytes mediate linkage 
between innate and adaptive immune system. While they act as crucial 
effector cells of the innate immune system, mediating the generation of 
inflammation, following the engulfment of foreign bodies they are also able to 
act as APCs in the context of MHC. Thus, a defect in monocytes with ageing 
may result in both reduced innate responses and a subsequent reduction in 
adaptive immune responses.
Dendritic cells also have an important role to play in the coordination of innate 
and adaptive immune responses. In normal, uninflammed skin, two main 
types of dendritic cell are observed; epidermal DCs, known as Langerhans 
cells, and dermal dendritic cells. DCs within the skin participate in the 
generation of a rapid innate immune response by reacting to invading 
pathogens and generating pro-inflammatory cytokines. Unlike macrophages, 
DCs are also uniquely able to stimulate naïve T cells and are essential for 
primary immune responses to antigens and the development of immune 
memory responses.
According to the classical model of the DTH response, DCs also play a role in 
the initiation of the secondary immune memory responses. After processing 
antigen, they are thought to migrate to the draining lymph node and stimulate 
the proliferation of effector memory T cells that subsequently migrate to the 
site of inflammation in the skin, resulting in the accumulation of antigen- 
specific T lymphocytes at the site of immune challenge. The observation that 
there is a large population of effector memory T cells within the skin with 
diverse receptor repertoire suggests however that local presentation of
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antigen within the skin may be sufficient to initiate secondary immune 
responses in the skin^^®°. Ageing has been shown to have various effects on 
dendritic cells including reduced phagocytosis and antigen presenting 
function. In the skin the effects of ageing, in particular photoageing, on 
Langerhans cells has been widely reported. Currently, however, available 
literature on the role of dermal dendritic cells and the effects of ageing on this 
is very limited.
In this chapter we compared the numbers and function of macrophage and 
dendritic cells following Candin injection in the young and old.
6.2 Proportions of cell types present at early time points in young and 
old.
In order to establish what proportions of cells were seen at an early time point 
in the young and old, skin suction blisters were induced at 24 hours after 
injection of Candida antigen in 3 old and 3 young volunteers. Blister cells were 
analysed using flow cytometry and the proportions of cells were calculated 
according to the forward and side-scatter profiles of the cells (Figure 6.5) Of 
interest, there was a reduced proportion of neutrophils in the old (Figure 6.1), 
indicating that there may be defective recruitment of neutrophils to the site. 
This did not reach statistical significance.
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FIGURE 6.1 Percentages of lymphocytes, monocytes and neutrophils 
present in the SB cell population In young and old.
Percentages of different cell types present in skin suction blister fluid were 
determined using FSC/ SSC profiles on flow cytometry (Figure 6.5). Blisters 
were induced at 24 hours after Candin injection in to 3 young and 3 old 
individuals. A slight decrease in the percentage of neutrophils within the 
blister leukocyte cell population was observed, although this did not reach 
statistical significance (Mann Whitney p=0.1)
6.3 Monocyte and macrophage cell numbers within the skin
In view of the reduction in concentration of chemokines in the skin in the old 
thought to be important for the attraction of monocytes in to the skin, we next 
decided to investigate whether the observed reduction in chemokine 
concentration did indeed result in a reduction of numbers of monocytes and 
macrophages present within skin biopsies from old individuals taken at 
different time-points after the injection of Candin into the skin using 
immunohistological staining for common monocyte and macrophage markers.
6.3.1 Numbers of CD14+ cells In young and old skin biopsies following 
Candin Injection.
CD14 is commonly used for the immunohistological identification of 
macrophages within tissues such as the skin and is the common epitope 
expressed on both monocytes and macrophages but not DCs. CD14 acts as 
a receptor for microbial antigens such as LPS in addition to yeasts such as
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Candida. We therefore stained skin biopsies taken at 0, 1 ,3  and 7 days after 
Candin injection into the skin for CD14 expression in the young and old 
groups in order to identify monocytes and macrophages. 5 young and 5 old 
individuals had skin biopsies performed for each time point. GDI4+ cells 
were identified by light microscopy and counted. The 5 largest perivascular 
infiltrates per section were counted in addition to 5 representative interstitial 
fields and the mean cell number was calculated (photo plate 3). In normal 
skin, only small numbers of G D I4+ cells were seen and these were most 
commonly found around blood vessels. No significant difference in 
perivascular GD14+ cells was seen between young and old (Mann Whitney 
p=0.55).
In both young and old groups, an increase in the number of G D I4+ cells was 
seen in both dermal interstitial and perivascular tissue at 24 hours (Figure 6.2 
A+B). No significant difference was found between the number of G D I4+ 
cells in the young and old at the 24 hour time point (Mann Whitney p=1 
interstitial cells, Mann Whitney p=0.3 perivascular cells). In the young, there 
was then a decline in interstitial G D I4+ cells at Day 3 (Mean: 24.93 cells at 24 
hours, 6.53 cells at Day 3) (Figure 6.2A) with no further change in cell 
numbers at Day 7. In the old, although there was a small decrease in cell 
numbers at Day 3 and an apparent increase in cell numbers at Day 7 in the 
old, although this did not reach statistical significance (Wilcoxon ranked pairs 
test p>0.5)).
Perivascular GD14+ cells were then counted for biopsies taken each timepoint 
(Figure 6.28). At 24 hours, there was an increase in the numbers of 
perivascular G D I4+ cells in both the young and the old. Numbers of 
perivascular cells appeared to reach a peak at Day 3, declining at Day 7 
although differences in cell numbers between these timepoints failed to reach 
statistical significance (Wilcoxon ranked pairs test p>0.5 for both young and 
old paired time points). No difference was found between old and young for 
all time points studied (Mann Whitney p>0.5 for all time points).
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FIGURE 6.2 Numbers of Interstitial and perivascular CD14+ cells In 
young and old skin biopsies following Injection of Candin skin test
solution.
Skin biopsies were taken from the inner aspect of the forearm of young and old individuals at various time points from 
0-7 days at the site of injection of Candin skin test solution. A minimum of 5 individuals was tested in both young 
and old groups for all time points sampled. Fresh frozen sections were prepared from the skin biopsies and stained 
for GDI 4 using the indirect immunoperoxidase technique. For each section the mean cell count for either the 5 
largest perivascular infiltrates or 5 representative interstitial fields was calculated. Error bars in A and B are 
representative of the SEM. A. Numbers of interstitial GDI 4+ cells. In both young and old interstitial cell numbers 
reached a peak at 24 hours, although in the old there appeared to be a further increase in cell numbers at Day 7. 
There was no significant difference in the numbers of cells between the 2 groups (Mann Whitney p>0.5) B. 
Perivascular GDI 4+ cell numbers reached their peak between days 1 and 3. No significant difference in cell 
numbers was found for any time point in the young and old. G. No correlation was found between the numbers of 
perivascular GDI 4+ cells at day 3 and the clinical score in both young and old individuals (Spearman r=0.59 p=0.1)
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It is of interest that highest numbers of perivascular CD14+ cells were found 
around day 3, the time at which a peak clinical response is seen. 
Macrophages are known to produce TNF, thought to be in part responsible for 
vasodilation and increased vascular permeability contributing to erythema and 
induration as part of the clinical response, respectively. In view of the 
variability in clinical score and CD14+ cell counts in both young and old at Day 
3 in the old, the data was analysed for a correlation between clinical score and 
CD14+ cell count. This did not reach significance (Spearman r=0.59, p=0.1) 
(Figure 6.2B).
6.3.2 Numbers of CD68+ cells
As an additional marker for monocytes/macrophages skin biopsies from the 
young and old skin biopsies were also stained for CD68, also used widely to 
stain for monocytes and macrophages in tissues (Figure 6.3, Photo plate 3). 
As for CD14, in the young and old there was a peak number of interstitial cells 
at 24 hours, however there was only a relatively small reduction in numbers of 
cells at the Day 3 and Day 7 time points in the young compared with CD14. 
This may be due to the fact that CD68 is also expressed on other cell types 
including neutrophils, basophils, fibroblasts and large lymphocytes. No 
statistical difference in the numbers of CD68+ cells was identified between 
young and old for all time points studied (Mann Whitney p>0.5 for all time 
points) apart from in normal skin where there was a significant increase in the 
number of interstitial CD68+cells in the old (Mann Whitney p=0.01). The 
reasons for this are unclear but may be reflective of an increased number of 
non-macrophage CD68-»- cells in old skin.
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FIGURE 6.3 Numbers of interstitial and perivascular CD68+ cells in 
young and old skin biopsies following injection of Candin skin test 
solution.
Skin biopsies were taken from the inner aspect of the forearm of young and 
old individuals at various time points from 0-7 days at the site of injection of 
Candin skin test solution. A minimum of 5 individuals was tested in both 
young and old groups for all time points sampled. Fresh frozen sections were 
prepared from the skin biopsies and stained for CD68 using the indirect 
immunoperoxidase technique. For each section the mean cell count for either 
the 5 largest perivascular infiltrates or 5 representative interstitial fields was 
calculated. Error bars in A and B are representative of the SEM. A. Numbers 
of interstitial CD68+ cells. In both young and old interstitial cell numbers 
reached a peak at 24 hours. No significant difference in cell numbers was 
found between the young and old groups. B. Numbers of perivascular CD68+ 
cells. Numbers of cells reached a peak at around 3 days. No significant 
difference in cell numbers was found between the young and old groups.
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PHOTO PLATE 3. Skin biopsies stained for CD14+ and CD68+ cells at 
Day 3.
Skin biopsies were taken from the inner aspect of the forearm of young and 
old individuals at various time points from 0-7 days at the site of injection of 
Candin skin test solution. Fresh frozen sections were prepared from the skin 
biopsies and stained for CD68 and CD14 using the indirect 
immunoperoxidase technique. Skin sections shown are taken from 2 young 
individuals at Day 3 following candin injection who had good clinical 
responses to skin testing.
1. CD68 staining in skin section at low power (X10 magnification). 
Perivascular infiltrate circled.
2. CD68 staining within a perivascular infiltrate circled in 1. (x40 
magnification).
3. Interstitial CD68+ cells (X40 magnification).
4. CD14 staining in skin section at low power (X10 magnification). 
Perivascular infiltrate circled.
5. CD14 staining within a perivascular infiltrate circled in 1. (x40 
magnification).
6. Interstitial CD14+ cells (X40 magnification).
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6.4 Activation of CD14+ monocytes at the site of the immune response
6.4.1 Expression of HLA DR, CD40, CD80, CD86 on G D I4+ monocytes
The reduced concentration of TNF, MCP-1 and MIP1 may also result in 
reduced monocyte activation. Monocytes are known to upregulate several 
surface receptors upon activation including HLA DR and the costimulatory 
receptors CD40, CD80 and CD86. In order to assess whether in the old there 
is reduced activation of monocytes, suction blisters were induced at 24 hours 
after Candin injection. The monocyte population within the blister cells was 
then identified on the basis of forward/side scatter profile in addition to the 
expression of CD14 on flow cytometric analysis. (Figure 6.5). Cells were also 
stained with HLA-DR, CD40, CD80 and CD86 and the MFI and percentage 
positive gated cell population was calculated for each receptor (Figure 6.5).
In both young and old individuals, the expression of HLA DR, CD40, CD80 
and CD86 on CD14+CD4+ monocytes derived from blister cells was 
significantly higher than in the blood-derived population (Wilcoxon ranked 
pairs test P<0.05 for all receptors) (Figure 6.4), indicating activation of 
monocytes derived from the skin at the site of the immune response. No 
significant difference in receptor expression was found between young and 
old (Mann Whitney p>0.05 for all receptors) respectively.
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FIGURE 6.4 Expression of surface markers on CD14+ monocytes 
Isolated from peripheral blood (PBMCs) and skin suction blisters 
induced following Candin injection Expression of receptors on CD14-I- 
monocytes isolated from skin suction blisters and PBMCs at 24 hours 
following the injection of Candin skin test solution in 3 old and 3 young 
volunteers. Skin suction blister cells were stained with antibodies to CD14 in 
addition to either HLA-DR, CD40, CD80 or CD86 and analysed by flow 
cytometry. The CD14+ monocyte population was identified on the basis of 
forward scatter and staining with CD14 (Figure 6.5). Cell populations with 
positive staining for the different receptors were then identified within the 
CD14+ monocyte population.
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FIGURE 6.5 Expression of surface markers on CD14+ monocytes 
isolated from peripheral blood (PBMCs) and skin suction blisters 
induced following Candin injection (flow cytometry).
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FIGURE 6.5 Expression of surface markers on CD14+ monocytes 
Isolated from peripheral blood (PBMCs) and skin suction blisters 
induced following Candin injection (flow cytometry).
Skin suction blister cells isolated from blisters induced at 24 hours after 
Candin injection in addition to PBMCs were stained with antibodies to CD14 
and HLA-DR, CD40, CD80, CD86, CD206 or ILT3 and analysed by flow 
cytometry. Representative dot plots and histograms are shown in this figure. 
Different cell populations were initially identified on the the basis of forward 
and side scatter profiles (A) and gates were defined for lymphocytes (R1), 
monocytes (R2) and neutrophils (R3). The CD14-H monocyte population was 
then identified on the basis of forward scatter, the R2 gate (green) and 
staining with CD14 on FL3 (R4) (B). Cell populations within the CD14-H 
monocyte population (R4 gate) with positive staining for the different receptors 
were then identified. Histograms were constructed and the Median 
Fluorescent Intensity (MFI) calculated. The percentage of CD14+ monocytes 
positive for the different receptors (M2 gate) (E) was also calculated based on 
isotype controls for blister cells(C) and PMBCs (D). This flow cytometry work 
was performed in collaboration with Dr. Leonie Taams, Lecturer in 
Immunology, King’s College London School of Medicine, London.
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6.4.2 Expression of the inhibitory receptor ILT3
In addition to pro-inflammatory effects, certain groups of monocytes are 
known to have tolerogenic properties including those expressing the 
Immunoglobulin- like transcript 3 (ILT3) receptor^"^®. We therefore investigated 
the expression of ILT3 on CD14+CD4+ monocytes (Figure 6.6). No 
significant difference was found for skin suction blister derived CD14+ 
monocytes between young and old groups (Mann Whitney p=1), suggesting 
that the reduced clinical and cellular response in the old is not secondary to 
an active suppression by monocytes. However, there was an increase in 
expression of ILT3 in skin- derived monocytes compared with the peripheral 
blood in both the young and old groups (Wilcoxon ranked pair test p=0.03 for 
both groups).
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FIGURE 6.6 Expression of ILT3 receptor In CD14+ monocytes on skin 
suction blisters and PBMCs at 24 hours after injection of Candin.
The expression of ILT3 receptor on CD14+ monocytes isolated from skin 
suction blisters and PBMCs at 24 hours following the injection of Candin skin 
test solution in 3 old and 3 young volunteers was assessed. Skin suction 
blister cells were stained with fluorescent labelled antibodies to CD14 in 
addition to ILT3 and analysed by flow cytometry (Figure 6.5). The CD14+ 
monocyte population was identified on the basis of forward scatter and 
staining with CD14. Cell populations with positive staining for ILT3 receptors 
were then identified within the CD14+ monocyte population. No difference in 
CD14+ monocyte expression of ILT3 was found between the young and old 
groups (Mann Whitney p=1)
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6.4.3 Expression of the mannose binding lectin protein receptor CD206
Previous studies have identified a reduction in the phagocytic capacity of 
monocytes in the old^^®. The expression of the mannose binding receptor 
CD206 is thought to correlate with the phagocytic capacity of monocytes and 
is upregulated on activated cells '^^V Comparison of CD206 expression on 
CD4+CD14+ monocytes in young and old did not reveal any significant 
difference between the two groups (Mann Whitney p=0.5) (Figure 6.7).
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FIGURE 6.7 Expression of CD206 receptor in CD14+ monocytes on skin 
suction blisters and PBMCs at 24 hours after injection of Candin.
Expression of CD206 receptor on CD14+ monocytes isolated from skin
suction blisters and PBMCs at 24 hours following the injection of Candin skin 
test solution was studied in 3 old and 3 young volunteers. Skin suction blister 
cells were stained with fluorescent labelled antibodies to CD14 in addition to 
CD206 and analysed by flow cytometry (Figure 6.5). The CD14+ monocyte 
population was identified on the basis of forward scatter and staining with 
CD14. Cell populations with positive staining for CD206 receptors were then 
identified within the CD14+ monocyte population.
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6.5 Dendritic cells
6.5.1 CD1 a expression
CD1a is expressed on Langerhans cells within the epidermis and also a small 
subset of dermal dendritic cells within the dermis. CD1 proteins bind to lipids 
to form antigen complexes that contact T cell receptors and activate T cells '^^^ 
Biopsies of normal skin from the forearm of both young and old individuals 
were analysed for CD1a expression after staining with a CD1a monoclonal 
antibody, using the immunoperoxidase technique. Transverse sections of the 
skin revealed CD1a+ dendritic shaped cells predominantly in the basal and 
suprabasal levels of the epidermis in both young and old individuals, 
consistent with Langerhans cells. (Photo plate 4). CD1a+ dendritic cell 
numbers were counted within the epidermis and the number of cells per unit 
area was calculated. No significant difference in the number of CD1a positive 
cells per unit area was found between young and old group (Mann Whitney 
p=0.28), however thinning of the epidermis with reduced rete ridges was 
observed in several individuals the old group (Photo plate 4 (3)) and thus it is 
possible that the actual total numbers of cells may have been reduced in the 
old. Normal skin also contained very small numbers of CD1a positive cells 
mainly around blood vessels in the young and old. These cells had less 
prominent dendrites (Photo plate 4 (2)) and therefore may be reflective of 
either migrating Langerhans cells with altered morphology compared with their 
epidermal counterparts or dermal dendritic cells.
Following injection of intradermal Candin, increased levels of CD1a positive 
cells were observed within the dermis at 24 hours in the young and old 
individuals (Photo plate 4(4+5)). GDI a cells were seen predominantly around 
blood vessels, although a few cells with dendritic morphology were also seen 
within interstitial areas. Unfortunately, the precise quantification of the 
numbers of CD1a+ cells around blood vessels was not possible due to lack of 
clarity of the staining. However, subjective qualitative analysis of stained skin 
biopsies indicated that in both the young and old there was an increase in 
dermal CD1a+ cells up to Day 7, the latest time point studied.
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In the young group, CD1a+ cells were counted in the epidermis and the 
number of cells per unit area was calculated for normal skin in addition to 
biopsies taken at 1,3 and 7 days. No change in the numbers of CD1a+ cells 
per unit area could be detected between any of the time points (Kruskall 
Wallis test p>0.5).
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PHOTO PLATE 4. CD1a staining in young and old skin biopsies
Skin biopsies were taken from the inner aspect of the forearm of young and 
old individuals at various time points from 0-7 days at the site of injection of 
Candin skin test solution. Fresh frozen sections were prepared from the skin 
biopsies and stained for CD1a as a marker for dendritic cells using the indirect 
immunoperoxidase technique. Nuclear fast red was used as a nuclear 
counterstain.
1. CD1a staining in young individual (X20 magnification) showing CD1a+ 
Langerhans cells in epidermis (black arrow) and dermal CD1a+ cells 
(red arrow).
2. CD1a positive cells in dermis (arrowed) (X40 magnification) in young 
individual. The cells have reduced dendritic processes compared with 
those seen in the epidermis in 1.
3. CD1a positive cells in epidermis (black arrow) and dermis (red arrow) 
in old individual with thinned epidermis (X40 magnification).
4. CD1a staining (X10 magnification) in skin biopsy from young individual 
at 24 hours following Candin skin testing.
5. CD1a staining (X10 magnification) in skin biopsy from young individual 
at 7 days following Candin skin testing showing increased perivascular 
CD 1a staining (arrowed) compared with the 24 hour time point shown 
in 4.
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6.5.2 HLA-DR expression
In order for antigen to be presented to T lymphocytes, the injected material 
such as PPD or Candin first needs to be ingested by dendritic cells and 
broken down small antigenic fragments. Upon digestion, small peptide 
fragments are bound to the peptide binding groove of MHC class II molecules 
(HLA-DR, HLA-DP and HLA-DQ) and are transported to the cell surface for 
display to CD44- T helper cells. Within the skin, HLA-DR is expressed on both 
dendritic cell populations such as Langerhans cells and dermal dendritic cells 
in addition to activated macrophages, endothelial cells^'^’^ ^ ’ '^^  ^ and 
lymphocytes. Previous studies have shown that in inflammatory skin diseases 
kératinocytes can also be induced to express HLA-DR^^ ^ ^.
HLA-DR expression within the skin was investigated as an indication of the 
number of cells present in the skin with potential antigen-presenting capacity. 
A reduction in HLA-DR expression would potentially result in reduced antigen 
presentation to T cells in the old and explain both the reduced numbers of 
CD4+ T cells in addition to a reduction in the number of antigen -specific cells 
present.
In normal skin biopsies from young and old individuals, HLA-DR expression 
was found to be present in both the epidermis and around blood vessels in the 
papillary dermis (photo plate 5 (1)). Positively staining cells within the 
epidermis had cellular morphology consistent with that of Langerhans cells . 
No difference in the extent of HLA-DR staining in young and old skin could be 
identified. It was not possible to accurately quantify HLA-DR 4- cells in the 
dermis however a qualitative increase in HLA-DR expression predominantly 
around blood vessels occurred within the skin at 24 hours and this was found 
to have increased further at both Day 3 and Day 7 in both the young and old 
groups (Photo plate 5 (2-k3)). There was a reduction in the expression of 
HLA-DR in old individuals who failed to develop any clinical response in the 
skin at both Days 3 and 7 (Photo plate 5 (4)).
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PHOTO PLATE 5 HLA-DR staining In young and old skin biopsies 
follow ing Candin skin testing.
Skin biopsies were taken from the inner aspect of the forearm of young and 
old individuals at various time points from 0-7 days at the site of injection of 
Candin skin test solution. Fresh frozen sections were prepared from the skin 
biopsies and stained for HLA-DR using an indirect immunoperoxidase 
technique. Nuclear fast red was used as a nuclear counterstain.
1. HLA-DR staining in normal skin (X10)
2. HLA-DR staining in a skin biopsy taken at day 3 following Candin 
injection (X10) in a representative young individual, showing increased 
perivascular staining compared with normal skin (arrowed).
3. HLA-DR staining in a skin biopsy taken at day 7 (X10) following Candin 
injection in a representative young individual showing further increase 
in HLA-DR staining around perivascular infiltrates compared with days 
3 and 7.
4. HLA-DR staining in an old individual at day 7 (X10) following Candin 
skin testing. The old individual had a poor clinical response to Candin 
injection in the skin. Reduced HLA-DR staining is seen compared with 
that seen in the young skin biopsy shown in 3.
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6.5.3 Dermal dendritic cells: DC-SIGN expression
The dermis is known to contain a group of HLA-DR + dendritic cells known as 
dermal dendritic cells. Unlike the epidermis, which contains a homologous 
population of DCs (Langerhans cells), dermal dendritic cells are rather 
heterogeneous in their phenotype, complicating the study of their role in 
immunity in the skin. As we have demonstrated, a small population of cells 
within the dermis stain with CD1a, possibly indicative of Langerhans cells 
either migrating from the skin to the lymphatics or migrating in to the skin from 
the peripheral blood. In addition, a small subset of cells that are CD1a 
positive, but Langerin (a marker specific for Langerhans cells) negative are 
also present in the dermis and these are thought to represent a population of 
dermal dendritic cells.
DC-SIGN is expressed on dermal dendritic cells but not Langerhans cells and 
was therefore used in this study to try to identify the dermal dendritic cell 
population within the skin. DC-SIGN is a C-type lectin and is thought to be 
involved in the internalization of antigens by dendritic cells in addition to 
contributing to the potency with which dendritic cells activate T cells^®.
Normal skin biopsies from both young and old individuals were found to 
contain DC-SIGN positive cells (Photo plate 6 (1)). As previously described, 
the cells were found within the papillary dermis predominantly around capillary 
vessels, although a few DC-SIGN-t- cells were also seen within the interstitium 
(Photo plate 6). Although there was a subjective, small increase in DC-SIGN 
expression seen at 24 hours in DC-SIGN expression in both the young and 
old, expression of DC-SIGN was then found to remain relatively constant 
throughout the course of the immune response with similar numbers of 
positive cells at all time points studied. The DC-SIGN+ cells remained in a 
predominantly perivascular location, around the edges of the perivascular 
infiltrates (Photo plate 6 (2-»-3)).
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PHOTO PLATE 6. DC-SIGN staining in skin biopsies
Skin biopsies were taken from the inner aspect of the forearm of young and 
old individuals at various time points from 0-7 days at the site of injection of 
Candin skin test solution. Fresh frozen sections were prepared from the skin 
biopsies and stained for DC-SIGN using the biotin/ streptavidin/ horseradish 
peroxidase technique. DC-SIGN expression was used to identify dermal 
dendritic cells. Nuclear fast red was used as a nuclear counterstain.
1. DC-SIGN staining in a representative normal skin biopsy (X10), 
showing DC-SIGN positive cells in a predominantly perivascular 
location (arrowed).
2. DC-SIGN staining in a representative skin biopsy (X10), taken at 7 
days following Candin skin testing in a young individual.
3. DC-SIGN positive cells in a perivascular infiltrate (X40) showing 
positively staining cells (arrowed) with dendritic morphology 
predominantly around the outer aspect of the cellular infiltration.
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6.6 Discussion
Monocytes/ macrophages play a key role during the initiation of DTH 
responses in the skin. Previous studies have shown that monocytes start to 
appear within the skin at around 12 hours, reaching a peak at around 24-48 
hours at which time they constitute around 80-90% of the cellular infiltrate®^’^ .^ 
These cells are likely to be important for the production of pro-inflammatory 
mediators, phagocytosis destruction of invading pathogens and antigen 
presentation to T lymphocytes within the skin. The finding that several key 
cytokines/ chemokines that are known to be produced by monocytes were 
reduced in our DTH model following candin injection (discussed in Chapter 5) 
led us to investigate whether a possible defect in monocytes/ macrophages 
within the skin in the old could explain the reduced immune responsiveness in 
ageing skin.
Firstly, the numbers of CD14-r- and CD68+ cells within the skin in old and 
young skin biopsies following the injection of Candin were compared. Both of 
these markers are known to identify monocytes/macrophages, although 
neither are entirely specific for these populations of cells. No significant 
difference in the numbers of cells could be identified in the young and old 
groups. Previous studies in the old have however identified reduced 
migratory capacity of macrophages, in particular a reduction in macrophage 
chemotactic response to complement derived factors^^^ although this 
conclusion was based on an in vitro assay rather than, as in this study, in vivo 
work.
As far as we are aware there have been no studies looking at the activation of 
monocytes within old skin during the course of a secondary immune 
response. Reduced production of monocyte- derived MIP-1a^^^ and MCP- 
within the skin have however been described and has also been found in 
our model, implying that there may be reduced activation of monocytes/ 
macrophages within the skin. In addition, reduced production of various 
cytokines including IL-6 and TNF-a have been described for monocytes from 
peripheral blood, in addition to reduced MHC class II expression. We were
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unable to identify any difference in the expression of a variety of activation 
markers on skin suction blisters in the young and old. However, only a limited 
number of samples were analysed. An unrepresentative old person who had a 
good clinical response to Candin injection possibly biased the results. 
Although no difference in the expression of HLA-DR was detected on CD14-H 
monocytes isolated from skin suction blisters, a potential overall decrease in 
MHC class II expression in old skin was seen within skin biopsies. It is of 
interest that an increase in HLA-DR expression has previously been reported 
in activated CD3-»- T lymphocytes in the old^^°. The reduction in HLA-DR 
expression seen in our samples may be representative of an overall reduction 
in lymphocyte cell numbers in the old, a reduction in cellular activation or 
reduction in antigen-presenting cell expression of this marker.
Both murine models^^"^ and in elderly humans with chronic bronchitis ^^ ®a 
reduction in the phagocytic capacity of macrophages has been identified. The 
mannose receptor CD206 is a type I transmembrance glycoprotein from a 
family of endocytic receptors that is expressed on macrophages in addition to 
fibroblasts and endothelial cells. Expression of CD206 on monocytes is 
thought to reflect their phagocytic capacity and is up regulated on activated 
cells. The increased expression of CD206 on monocytes in the skin 
compared with the blood in both the young and old indicates that monocytes 
recruited to the skin during the immune response are activated. No difference 
in CD206 expression on monocytes isolated from the young and old skin 
suction blisters could be identified. The role of phagocytosis promoting 
receptors and signal transduction components in ageing skin remain 
unknown.
The expression of the soluble Immunoglobulin- like transcript 3 (ILT3) receptor 
was also analysed on CD14+ monocytes. ILT3 is a cell surface molecule that 
is thought to be selectively expressed by myeloid antigen presenting cells 
such as monocytes, macrophages and dendritic cells^° and is thought to 
render the cells tolerogenic by reducing their expression of co-stimulatory 
molecules and inducing antigen-specific unresponsiveness in CD4+ T helper 
cells^'^°’^ ^\ ILT3 expression on monocytes is thought to be induced by a
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subset of regulatory T cells known as CD8+CD28- T suppressor cells^^^. 
Although we were unable to identify any difference in the expression of ILT3 
between young and old groups it is of interest that there was significantly 
higher expression of this receptor in the skin at the site of inflammation 
compared with peripheral blood. This indicates that there may be some role 
for this receptor in the control of immune responses in the skin
Skin biopsies taken from the young and old were also analysed for 
populations of antigen presenting cells at different time points following the 
injection of Candin. The DC system within the skin has great heterogeneity 
and complexity and the study of these populations is made difficult by 
overlapping expression of different cell surface markers. There are two main 
populations of DCs that occur in normal skin: epidermal langerhans cells 
characterized by the expression of Langerin/CD207 and DDCs in the dermis 
in humans characterized by the expression of DC-SIGN. CD1a was used as 
a marker for Langerhans cells in this study. CD1a is used commonly as a 
marker for Langerhans cells however a small subset of DDCs also express 
CD1a^^^. Dermal dendritic cells can also express CD14 used as a marker for 
monocytes in this study^^^. DC-SIGN distinguishes DDCs from other dermal 
populations although DC-SIGN can also be expressed by macrophages under 
certain conditions^^'^.
There is currently very little data on the relative contribution of different DC 
subsets in shaping the immune response. Further, although a significant 
amount of work on skin DCs has focused on LCs and migration in primary 
immune responses, in particular in response to the topical application of 
contact sensitizing agents, little data exists for role/migration of DCs in 
secondary immune responses in the skin. Although work on epidermal APCs 
such as Langerhans cells is likely to be relevant to the topical application of 
antigen, the investigation of dendritic cells derived within the dermis is equally 
important and it has been proposed that some skin diseases may begin in 
dermis via activation of DDCs^^^. Dermal dendritic cells have been 
demonstrated to be at least as potent as epidermal and peripheral blood 
derived DCs in their capacity to stimulate allogeneic resting T cells or
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providing accessory function to autologous T cells activated with SEB or 
PHA^se Furthermore, DDCs have been shown to be more potent than 
monocytes in their antigen presenting capacity^^^, suggesting that monocytes 
that are seen to infiltrate sites of DTH responses may not be the strongest 
ARC population present in the skin.
Both Langerhans cells and dermal dendritic cells are derived from CD34+ 
myeloid progenitor cells within the bone marrow. In humans, the subsequent 
differentiation of these cells is based on in vitro studies. Several precursors, 
including CD14+ monocytes, that can differentiate in to LCs in vitro have been 
described in peripheral blood following exposure to combinations of GM-CSF, 
TGF-p, TNF-a, IL4 and In addition, skin-resident CD14+ cells
have been shown to acquire features of LC when cultured with TGF^^®.
The majority of resident skin antigen presenting cells are present in immature 
state. Maturation of DCs is dependent on several signals including TNF 
production, T cell signals and stimulation of TLRs^®°. Maturation of DCs is 
necessary in order for them to change from immature antigen capturing cells 
to antigen presenting cells, allowing for development in adaptive immune 
responses. Although studies in mice have shown a reduction in TLR4 
expression on dendritic cells in old mice^^\ studies on monocyte derived DCs 
in humans has failed to confirm this finding^^^. Reduction in TNF levels seen 
in this study may also have an impact on DC maturation and may impact on 
ability to present antigen in skin in old.
Using transverse skin sections we were unable to determine any reduction in 
the number of CDIa cells within the epidermis during the course of the 
response. Previous studies have however reported a reduction of around 
20% of cells following either trauma or injection of cytokines TNF-a and IL-1p 
into the skin. Reduced migration of LCs in response to TNF have also been 
demonstrated in the old, however there was only a slight reduction and it is 
not clear whether there is redundancy, whether this relates to the intradermal
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injection of an antigen or whether LC migration is in fact important for the 
development of a DTH response in the skin.
Traditionally, epidermal sheets have been used for the analysis of numbers of 
Langerhans cells within the epidermis as this enables more accurate 
identification of individual cells. Although in our study only cell bodies and not 
dendrites were counted it is possible that some dendritic processes were 
counted as cells, resulting in an overestimation of the numbers of Langerhans 
cells present in the skin. It is however possible that in our model significant 
LC migration did not occur. To our knowledge there are no previous in vivo 
human models of secondary immune memory responses where responses of 
LCs to intradermal injection of antigen has been investigated. It is of interest 
that in Langerhans cell knock out mice there are enhanced DTH responses^®\ 
suggesting that LCs are not necessary for DTH responses in mice. In 
addition, a recent study has shown that in psoriasis, a chronic inflammatory 
skin condition, there is reduced LC migration^®^. The authors proposed that 
impaired migration may lead to enhanced responses due to localized antigen 
presentation in the skin.
Previous studies on ageing skin have identified a reduction in the absolute 
numbers of Langerhans cells within both photoprotected and photoaged non­
inflammed skin. We did not identify any changes in the numbers of 
Langerhans cells in normal skin in the young and old individuals that were 
used in this study. However, epidermal thinning was observed in the old 
group, with smaller overall area of epidermis. Thus, there may have been a 
proportional reduction in LC numbers that we did not detect. It is of interest, 
however that several studies have reported no changes in the numbers of LCs 
within the skin in the old and certain mouse models have shown an increase 
in LC numbers in photoprotected skin. Changes in LC morphology have also 
been identified in the old with reduced dendritic processes^'^V This was not 
observed in our study.
An increase in the number of CD1a-r- cells was seen in this study around 
blood vessels during the course of an immune response in the skin. This has
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also been reported by previous investigators in addition to an increase in the 
total numbers of CD1a+ cells in the skin. This observation may be 
representative of migration of DCs into the skin from the peripheral blood 
during an inflammatory response in order to enable the repopulation of the 
skin and may also allow for increased antigen presentation and amplification 
of the immune response. Alternatively, the increased number of CD1a+ cells 
may be reflective of the induction of CD1a expression on skin resident cells as 
a result of the local inflammatory milieu. In vitro, immature DCs express a 
variety of chemokine receptors including CCR1 ®^^ , the ligands for which are 
MIP-1a and RANTES. The levels of both of these chemokines are reduced in 
old skin and may result in the reduced recruitment of immature DCs during 
course of immune response in the old.
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7. Summary and future directions
In this thesis the effects of ageing on cutaneous immunity were investigated. 
In particular I investigated whether the reported reduction in DTH responses in 
the skin were as a result of a previously assumed overall decline in immune 
responses in the old or whether changes specific to the skin could account for 
observed reduction in clinical response to the injection of antigen in to the 
skin. Using bacterial, fungal and viral antigens it was possible to examine 
both clinical and cellular cutaneous responses in young and old skin. To 
perform these studies the complimentary techniques of skin suction blister 
induction and histological analysis of skin biopsies were used. The use of 
skin suction blisters enabled the isolation of lymphocytes and monocytes 
directly ex vivo from the site of the immune response that allowed for various 
phenotypic and functional characteristics to be assessed. In addition, the 
collection of blister fluid allowed for the quantification of the production of 
chemical mediators at the site of the response. Histological analysis of skin 
biopsies allowed for the identification and quantification of cells present at the 
site of the response and their location within the skin.
Only human models were used in order to study immune responses in the 
skin. Ethical and practical constraints in humans make in vivo investigation of 
the immune system difficult. However, there are several indications that the 
use of murine models to investigate cutaneous immunity may not accurately 
reflect humans. In particular, the differences in anatomical sites utilised for 
the study of DTH responses, the time course of the response and possible 
differences in lymphoid tissue involvement during recall responses. Further 
the use of mice to study ageing is also complicated by the vast difference in 
life expectancy between mice and humans and important differences in 
lymphocyte differentiation with ageing. We therefore felt justified in using 
human models alone for the purpose of this study.
The lack of homogeneity between individuals recuited for studies on ageing 
adds complexity to human studies. Previous studies investigating the effects
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of ageing on cutaneous immune responses have been performed on nursing 
home residents^®® with significant comorbidities and so the interpretation of 
this data is difficult in the context of defining change as a result of intrinsic 
ageing alone. A modified version of the SENIEUR protocol was employed in 
this work in order to reduce confounding factors due to associated significant 
comorbidity but without excluding significant numbers of old individuals. The 
aim of the SENIEUR protocol is to reduce confounding factors by excluding 
individuals with disease^^^’^ ^^ . However, it has been predicted that this 
protocol excludes over 90% of the aged population^^® and is therefore 
selecting individuals who are poorly representative of the ageing population as 
a whole. It is important that research can be utilised with a view to future 
therapeutic benefit. The modified version of the SENIEUR protocol used in 
this study was aimed at selecting a group of well- characterised healthy old 
individuals, representative of the ageing population as a whole.
We have made several novel observations. Firstly, we have identified a group 
of healthy old individuals who fail to develop a clinical response to the 
injection of antigen in the skin in spite of good peripheral blood responses to 
the antigen, implying that the reduced cutaneous response may not be 
reflective of a reduced global immunity to the antigen. This indicated that 
there may be a skin-specific defect in immunity that occurs with ageing. 
Secondly, the reduced clinical response in the skin is also accompanied by a 
reduced lymphocytic response. Importantly, in the old and the young the 
degree of clinical response was been shown to be proportional to the 
lymphocytic response at day 3, the peak of the clinical response, in addition to 
at day 7 when the peak of the lymphocytic response is observed. Additionally, 
the lymphocytes present at the site of the response in the old have reduced 
activation and proliferation markers with a reduced percentage of cells specific 
for the antigen injected. Thirdly a reduction in various pro-inflammatory 
cytokines and chemokines has been shown at the site of the immune 
response in the old, possibly indicative of defective initiation of the immune 
response.
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The observation that old individuals fail to develop a clinical response to the 
injection of antigen in spite of peripheral blood responses has potentially 
important implications for the use of skin testing. The Mantoux test is used 
widely to assess for both immunity to and potential infection with tuberculosis. 
This work suggests that cutaneous immune responses are not reflective of 
global immunity as a whole and therefore the use of skin testing as a way of 
assessing overall cell mediated immunity to certain antigens cannot be used 
in the old. The ability of PBMCs to proliferate in vitro in response to antigen 
was used as a measure of immune responsiveness to antigen in our young 
and old groups. It is possible that the simplified use of in vitro proliferation 
assays is not truly representative of systemic immune responses as a whole. 
However, in vitro proliferation assays require intact antigen presentation and 
lymphocytic responses in order for cellular proliferation to occur and this did 
not appear to be compromised in the old group.
The apparent dissociation between cutaneous and systemic immune 
responses in the old also suggests that there may be a skin-specific decline in 
immunity that occurs with ageing. This observation is supported by the 
observation that various skin cancers increase with age^^° whereas there is an 
improvement in atopic dermatitis^^^, an inflammatory skin disease. As far as 
we are aware there are no previous reports of an organ specific decline in 
immunity with ageing, suggesting that the skin may be unique in this aspect. 
In fact, many authors have reported an increase in inflammation with ageing- 
so called “inflammaging”, that is thought to explain the increase in several 
age-related diseases including ischaemic heart disease "^*" .^
The data from this work suggests that there may be various defects in 
immune responses that account for the reduction in cutaneous immunity with 
ageing. Successful cell mediated immune responses in the skin require 
initiation with recruitment of cells to the site of infection, localised proliferation 
of cells and then resolution with either emigration or apoptosis of the cells 
present at the site. A balance between these processes is crucial in order to 
mount an adequate immune response but also to prevent the development of
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pathology due to inappropriate persistent inflammation. Potential changes in 
cell-mediated immunity in ageing skin are highlighted in Figure 7.1.
Following the findings from this thesis three potential mechanisms are 
proposed that may account for the observed reduction in immunity:
1. Defective cellular recruitment/migration into the skin.
2. A defect in skin microenvironment such that immune responses are not 
supported.
3. Defective initiation of immune responses in the skin.
1. Defective cellular recruitment/migration into the skin.
The finding that there are reduced numbers of lymphocytes present at the site 
of the response in the skin in the old may indicate that there is defective 
migration of cells from the peripheral blood into the skin. Reduced numbers of 
CD4+ T lymphocytes were observed at all of the time points studied in the old, 
seen in association with a reduced clinical score. We investigated the 
expression of various cell surface receptors on lymphocytes, derived from 
peripheral blood in the young and old, thought to be important for cellular 
recruitment in to the skin. Although no difference in the expression of the key 
skin homing receptors CLA, CCR4 and C D IIa  was identified, we have 
identified a reduction in the expression of CXCR3 on CLA+ T cells in the old 
compared with the young.
It remains unclear as to whether the observed reduction in CXCR3 expression 
has an effect on the migratory capacity of cells in to the skin and if there is 
some redundancy in receptor expression. Very recent work, however, has 
suggested that whilst CXCR3 expression on T lymphocytes is important for 
responses to PPD antigen, the expression of CCR4 is important for responses 
to Candida^^. Thus, whilst a reduction in CXCR3 expression could explain 
the observed reduction in responsiveness to PPD antigen in the old, it may 
not account for the observations seen with Candida antigen. CXCR3 
expression is known to be upregulated on T lymphocytes at sites of 
inflammation^^° and it has been proposed that this may be an important 
mechanism for cellular retention. Future work to investigate
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CXCR3 expression on T lymphocytes within the skin at sites of inflammation 
in the young and old would be of interest as reduced cellular retention in the 
old may also explain the reduction in cell numbers. We did not identify any 
differences in the production of the ligands for the skin homing receptors 
(CCL17, CCL27, IP-10) in the old suggesting that defective production of skin 
homing chemokines is not the cause of reduced cellular infiltration.
In spite of expression of key receptors for migration in to the skin it is possible 
that there is an inherent problem with the functional capacity of lymphocytes 
to either attach to the endothelium or migrate across the endothelium. In this 
work we did not identify any difference in the ability of CLA-i- and total CD4+ 
lymphocytes to migrate in an in vitro transwell migration assay. This does not 
exclude the possibility that there is a defect in vivo, however a previous study 
looking at ability of cells to migrate across endothelium showed no difference 
between young and old individuals^®^, suggesting that transendothelial 
migration remains intact with ageing. Differences in the avidity of binding of 
the skin homing receptors to their ligands may also be affected by ageing. 
Further work is needed to the ability of young and old lymphocytes to bind to 
endothelium.
We did not investigate the endothelial expression of E-selectin and ICAM-1, 
the ligands for CLA and C D IIa  (LFA-1) receptors respectively, in this study. 
However, recent unpublished work in our laboratory performed on skin 
biopsies taken from the individuals investigated in this study has shown that 
there is a reduction in ICAM-1 expression and absent E-selectin expression at 
day 3 following injection of antigen in the old compared with the young. 
Changes in the expression of ligands such as E-selectin and ICAM-1 may 
result in defective recruitment by affecting cellular rolling, activation and 
adherence on endothelium. The reduction in HLA-DR expression seen in old 
skin in this study may also be reflective of a reduction in endothelial cell 
activation. In addition to LFA-1, the integrin VLA-4 is thought to be important 
for adhesion to endothelium through interaction with the ligand VCAM the 
expression of which is also up regulated in inflamed skin. The expression of
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VLA-4 on T lymphocytes in the peripheral blood was not investigated in this 
study.
There is limited evidence from previous studies to suggest that the expression 
of E-selectin, ICAM-1 and VCAM is altered in ageing skin. A previous study of 
wound healing in humans has indicated that there is an altered inflammatory 
response and endothelial cell adhesion molecule profile in old skin with a 
delay in lymphocyte and monocyte infiltration in to the skin associated with 
increased early expression of E-selectin but delayed endothelial expression of 
ICAM-1 and VCAM-1^®. Altered expression of ICAM-1 in response to IFN-y 
has also been seen in basal cell carcinomas^®^, a common form of cutaneous 
neoplasia in the old. In future work it would be of interest to investigate 
whether similar changes were present in an antigen-driven model of 
inflammation in old skin.
Changes in the blood supply to the skin could also account for a reduction in 
cellular recruitment seen in the old. Certain changes to the cutaneous 
vasculature are well documented in old and are outlined in the
introduction, although marked variability in vasculature has been reported 
depending on the site investigated and the degree of photo-exposure^^°. In 
this study, although there was an overall reduction in the numbers of 
lymphocytes seen within perivascular infiltrates, the actual number of 
perivascular infiltrates was not significantly different between the young and 
old groups. This indicates that there was not a marked reduction in the actual 
number of dermal blood vessels in the old individuals studied. The degree of 
erythema and induration seen as part of the clinical response at the test site is 
dependent on both blood flow and vasodilatation. Changes in these 
parameters could potentially explain the reduced or absent clinical response 
in the old and in future it would be of interest to assess this using laser 
Doppler technology, previously employed to assess the Mantoux test 
response in the skin in young individuals^^^.
215
It is possible that there is defective immunosurveillance in old skin. The 
trafficking of lymphocytes through the skin may not only be important for 
detecting potential pathogens but may also have an important role in 
preventing skin neoplasias. The CCL1/ CCR8 axis has been demonstrated to 
be important for cutaneous immunosurveillance®^. We did not detect any 
difference in the levels of CCL1 in blister fluid from blisters induced over either 
normal skin, following saline injection or after Candin injection, suggesting that 
CCL1 may not be involved in acute inflammatory responses. A possible 
reduction in CCR8 expression on CLA+ peripheral blood T lymphocytes was 
found although the population of cells analysed was too small population to 
draw definite conclusions. As the majority of CLA+CCR8+ lymphocytes are 
found in the skin it would be useful to analyse this population in young and old 
either by staining skin biopsies or analysing cells from skin suction blisters.
2. Defect in the skin microenvironment.
In spite of the apparent reduction in the numbers of CD4+ lymphocytes 
present at the site of the immune response in the skin a significant reduction 
in other cell types including CD8+ lymphocytes and monocytes was not seen. 
Although it is possible that there there is a CD4+ T lymphocyte- specific defect 
in migration in to the skin, the finding of similar numbers of other cell types 
suggests that changes in cellular recruitment into the skin alone cannot 
completely explain the observed reduction in immune responses in the old. 
One possible explanation is that the local microenvironment of the skin is 
unable to support or maintain immune responses once cells have migrated to 
the site of the response.
Our laboratory has previously shown that during the course of the Mantoux 
Test response the expansion of CD4-i- T lymphocytes is dependent on the 
localised proliferation of cells within the skin rather than ongoing recruitment 
from the peripheral blood®®. This conclusion is supported by several 
observations; that the cells in the skin express high levels of the proliferation 
marker Ki67, that they bear the same clonality of T cell receptor and that no 
detectable changes in cellular proliferation or activation occur in the peripheral 
blood during the course of the immune response. It is therefore possible that
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although there is initial recruitment of CD4+ lymphocytes into the skin in the 
old these cells are unable to become activated and proliferate locally resulting 
in reduced expansion of the CD4+ lymphocyte population.
Using the skin suction blister technique, we have demonstrated that CD4+ 
lymphocytes examined directly ex v/Vo from the site of the immune response 
in the old have reduced expression of CD69, suggesting reduced cellular 
activation, and Ki67, indicating that fewer cells are proliferating at the site. In 
particular, the finding that there are reduced percentages of antigen specific T 
lymphocytes in the old may reflect the inability of this cell population to expand 
within the skin in the old.
At present, little is known about the effects of ageing on cytokine/ chemokine 
production in humans and studies on their production have produced varying 
and conflicting results. This may be reflective of the different study 
populations selected and the nature of the assays used to assess chemokine 
and cytokine production. In vivo studies in mice and humans have 
investigated the results of intradermal injection of different chemokines and 
cytokines in to the skin, however the cutaneous response to infection is likely 
to activate production of numerous chemokines making the interpretation of 
these studies difficult. The use of skin suction blister fluid analysis in this 
study allowed for the quantification of multiple chemokines and cytokines at 
the site of an evolving immune response.
We have identified reduced concentrations of various pro-inflammatory 
mediators in the blister fluid from blisters induced over the site of immune 
responses to Candida in the old. The reduction in concentrations of TNF-a 
and IFN-y could be explained by the lack of T lymphocyte numbers and 
activation in that both are produced by activated T lymphocytes. Both of 
these mediators also have an important role to play in the amplification of the 
immune response. TNF not only acts to increase blood flow and vascular 
permeability but also to increase the recruitment of T lymphocytes to the site 
of inflammation by increasing the expression of E-selectin, ICAM-1 and
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VCAM-1 on the endothelial cell surface^°\ Thus a reduction of TNF 
production in the skin could explain the observed clinical response and 
reduced number of lymphocytes in the old. However, a reduction in TNF 
levels is unlikely to be the sole reason for reduced responses in the old in that 
in the few old individuals who did have a good clinical and cellular response to 
the injection of antigen low concentrations of TNF were measured in the 
blister fluid.
It is also possible that there is active suppression of immune responses in the 
skin in old individuals. Recent interest in a subgroup of T lymphocytes with 
ability to suppress the immune response known as suppressor or regulatory T 
cells. Of interest this group of cells expressing CD25 receptor are enriched in 
skin homing receptors including CLA, CCR4 and CCR8 ®^® while they are 
relatively depleted in gut homing receptor expression^®^’^ °^. CD4+CD25+ 
suppressor cells isolated from cord blood are deficient in CCR4 expression 
and it is therefore possible that CCR4+CD25+CLA+Ts cells may be generated 
in the periphery after birth in response to skin-associated antigens^^\ The 
peripheral generation of T regs is also supported by previous work from our 
laboratory^^\ An increase in the number of circulating peripheral regulatory T 
cells has been reported in the old^^^. It is therefore possible that, with ageing, 
there is a progressive accumulation of regulatory T cells with suppressive 
properties that are specific for cutaneous antigens that result in diminished 
responses in the skin. Future work studying the role of these cells during 
acute inflammatory responses in both the young and old would be of interest. 
Other potential mechanisms of active suppression such as IL-10 production 
and expression of the inhibitory receptor ILT3 on monocytes were investigated 
but did not show any differences between the young and old groups.
Although we have not detected a reduction in the functional capacity of T 
lymphocytes isolated from peripheral blood in the old it is possible that the 
function of lymphocytes recruited into the skin is impaired. A process known 
as replicative senescence, where there is loss of T cell telomere length due to 
cellular replication with subsequent apoptosis, is thought to prevent over­
expansion and inappropriate inflammation in normal skin. This process is
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unlikely to place restraints on the development of immune responses in the 
young. However, in the old it is known that both CD4 and CD8 subsets of T 
cells have significantly shorter telomere lengths^°"^ and therefore cutaneous T 
cell telomere shortening may result in diminished immune responsiveness due 
to limited replicative potential of T cells. Although, to a certain extent telomere 
length can be restored by the cellular induction of telomerase, previous work 
from our group has shown that the production of IFN-a within the skin at the 
site of an immune response has an inhibitory effect on this enzyme®®. Ageing 
cells may also have a reduced capacity to induce telomerase^®^, placing 
further limitations on the replicative potential of ageing T lymphocytes. Future 
work to study the effects of ageing on telomere erosion, telomerase 
inducibility and IFN-a production during an acute immune response in the skin 
would help to clarify whether the reported reduction in telomere length in 
ageing lymphocytes has an effect on cell-mediated responses in the skin.
It may be possible to induce telomerase in ageing cells^ ®®. Gene therapy 
studies on cells in culture have demonstrated that the process of replicative 
senescence can be retarded by the manipulation of telomerase. Gene 
transduction with the catalytic component of human telomerase (hTERT) was 
performed on a variety of skin-derived cells including human fibroblasts, 
epithelial cells and keratinocytes^®\ Introduction of hTERT led to unlimited 
proliferation, telomere length stabilisation and normalisation of function of the 
cell populations studied. Similar results found for HIV-specific CD84- cells 
from individuals with HIV. This type of treatment has been proposed as 
potential therapeutic target not only for HIV but also as a means of enhancing 
viral immunity and responses to vaccines in the old^®\
3. Defect in the initiation of the immune response.
Innate immune responses are critical for the initiation of immune responses in 
the skin and are required for effective adaptive immune responses to 
develop®^®. Antigenic infection of the skin is thought initially to result in the 
activation of resident innate immune cells such as Langerhans cells, dermal 
dendritic cells and monocytes through various mechanisms including Toll-like
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receptors, surface bound immunoglobulin and exposure to pro-inflammatory 
cytokines such as IL-1 and TNF-a released by kératinocytes and dendritic 
cells in response to epithelial trauma.
We were unable to detect any significant differences between the young and 
old in the numbers of antigen presenting cells in the skin as determined by 
CD1a and DC-SIGN expression. However, a possible reduction in HLA-DR 
expression was seen indicating that antigen presenting function in the skin in 
the old may have been compromised with reduced activation of dendritic cells. 
There is currently conflicting evidence regarding the effects of ageing on 
antigen presention by dendritic cells, with reports of both reduced and 
enhanced antigen presenting capacity in the old^^^’^ ^^ . Future work using the 
skin suction blister technique to extract antigen-presenting cells from the site 
of a dynamic immune response may permit a better understanding of the 
antigen presenting capacity of cells within the skin in the old.
Plasmacytoid dendritic cells (PDCs), derived from lymphoid progenitors, may 
also have an important role in antigen presentation in the skin. They are 
present in very small numbers in normal skin, however large numbers of 
PDCs have been found to be present in allergic contact dermatitis^^"^, 
psoriasis^^^ and cutaneous lupus erythematosis^^®. The role of PDCs in DTH 
responses is unknown and is currently under investigation in our laboratory. 
PDCs produce IFN-a, known not only to inhibit telomerase within the skin®® 
but also to have an important role in anti-viral responses. In particular, IFN-a 
has been shown to induce virus specific CD4+ cells within the peripheral 
blood to express the skin homing marker CLA®^ .^
Monocytes play an important role in the skin in both local antigen presentation 
in addition to the production of pro-inflammatory mediators. The reduction in 
levels of TNF, MIP- 1a, MCP-1 and RANTES raises the possibility that there 
is a defect in monocytes in ageing skin in that all of these cytokines/ 
chemokines are produced by monocytes and are also responsible for 
monocyte activation. Defective production of monocyte- derived chemokines
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may also impact on lymphocyte recruitment in to the skin as a previous study 
in humans has shown that the injection of MIP-1a results in upregulation of E- 
selectin on endothelium^^V We were unable to identify any significant change 
in either the numbers of monocytes in skin or their activation in the old. 
However only small numbers of old individuals were studied, some of whom 
had good immune responses in the skin, and so the individuals recruited in 
this study may not have been representative of the old population as a whole. 
It is also possible that in spite of the expression of normal levels of monocyte 
activation markers on skin-derived monocytes in our study there was a defect 
in the ability of these cells to produce chemokines. This requires further 
investigation.
In addition to acute inflammatory responses to pathogens, macrophages are 
also thought to have an important role in wound healing. It is well recognised 
that wound healing in the old is impaired which results in considerable 
morbidity and also financial costs in healthcare provision^^®. MCP-1 has been 
found to be important in both mice and humans for effective wound healing by 
influencing macrophage effector state^^^’^ ^'^^^. Defective macrophage 
function may therefore be responsible for deterioration in wound healing with 
ageing. Identification of the mechanism for the reduced production of 
monocyte- derived chemokines, as found in our study, may therefore help to 
provide therapeutic targets for improving not only cutaneous immunity but also 
wound healing in the old.
Although there is very limited information on the effects of ageing on toll-like 
receptor (TLR) expression in humans, murine studies have indicated that the 
expression of some toll- like receptors (TLRs) is reduced with ageing^^V The 
use of imidazoquinolones, such as Imiquimod, for the treatment of various 
cutaneous diseases including basal cell carcinomas and genital warts is 
currently increasing. Importantly, Imiquimod is used commonly in the old for 
the treatment of basal cell carcinomas and is thought to result in tumour 
clearance by inducing an inflammatory response in the skin^®°. Imiquimod is 
thought to work by stimulating the innate immune system via TLR7 and has
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been shown to induce the production of IFN-a^®°, TNF-a^®\ MIP-1a and MCP- 
1^°. It has also been shown to induce IFN-y production in T cells either 
directly or via T-cell receptor triggering^®^. It is therefore possible that a defect 
in cutaneous immunity in the old, resulting in diseases such as basal cell 
carcinoma, may be overcome by pharmaceutical methods. Future studies 
investigating whether the application of Imiquimod can overcome poor 
responsiveness to antigen in old using the models used in this thesis may 
provide clues regarding changes in innate immunity in ageing skin.
In conclusion, both reduced clinical and lymphocytic responses to antigen in 
old skin have been identified. The observed reduction in immunity in ageing 
skin may be multifactorial. However, a defect in the initiation of the response 
by the innate immune system would explain the reduction in the production of 
pro-inflammatory mediators, cellular activation and endothelial expression of 
ligands with a resulting reduction in lymphocyte recruitment and proliferation. 
The identification of a mechanism for the apparent skin-specific reduction in 
immunity seen in the old may in the future be able to identify therapeutic 
targets in order to selectively enhance cutaneous immunity.
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